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Abstract
Several domains of cognitive function show lower mean scores and increasing
variability with increasing age. Little is known about the biological mechanisms
underlying these changes. There is evidence, largely from animal studies, that
prolonged exposure to high levels of glucocorticoids is associated with (a) atrophy of
brain regions known to be essential for cognitive functioning, such as the
hippocampus, and (b) decrements in cognitive function with ageing. There are few
human studies examining these links. The studies in this thesis were aimed at testing
the hypotheses that elevated levels in Cortisol are associated with relative cognitive
impairment, with relative atrophy of the hippocampus and other brain regions, and
also with variations in the levels of brain metabolites, and also that cognitive
function is associated with brain size and metabolites. Additionally, measures of
glucose homeostasis (fasting glucose and glycosylated haemoglobin (HbAlc)) were
hypothesised to be negatively correlated with cognitive function. Ill healthy,
unmedicated men aged 65-70 were recruited. Subjects had blood taken for 9am,
2.30pm, and post-dexamethasone (0.25mg) Cortisol levels, fasting glucose, and
HbAlc, and did a battery of cognitive tests, including tests of 'premorbid'
intelligence, fluid intelligence, verbal and visuospatial memory and processing
speed. 100 of the subjects underwent two modalities of neuroimaging: (a) structural
magnetic resonance imaging, with intracranial area, hippocampus, temporal lobe and
frontal lobe volumes measured, and (b) magnetic resonance spectroscopy (MRS),
with N-acetylaspartate (NAA), choline (Cho) and creatine (Cr) levels measured.
Principal components analyses showed that a single component (designated the
'general cognitive factor') accounted for 51% of the variance in cognitive
performance; rotation yielded two correlated components representing fluid
intelligence / visuospatial memory tasks, and verbal memory tasks. Intracranial area
and several regional brain volumes correlated positively and significantly with
'premorbid' and fluid intelligence and visuospatial memory. Verbal memory and
verbal fluency did not correlate significantly with any brain volumes. Structural
equation modelling showed that the relationships between cognitive tests and brain
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volumes could best be summarised by a significant positive relationship between
overall brain size and the general cognitive factor (r=0.42, p<0.05), and not by
associations between individual tests and particular brain regions. Both NAA/Cr and
Cho/Cr ratios correlated positively with tests of verbal memory and a verbal memory
factor (e.g. NAA/Cr and Logical Memory: r=0.24, p<0.05). Cho/Cr ratios also
correlated positively with visuospatial memory (eg. Visual Reproduction: r=0.21,
p<0.05). There were several small but statistically significant correlations in the
predicted (negative) direction between brain volumes and Cortisol levels. Left
temporal lobe volumes correlated with 9am Cortisol (r=-0.22) and 2.30pm Cortisol
(r=-0.26), right temporal lobe volumes correlated with 9am Cortisol (r=-0.21), right
hippocampal volumes correlated with 9am Cortisol (r=-0.22) and post-
dexamethasone Cortisol (r=-0.24). These correlations were significant at p<0.05, 2-
tailed. There were no significant correlations between Cortisol measures and
metabolite ratios (from MRS). Correlations between Cortisol measures and cognitive
tests were largely in the predicted direction, though few of these correlations reached
conventional levels of statistical significance. The general cognitive factor and the
fluid / intelligence factor, adjusted for 'premorbid' intelligence, correlated
significantly and negatively with 9am Cortisol levels, at r=-0.23 (p=0.028, 2-tailed).
HbAlc was significantly negatively correlated with two measures of verbal memory,
but not with other cognitive tests (list-learning: r=-0.24, p=0.01; delayed paragraph
recall r=-0.31, p=0.018, 2-tailed). These results demonstrate that in healthy, elderly
men, overall brain size and metabolite ratios are significantly related to cognitive
ability. A possible mechanistic link between these two domains is variations in
Cortisol with ageing. The results of the present studies are supportive of the
hypothesis that elevated glucocorticoids are associated with ageing-related changes
in brain volumes, and, less clearly, cognitive function. Follow-up studies will help
determine whether Cortisol levels are predictive of worsening brain atrophy and
cognitive decline.
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Cognitive function, the brain and glucocorticoids
Chapter 1: General Introduction
Individuals differ widely in how their cognitive ability changes with ageing
(Christensen et al., 1999; National Research Council, 2000). Some develop the
severe loss of cognitive ability seen in the dementias, others show milder but
functionally significant degrees of cognitive impairment, and some exhibit very mild,
if any, decline in some abilities. These variations are important, as those with relative
preservation of cognitive function have a higher life expectancy and a higher quality
of life (Korten et al., 1999).
A current major focus of research is the search for biological correlates underlying
these important variations. Much of this work is aimed at discovering risk factors for
the dementias, but there is also a substantial effort to determine the correlates of
milder forms of cognitive impairment. In the last two decades various neuroimaging
techniques have grown into a key part of the search for biological correlates of
ageing-related cognitive decline, both in terms of an as yet unsuccessful method of
reliably diagnosing the dementias (Scheltens et al., 2002), and in basic research.
Elevated levels of glucocorticoid hormones have been hypothesised to cause
neuronal dysfunction, damage and eventual death, and to be an important cause of
cognitive impairment in older people (Seckl and Olsson, 1995). However, there are
many unresolved issues and few large studies in humans.
In this introductory chapter the issues involved in the measurement and
characterisation of cognitive ability will be discussed, followed by a general survey
of the literature on cognitive ageing. The background to the glucocorticoid
hypothesis of cognitive ageing is surveyed and other putative risk factors for ageing-
related cognitive decrements are also briefly reviewed.
Chapter 1: Cognitive function and brain volumes
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1.1 General issues in the study of cognitive abilities
1.1.1 Definitions
There are many overlapping definitions of the term "cognition". Common to most is
that cognition involves the storage and manipulation of information by the brain.
Under this broad definition terms such as 'reasoning', 'problem-solving', 'memory',
and so on, can be subsumed. In this thesis, operational definitions are used wherever
possible.
The concept of intelligence is related to cognition but is more involved with the
study of individual differences in cognitive abilities. Traditionally, delayed memory
is not part of tests used to assess intelligence. The term 'cognitive ability' is broadly
similar to intelligence, but implies the inclusion of a broader range of tests, for
example tests ofmemory, than the term 'intelligence' has traditionally implied.
1.1.2 Approaches to the study of cognitive function
As in many branches of the behavioural sciences, the study of cognitive function has
evolved into different domains or schools of thought, each with its own collection of
assumptions, experimental approaches, database and theoretical foci. Perhaps three
overlapping approaches can be identified: psychometric, neuropsychological and
cognitive / experimental (Table 1.1). These approaches are becoming increasingly
intertwined but important differences remain.
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Table 1.1: Approaches to the study of cognitive function
Approach Focus Example of test
Psychometric Individual differences in cognitive ability;
structure of these individual differences.





Neuropsychological Individual differences in cognitive ability
explicitly related to disorders of the brain.




Cognitive/Experimental Investigation of 'elements' of cognitive
function, previously with little reference to
the brain. The recently developed
subdivision of cognitive neuroscience is
more concerned with mapping of cognitive
functions to particular brain











The psychometric approach is largely concerned with the science ofmeasurement of
differences in cognitive ability, and the determination of the covariance structure of
cognitive abilities. This approach grew out from the development of intelligence
quotient (IQ) testing more than one hundred years ago and is still best exemplified by
the development of IQ-type tests and increasingly sophisticated methods of
understanding the underlying structure of performance on various cognitive tests, in
particular structural equation modelling (Deary, 2001a).
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A simple form of this question is as follows: how do performances on different
cognitive tests relate to one another? For example, is a person's performance on a
test of list-learning independent of his or her performance on test of visuospatial
problem-solving?
A major finding ofpsychometric psychology, first established by Spearman in 1904
(Spearman, 1904), is that performance on diverse cognitive tests correlates
positively. Factor analytic techniques have been used to summarise these data, and
have virtually universally found that the data are best summarised as a hierarchy of
increasingly general sources of test variance with a general factor accounting for
about 40-50% of the total test variance (Deary, 2001a). This general factor is
commonly termed 'g', for general intelligence (Carroll, 1993). This g factor has
several features which have added to its interest as an important variable and not just
a statistical abstraction, g appears to have validity as a positive predictor of academic
success, occupational success, health, and other real-life outcomes (Brody, 1992;
Jensen, 1998; Mackintosh, 1998). g is relatively stable, in that a person tends to
perform at around the same level when re-tested in the short term, and even several
decades later (Crawford et al., 2001; Deary et al., 2000b).
Two other features of this approach must be noted. First, the vast majority of studies
using the psychometric approach are on participants with brains which are largely
intact, ie. in healthy populations. Second, the psychometric approach is essentially
concerned with description and classification and no assumptions are made regarding
the neurobiological apparatus underlying the different tasks, though there are many
(largely speculative) correlative studies in the literature.
Chapter 1: Cognitive function and brain volumes
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Neuropsychological
The neuropsychological approach has grown out of the clinical need to quantify the
cognitive deficits occurring in the context of various injuries or diseases affecting the
brain. The main principles in this approach are that different cognitive functions are
performed by relatively discrete parts of the brain and that damage to particular brain
structures is thought to cause predictable and quantifiable changes in performance on
particular cognitive tests. As Sergent puts it, "More than a century of research has
firmly established that the brain is organized into distinct areas of relative functional
autonomy and specialization, and that local cerebral damage results in selective
impairment ofmental functions" (Sergent, 1988, quoted in (Salthouse, 2001a)). A
list of the cognitive domains under study would include attention, language, memory,
spatial abilities, executive function, working memory and general intellectual
functioning (Lezak, 1995; Woodruff-Pak, 1997; Boiler and Cappa, 2001).
In humans the hippocampus in the medial temporal lobe is known to be one of the
structures essential for the storage and recall of factual information (Squire et al.,
1993). One of the key advances in this field was provided by the study of a patient
with intractable epilepsy, HM, who had both medial temporal lobes excised for the
treatment of intractable epilepsy (Scoville and Milner, 1957). HM could then no
longer store or recall new factual information such as a list ofwords read to him just
minutes before. Thus his performance on delayed memory tasks is catastrophically
poor. However, his performance on tasks not requiring the delayed recall of
information was unaffected. He was even able to develop a high degree of skill in
certain motor tasks, such as mirror-drawing (though he had no conscious awareness
ofhaving practised these skills before). In addition, his scores on IQ tests appeared to
be largely unaffected. This led to the distinction between procedural and declarative
memory and also to the conclusion that medial temporal lobe structures are essential
for the normal functioning of declarative memory (Barba and Rieu, 2001).
Traditionally, the neuropsychological approach is orientated towards clinical
practice, such as in neurosurgery and in memory clinics. Most of the data informing
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this approach are thus derived from studies ofpatients with brain injuries or severe
brain diseases such as the dementias. The variations in performance tend to be much
larger than those seen in health or in milder, more diffuse disease processes. A
memory deficit described by a neuropsychologist may be almost absolute, as in the
case ofHM.
Neuropsychologists and psychometrically-orientated psychologists use similar tests
but the database, theoretical framework and goals and are not identical. A crude
analogy might be that a neuropsychologist is like a physiotherapist documenting why
a person who has had a stroke cannot walk whereas a psychometrician is like an
exercise physiologist studying the variables involved in determining the variance in a
group ofuniversity students' speed over 100 metres.
Cognitive / Experimental
The cognitive approach is broadly concerned with understanding how the brain
processes information; another way ofputting this would be teasing apart the
cognitive 'elements' involved in cognitive activities such as delayed memory. In the
definitive early textbook, Neisser characterised cognitive psychology as, "refer[ing]
to all processes by which the sensory input is transformed, reduced, elaborated,
stored, recovered and used." (Neisser, 1967). For example, cognitive psychologists
are interested in the multiple cognitive processes involved in reading.
A prominent example of this approach is the study ofworking memory, a construct
first proposed by Baddeley and Hitch (Baddeley and Hitch, 1974). According to
Baddeley and Logie, "working memory comprises multiple specialized components
of cognition that allow humans to comprehend and mentally represent their
immediate environment, to retain information about their immediate past experience,
to support the acquisition of new knowledge, to solve problems, and to formulate,
relate, and act on current goals." (Baddeley and Logie, 1999). There is a variety of
models ofworking memory, but most involve a central executive with two associated
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'slave' systems, a visuospatial sketchpad and a phonological loop. The phonological
loop is the theoretical subsystem which is responsible for maintaining in mind for
briefperiods small pieces of information such as a telephone number, which decay
rapidly without rehearsal. The central executive is brought into play when such
information has to be manipulated in some way. There is currently much debate as to
the exact configuration ofworking memory, which is perhaps unsurprising given the
sheer amount of cognitive work it is hypothesised to subserve (Shah and Miyake,
1999).
Increasingly, with the growth of technologies such as functional magnetic resonance
imaging, cognitive psychologists are also interested in discovering what structures
and systems in the brain are necessary for a certain task. This has led to the birth of
the discipline of cognitive neuroscience, which, "... aims to understand how
cognitive functions, and their manifestations in behaviour and subjective experience,
arise from the activity of the brain." (Rugg, 1997).
1.1.3 The classification of cognitive abilities: the hierarchical
model
A glance through a selection of the major neuroscience and psychology journals
quickly informs the reader that there is a confusion of terms and constructs in the
study of cognitive ability. Researchers use terms like short-term memory, executive
function, processing speed, attention, frontal lobe function, hippocampal function,
and so on. It is an interesting feature ofpsychological research that few acknowledge
that these terms represent a loose collection of ill-supported and ill-defined
constructs rather than well-established and quantifiable natural phenomena with
parallels in the natural sciences. In fact, there is no classification of cognitive abilities
which is in use for the majority of researchers studying cognitive abilities.
From an empirical perspective, one of the most consistent findings in any field of
cognitive ability research is that virtually all cognitive tests positively intercorrelate.
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Perhaps the clearest demonstration of this has been provided by Carroll, who
collected the data from 450 studies (selected for size and in which diverse tests had
been used) and subjected these data to factor analysis, by the same procedures for
each dataset (Carroll, 1993). Carroll found that all the tests intercorrelated positively.
That is, tests on apparently very different tasks, such as recalling geometric shapes or
knowing the correct pronunciation of irregularly-spelt words, vary together.
Typically the covariance among a battery of cognitive tests ranges from 40-60%, that
is, 40-60% of the variance is shared among the tests.
Performance on tests which are more similar to each other (eg. tests of abstract
reasoning) correlate more closely than with different types of tests (eg. tests of verbal
memory), though the correlation with g is usually higher. Because of this, Carroll
proposed the three-stratum model of cognitive abilities. At the top of the hierarchy is
g. In the second stratum is a variable number of group factors. The second stratum
factors are labelled according to the type of tests which tend to correlate more closely
together. In Carroll's model these factors are labelled fluid intelligence, crystallised
intelligence, general memory and learning, broad visual perception, broad auditory
perception, broad retrieval ability, broad cognitive speediness, and processing speed
(Carroll, 1993). There are other versions of the model, with fewer second stratum
factors; differences in versions of the model depend partly on the tests used and the
type of factor analytic procedures used. The third stratum is made up of the
individual test scores. Factor analysis and structural equation modelling studies have
supported the validity of this structure, and have also repeatedly refuted the main
alternative hypothetical structure of statistically separate cognitive components.
The hierarchical model finds that a raw test score results from a combination of
general variance, group factor variance, test-specific variance, and other (error)
variance. This is a very important finding because of the widespread use of cognitive
tests. However, the influence ofg on an individual test score is often not taken into
account.
Many researchers question the existence ofg and/or the hierarchical model.
Objections have been made on various grounds, including methodology, with
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criticisms directed at the selection of samples, and the use of factor analysis; the
conceptual basis g - for example, how can a brain thought to be composed of
functionally distinct modules give rise to a large general factor?; the social
undesirability of IQ; and the associations of a minority of IQ researchers with
eugenics (Gould, 1981; Neisser et al., 1996; Montagu, 1999). Interestingly, there are
very few empirically-based refutations of the existence ofg, in large-scale studies, at
least.
Perhaps the best-known semi-popular work arguing against a general factor in
intelligence is Howard Gardner's Frames ofMind (Gardner, 1993). In this book
Gardner puts forward the argument that there are 'multiple intelligences' which are
independent in each person. These are: visual/spatial, verbal/linguistic,
mathematical/logical, bodily/kinaesthetic, musical, intrapersonal, interpersonal. Of
these the first three are in the generally accepted area of study of cognitive ability
research. Although these ideas make intuitive sense, no empirical evidence has
emerged to support the idea that performance on these visual/spatial, verbal/linguistic
and mathematical/logical domains varies orthogonally (that is, showing no
correlation). However, there are clearly parallels between these 'intelligences' and
second-order factors commonly identified in the hierarchical model.
Some neuropsychologists continue to question the ideas ofg, or at least its
interpretation, and the hierarchical model (Das, 2002; Dodrill, 1997; Larrabee, 2000;
Pallier et al., 2000; Ardila et al., 2000; Ardila, 1999; Tremont et al., 1998b; Larrabee
et al., 1983; Woodruff-Pak, 1997). For example, Woodruff-Pak has claimed that,
"Intelligence tests do not really belong in the category ofneuropsychological
assessments, as the global IQ score is not associated with discrete brain function."
(Woodruff-Pak, 1997). Examples of case studies showing clear dissociations
between cognitive domains are often given, with HM as the prototypical example.
These dissociations do demonstrate that the hierarchical model in its original form
does not apply to every conceivable circumstance. In particular, where there is
discrete damage, performance on certain tests (which may or may not correspond to
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a group factor) might show dramatic decline. However, this does not mean that in
healthy populations the hierarchical model is invalid.
Objectors often confuse the concept ofg as an empirical reality with the assumption
that believers in g favour a monolithic explanation of brain function. However, the
idea that the brain is composed of an unknown number ofmodules performing
different processing tasks is not incompatible with idea ofg. g might reflect
important bottlenecks in the process, or there may be genetic or biological effects
that affect a large proportion of the processing modules (Anderson, 1992). In
addition, only 50% of the variance of a battery of cognitive tests is shared; the group
factors represent more specific clusters of variance and thus the hierarchical model
can readily accommodate the notion of theoretical modules or clusters ofmodules
(Deary, 2001a). As stated above, the psychometric approach is primarily concerned
with the accurate measurement and classification of cognitive function and not with
determining the underlying brain processes and structures responsible for cognitive
function.
1.1.4 Memory
Although performance on memory tasks is incorporated into the hierarchical model
of cognitive ability, memory has a prominent place in cognitive ageing research and
a brief overview of the field ofmemory research is presented here. Cognitive and
neuropsychological research over several decades in animals and humans has yielded
a broad consensus on a behavioural model ofmemory. Performance on memory
tasks is reliably separable with respect to the lengths of time involved, and also in the
type of information that is being stored. In terms of time, short-term memory can be
distinguished from long-term memory. Amnesic patients are characterised by their
inability to register and/or recall information beyond periods of a few seconds or
minutes, but commonly show normal performance on when asked immediately to
reproduce short strings of letters or numbers or other material (Cave and Squire,
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1992). Working memory is a construct which is related to short-term memory; it is
discussed below.
Long-term memory involves retaining information beyond a few minutes. It is
separable into "... conscious memory for facts and events and various forms of
nonconscious memory, including skill and habit learning, simple classical
conditioning, the phenomenon ofpriming, and other instances where memory is
expressed through performance rather than by recollection." (Squire et al., 1993).
Squire has called the conscious memory for facts, "declarative memory", and other
types ofmemory "nondeclarative memory". This declarative versus nondeclarative
dichotomy has been given other labels, such as explicit versus implicit.
A model ofmemory in humans which has gained widespread acceptance is that of
Schacter and Tulving (Schacter and Tulving, 1994). This is displayed in simplified
form in Table 1.2.






3. Semantic Generic, Factual, Knowledge
4. Primary Working memory, Short-term memory
5. Episodic Personal, Autobiographical, Event memory
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This model divides declarative memory into primary, semantic and episodic
categories. Semantic memory refers to general knowledge about the world and
episodic memory to events with a specific context in space and time. This distinction
has been made on the basis of the study of patients with different types of dementia,
in which, to some extent at least, some patients with severely impaired episodic
memory can acquire semantic knowledge, and vice versa (Squire et al., 1993;
Hodges and Graham, 2001).
In animals, parallels to the declarative versus non-declarative model can be found. In
the Morris water maze (Morris, 1981), rats are placed in a circular tank ofwater with
sheer walls and swim until they find a submerged platform which they mount. The
tank is in a room with some spatial cues on the walls, providing the rats with spatial
information. Rats learn in a few trials where the platform is and this can be measured
by the time from placement into the tank to mounting of the platform. Lesions to the
hippocampal system in rats and other animals severely disrupts or abolishes this type
of learning, but does not abolish simple classical conditioning, priming, or other
types of learning analogous to nondeclarative learning in humans. Thus, a broad
parallel between declarative memory in humans and spatial memory in animals has
been drawn (Cohen and Eichenbaum, 1994).
Research on memory has mainly been orientated towards describing the general
cognitive processes involved in memory tasks and the brain structures and systems
involved in these processes. Most of the individual differences research on memory
and g has focused on short-term memory and working memory, in which positive
associations with g are consistently found (Carroll, 1993; Conway et al., 2002).
However, less is known concerning performance on tests of delayed memory and g
in healthy populations. What research there is has shown positive associations, as
predicted by the hierarchical model (Salthouse, 2001a).
In the next section, sample studies from the literature on the relationships among
diverse cognitive tests are summarised.
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1.1.5 General cognitive ability and performance on
neuropsychological tests
In this section, the term 'neuropsychological tests' refers to tests which are used to
assess memory and other 'specific' cognitive abilities, as distinct from tests thought
to measure general cognitive ability.
Dozens of functions have been attributed to the frontal lobes, including working
memory, executive function, planning, reasoning, problem-solving, temporal
organisation of behaviour, selective inhibition of responses to immediate memory,
monitoring of function, and so on (Ardila et al., 2000; David, 1992). Amongst most
neuropsychologists the prevailing view has been that there is little relationship
between performance on standard tests of intelligence and tests of the various
constructs attributed to the frontal lobe listed above (Duncan et al., 1997; Damasio,
1985), at least in situations in which there is damage to the frontal lobes. Recently,
however, there have been increasing efforts to examine performance on tests of these
constructs in the context of general cognitive ability.
Frontal lobe function
Obonsawin and colleagues (Obonsawin et al., 2002) examined performance on
several tests of 'frontal lobe' function (verbal fluency, Modified Card Sorting Test,
Stroop test, Tower of London, cognitive estimates, paced auditory serial addition
task, and uses of common objects task) in relation to performance on performance on
a standard test of IQ, the Wechsler Adult Intelligence Scale-Revised (WAIS-R). The
subjects were 123 healthy individuals recruited from the community. All of the
frontal lobe tests correlated significantly with WAIS-R scores in the predicted
directions at between 0.24 and 0.63. The intercorrelations among the frontal lobe
tests were virtually all significant. When these intercorrelations were controlled for
WAIS-R scores very few significant correlations remained. This suggests that much
of the shared variance among the frontal lobe test scores is due to general cognitive
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ability and not a specific factor reflecting frontal lobe functioning. Principal
components analysis of the frontal lobe test scores yielded two factors accounting for
53% of the variance; all but the Modified Card Sorting Test scores loaded on the first
factor. Interestingly, loadings on the first correlated at 0.72 with WAIS-R scores. The
authors interpreted their findings as showing that in a healthy population, general
cognitive ability is the single most important determinant ofperformance on tests
designed to measure 'frontal lobe function'. Further doubt on the labelling of 'frontal
lobe' tests as such has emerged with functional magnetic resonance imaging (fMRI)
studies on subjects performing these tasks. Several of these studies have found that
during the performance of tasks such as card sorting and the Tower of London
several parts of the brain show activity, including the basal ganglia, thalamus and
cerebellum (Cabeza and Nyberg, 2000).
Working memory
Working memory is a construct that is characterised as an active system for
temporarily storing and manipulating information needed in the execution of
complex cognitive tasks (Baddeley and Wilson, 2002; Bright and Kopelman, 2001).
The working memory model incorporates a central executive served by two systems,
one holds verbal and acoustic information and the other visuospatial information;
recently Baddeley proposed the existence of another system: the 'episodic buffer',
which combines information in working memory and long-term memory into a
single representation (Baddeley, 2000). Studies ofworking memory have largely
been of the cognitive/experimental and neuropsychological approaches. Until fairly
recently working memory was not part of the vocabulary ofpsychometric
psychologists. Recently, there is a growing number of studies which have examined
correlations among individual differences in working memory tasks and measures of
general cognitive ability.
Larson and Saccuzzo (Larson and Saccuzzo, 1989) found a correlation of 0.5
between a working memory task called 'mental counters' and performance on
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Raven's Standard Progressive Matrices, a standard test of intelligence. In 1990
Kyllonen and Christal found correlations of 0.45 to 0.58 (these were all statistically
significant at p<0.01) between working memory tasks and tests of reasoning, which
are known to correlate highly with g (Kyllonen and Christal, 1990). The correlations
among the latent traits were even higher. They suggested that their results are
supportive of the hypothesis that individual differences in "working memory
capacity [are] primarily determined by individual differences in reasoning ability."
Engle and co-workers (Engle et al., 1999) asked 133 subjects to perform nominally
different types of tests: working memory tests, which they had selected as being the
best examples in the field, short-term memory tests including forward and backward
word-span, and fluid intelligence (Gf), using Raven's Standard Progressive Matrices
and the Cattell Culture Fair test. Performance on the working memory and short-term
memory tasks was correlated but structural equation modelling indicated that the best
model did indeed have separate factors for working memory and short-term memory.
The overall model showed that factor representing the shared variance between the
working memory factor and short term memory factors correlated at 0.29 with the Gf
factor (derived from the Raven's Standard Progressive Matrices and the Cattell
Culture Fair test), and the specific relationship between the working memory factor
and Gfwas 0.49. These results suggest that the variance on the working memory
tests closely corresponds to variance on the fluid intelligence tests.
Memory
Most studies looking at dementias and other forms of cognitive impairments will
include tests ofmemory in their batteries. These tests tend to involve presentation of
lists of words or pictures of shapes followed by requests that the subject recall the
material immediately and at defined intervals. As indicated above there is a
consistent positive relationship between the two constructs, but surprisingly studies
which measure both rarely measure this correlation.
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Rapport and co-workers (Rapport et al., 1997) studied the relationship between IQ as
measured by the WAIS-R and several memory tests, including immediate and
delayed paragraph recall and list-learning. Tests were administered twice, on
sessions two weeks apart. The Verbal Comprehension and Freedom from
Distractibility scores on the WAIS-R explained 42% of the variance in the memory
scores. Full scale IQ from the first session explained between 22% and 41% of the
variance in memory scores in the second session. A similar pattern was reported by
Salthouse and co-workers (Salthouse et al., 1996), who studied performance on a
variety of tests in 259 healthy subjects aged 18 to 94. They found multiple significant
positive intercorrelations, for example the Wisconsin Card Sorting Test, traditionally
a test of executive function, correlated at r=0.49 with the WAIS-R Block Design
subtest and at r=0.27 with the Rey Auditory-Verbal Learning Test (a test of
declarative memory).
Keenan and co-workers (Keenan et al., 1996b) analysed the relationship of the
WAIS-R Vocabulary scale to performance on a widely-used test of declarative
memory, the California Verbal Learning Test. Subjects were 82 healthy adults aged
16-95. In hierarchical multiple regression analyses Vocabulary scores accounted for
31% of the variance in memory scores. These studies are in keeping with the
hierarchical model and suggest that researchers cannot ignore the effects of general
cognitive ability when interpreting memory scores, particularly in relatively healthy
populations.
Chapter 1: Cognitive function and brain volumes
16
Cognitive function, the brain and glucocorticoids
1.1.6 Conclusions
Researchers studying cognition have generated a large number of terms to describe
aspects of cognitive function. Many of these terms have face validity; that is, it
seems reasonable to write about 'executive function' and 'speed ofprocessing'.
However, quite apart from frequent semantic overlapping, there is also the issue of
what empirical evidence there is to support the existence of a cognitive construct. As
Deary states, "Construct validity ... tell[s] us that there is only as good evidence for
the existence and usefulness of a construct as there is empirical evidence." (Deary,
2000)(p.l01). Many of the terms in widespread use fall short ofhaving achieved
construct validity.
For example, the term "hippocampal function" is in common use in studies on
memory in humans (Collie et al., 2002; Small et al., 2002). This term is sometimes
used interchangeably with constructs such as delayed declarative memory. However,
although certain memory tasks probably depend on a functioning hippocampus, the
extent to which performance on these tests actually reflects individual differences in
the functioning of the hippocampus is unknown. Intuitively, performance on most
cognitive tests would seem to depend on the correct functioning of several
hypothetical cognitive functions or operations involving multiple unknown brain
systems. For example, in an ostensibly simple test ofparagraph recall, the subject is
required to maintain attention on task instructions, understand these instructions and
keep them in mind, attend to the paragraph being read, retain this information, and so
on. Given the complexity and number of these cognitive operations it is hard to see
how, in absence of focal brain damage, one can confidently assert that the individual
differences in the function of the hippocampus is the only or even the most important
neurobiological variable and that this is reflected in test performance which is
orthogonal to other performances on other tests. This intuitive objection is bome out
empirically by the massive weight of evidence underlying the hierarchical model.
Some mapping of structure to function is possible when there is severe damage to a
structure; the best example of this is the link between hippocampal damage and
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deficits in declarative memory. Here there is not only focal brain damage but also a
change in cognitive performance which is considerably more severe than the types of
ranges seen in healthy populations. Therefore, the structure of the cognitive abilities
as described in the hierarchical model does not apply in all circumstances.
With most populations, however, cognitive tests show positive intercorrelations, and
failing to take this into account could lead to misinterpretation of cognitive test data.
This is a problem which might be particularly important in circumstances in which
cognitive change is relatively diffuse and/or subtle. This is a common scenario in
research in cognitive ageing, which is covered in the next section.
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1.2 Cognitive function and ageing: descriptive
studies
1.2.1 Introduction
Cognitive function changes with ageing. This is an extremely complex research issue
because (1) these changes occur on the background of individual differences in
cognitive abilities, (2) different abilities might change at different rates and with
different trajectories, (3) there are individual differences in the extent to which these
abilities change. Underlying some of these changes are universal changes in the
nervous system as well as the emergence of several more specific disease processes
with increasing age, which affect cognitive abilities in different ways.
The literature reflects not only the complexities outlined above but also the different
theoretical perspectives of the researchers. A variety ofmodels, some stated more
explicitly than others, influence the selection of tests, subject populations and
interpretations of results. An important divide is between studies which simply
document the scores on various tests across age ranges or across time and studies
which attempt to take account ofpre-morbid functioning and/or use statistical
techniques to look for more parsimonious explanations in terms of latent traits.
Studies also differ in terms of their aim. Some are concerned with the natural history
ofvarious cognitive abilities with ageing, whilst others are focused on identifying
patterns ofcognitive function which are predictive of dementias or which are
characteristic of dementias.
In this section of the introduction, an overview of study designs and concepts in
cognitive ageing research is provided, and then some of the key empirical literature
is reviewed.
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1.2.2 Study designs
Studies on humans of cognitive function in ageing are cross-sectional, longitudinal or
a combination of cross-sectional and longitudinal, cross-sequential (Deary, 2000;
Schaie and Hofer, 2001). Most studies are cross-sectional, using either a narrow
range of ages and comparing performance to 'norms' for the tests concerned, or
using a range of ages and examining the effects of age. The main problem with this
method is cohort effects, that is, older subjects have a different cultural and
educational history than younger subjects and it is impossible to attribute differences
in cognitive function to age alone. These studies are also affected by the finding that
IQ scores have risen in real terms over the past few decades (Flynn, 1987).
The next major category is longitudinal, in which a cohort of subjects is examined at
intervals over time. These studies are affected by several problems, including
practice effects, in which subjects' performances on tests improves with each wave
of analysis, non-random attrition, in which the survivors, particularly in older age
groups, tend to be healthier. Also, cohort and period effects affect interpretation, that
is, a group people born and developing in a certain period in history are subject to a
combination ofbiological, social and cultural influences which are unique to that
group ofpeople (Schaie and Hofer, 2001). Prominent examples of this type of study
include the Nun Study (Riley et al., 2002) and the MacArthur Studies of Successful
Aging (Chodosh et al., 2002).
The third main category is cross-sequential. This is a combination of cross-sectional
and longitudinal designs. An initial cohort is recruited, examined and followed up as
in the case of standard longitudinal designs. However, further cohorts are recruited at
each wave of examination, allowing for both cross-sectional and longitudinal
analyses, as well as allowing the researcher to examine cohort effects. The best
example is the Seattle Longitudinal Study (Schaie, 1994), which began in 1956 and
has involved over 5000 subjects. Initially, 500 subjects aged between 20 and 90 had
their cognitive ability tested with a set ofwell-validated tests from Thurstone's
primary mental abilities battery. These subjects were followed up every 7 years, with
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between 600 and 1000 new subjects from across the age range being recruited and
tested at each wave. This study has yielded important data on cognitive changes with
ageing, and also has demonstrated strong cohort effects: the most recently-recruited
cohort showed significantly better mean cognitive performance than the first cohort
(Schaie, 2000).
1.2.3 Concepts in cognitive ageing research
Salthouse (Salthouse, 2001b) recently posed the question of how one might explain
the well-documented age-related effects on a measure of free recall memory. Are
there "age-related effects on processes specific to free recall [?]" Or might there be
general effects of ageing affecting many different tasks, including free recall tasks?
As with general research on individual differences in cognitive function,
psychometric and neuropsychological approaches to cognitive ageing research can be
distinguished. The neuropsychological approach is based on the premises that, "...
age-related effects on different variables are attributable to discrete effects on
specific neuroanatomical structures, and each compromised function should
ultimately be traceable to a deficit in the structure or region specialized for that
function." (Salthouse, 2001a). The psychometric approach is concerned with
describing and analysing the covariance among cognitive tests in an attempt to
discover possible latent variables which explain the patterns observed.
Inhibition
A construct in common use in the cognitive ageing literature is that of inhibition.
This can be defined as, "... the ability to attend selectively to goal-related signals and
to ignore, and withhold ("inhibit"), habitual, or over-practised responses to other
stimuli..." (Rabbitt, 1997). The frontal theory of cognitive ageing is based on the
two basic premises that the frontal lobes show the greatest decrements in volume
with ageing, and that this is reflected in performance on 'frontal' tasks (West, 1996).
Chapter 1: Cognitive function and brain volumes
21
Cognitive function, the brain and glucocorticoids
Most other studies with the neuropsychological approach are focused on declarative
memory in relation to decrements in medial temporal lobe structures, particularly the
hippocampus. These studies are often aimed at attempting to predict individuals at
risk of dementia. Most studies centring on inhibition and/or memory do not address
the issue of possible shared variance among tests, or the influence of baseline
cognitive ability on test performance.
Fluid and crystallised intelligence
Two of the most important concepts in the psychometric approach are the distinction
between fluid and crystallised intelligence, and the role ofprocessing speed. The
ideas of fluid and crystallised intelligence were originated by Cattell in the early
1960s. Cattell's theory of intelligence (Cattell, 1963) is based on the idea that g is
separable into two components, fluid intelligence (Gf) and crystallised intelligence
(Gc). Cattell hypothesised that Gfwas biologically determined and showed decline
over the adult lifespan and that Gc reflected knowledge acquired over the lifespan
and did not show decline (Brody, 2000). Currently, Gf is seen as being equivalent to
fluid, abstract reasoning and Gc as being broadly equivalent to overall knowledge
(Mackintosh, 1998). This theory predated CarrolTs factor analytic survey; in that
framework Gf and Gc are first two second stratum factors, and are the two which are
most closely correlated with g.
Gf and Gc are very highly correlated in young adulthood, but start to show lower
correlations with ageing (Schaie, 1994). The Gf/Gc split in terms ofageing in
relatively healthy populations has broadly been supported by numerous large studies
(Kaufman, 2001). Some of these studies are reviewed below. However, there is a
paucity of studies applying these constructs to the prediction of dementia (Deary et
al., 1998) and little is known about their utility in that context.
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Processing speed
Related to the Gf/Gc model of cognitive ageing is Salthouse's processing speed
theory of cognitive ageing (Salthouse, 1985). This is centred on the proposal that
age-related decrements in the construct 'processing speed' account for much of the
variance in any age-related cognitive decline. Processing speed has been measured
with numerous psychometric tests whose score depends on speed of response and/or
speed ofactivity, such as the Digit-Symbol Substitution Test of the WAIS. The
implication is that the effects of ageing are mediated through a common mechanism
or set ofmechanisms rather than there being specific age-related effects for each
cognitive domain.
Numerous studies using multiple regression and structural equation modelling
techniques have indeed confirmed that performance on tasks involving a timed
element and/or problem-solving with novel information shows much shared variance
which more-or-less accounts for the effects of age. However, the nature of
processing speed remains unclear and the original hypothesis that this shared
variance was all due to processing speed has undergone some modification. Recently
Salthouse and others have concluded that the nature of this shared variance is
perhaps not best defined as specifically as 'processing speed' but is perhaps more
closely aligned with the construct ofGf (Deary, 2000; Salthouse, 2001b).
1.2.4 Overview of the literature
In this section studies drawn from various approaches will be reviewed. It is difficult
to classify the different types of studies because of their different conceptual bases
and aim. Therefore the studies reviewed are only loosely grouped according to the
main focus of the enquiry. The studies are selected on the basis of size and aim and
are intended to be a sample of the literature rather a systematic review.
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The long-term stability of individual differences in cognitive ability
There are few studies which have looked at the long-term stability of individual
differences in cognitive ability. These studies are rare mainly because of the long
time periods involved.
Deary and co-workers recently discovered records from the Scottish Mental Survey
of 1932, in which virtually all Scottish schoolchildren born in 1921 had their
intelligence measured using the IQ-type Moray House Test, which correlates at 0.80
with the Stanford-Binet standard test of intelligence (Deary et al., 2000b). A total of
87,498 children took the test. 101 of these individuals were identified and
administered the same test at the age of 77. Performance on these tests correlated at
0.63, 66 years apart. Correction for restricted range increased the strength of the
correlation to 0.73. This study provides the longest follow-up period ofany such
study and is the only one which used identical tests. Clearly, the stability
demonstrated here was in surviving, healthy individuals; it cannot be known from
this study whether good health is a determinant of relatively greater stability in
intelligence.
Plassman and co-workers (Plassman et al., 1995) performed a 50-year follow-up of
cognitive function in 930 men who had been administered the Army General
Classification Test as part of the general evaluation process for new recruits in the
Second World War. This test correlates highly (0.70 - 0.90) with standard tests of
intelligence. They did not administer this test again, but used a modified form of
Telephone Interview for Cognitive Status, a brief telephone-administered test often
used to screen for dementia. The two tests correlated at 0.46.
Studies focusing on IQ
The following studies have used IQ-type tests in the context of ageing. That is, other
than the literature underpinning the construct validity and reliability of IQ,
assumptions were not made about the biological mechanisms involved in any
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changes observed. However, IQ tests are typically made up of several subtests, and
several investigators have attempted to examine possible differences in the impact of
ageing on different subtests or clusters of subtests, in particular those thought to
reflect Gc versus Gf.
Korten and co-workers studied cognitive function on two occasions three and a half
years apart in 1135 subjects aged between 70 and 102 years (Korten et al., 1997).
They used four tests. The National Adult Reading Test (NART) was used as a
measure of crystallised intelligence. The Mini-Mental State Examination (MMSE) is
a broad cognitive screening test including items on memory, orientation, language,
and other cognitive domains. It is scored out of 30; in healthy subjects scores range
from 27-30 with most scoring 30, thus there is a strong ceiling effect. The Symbol
Letter Modalities Test is designed to measure 'cognitive speed'. Subjects are asked
to read out letters corresponding to geometric symbols as quickly as possible.
Finally, the Episodic Memory Test, which consists of three short memory tasks:
three-word recall, name and address recall, figure reproduction and face recognition.
NART scores showed no change over this period. MMSE scores showed small but
significant declines despite clear evidence of a ceiling effect. The Episodic Memory
Test, perhaps surprisingly, showed an improvement overall, though the older subjects
showed decline. The authors attributed any improvements partly to learning effects.
The Symbol Letter Modalities Test showed significant decline across the age range.
This study showed the commonly-observed pattern of clear decrements in a test
requiring rapid responses but no decrements in crystallised ability.
Ryan and co-workers examined age effects on Wechsler Adult Intelligence Scale III
(WAIS-III) subtests (Ryan et al., 2000). The IQ score from the WAIS and other
intelligence tests reflects a composite of scores from 14 subtests, adjusted for age. On
the basis of factor analysis these are traditionally divided into two groups, named
Performance and Verbal subtests. This study examined data from the WAIS-III
standardisation sample. This has 13 age groups with about 100 males and 100
females in each group. The WAIS-III was administered to each participant. Scores
on five (Vocabulary, Similarities, Arithmetic, Information and Comprehension) of
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the seven Verbal subtests did not show declines with age, apart from in the two age
group bands above the age of 79. Scores in these five subtests tended to show small
improvements from the age of 30 to 80. Scores on the Digit Span and Letter-Number
Sequencing subtests showed small declines from the 45-54 age group. By contrast,
scores on all seven of the Performance subtests (Picture Completion, Digit Symbol,
Block Design, Matrix Reasoning, Picture Arrangement, Symbol Search and Object
Assembly) showed significant declines from the 45-54 age group onwards. Although
the WAIS III subtests are not specifically designed to measure fluid or crystallised
intelligence, scores on certain Performance subtests (such as Matrix Reasoning) are
often assumed to be linked with Gf and certain Verbal subtests (such as Vocabulary)
with Gc. This notion holds true for 12 of the 14 tests in this study.
Many other studies have confirmed this general pattern with the WAIS subtests.
Another large cross-sectional study was conducted by Kaufman and Horn (Kaufman
and Horn, 1996). They used the Kaufman Adolescent and Adult Intelligence Test
(KAIT), a cognitive battery with three subtests designed to measure Gc and three to
measure Gf. They studied scores on this test in a sample of 1500 men and women
aged 17-94. The age range was divided into 13 groupings. They found that the
measures ofGfpeaked in the second youngest group (20-24) and showed steady
decline from that point onwards, with the rate of decline accelerating from the 50-54
age group onwards. The Gc subtests were stable until the 60-64 age-group, at which
point there was small decline in each age group. This decline was smaller than for
the Gf subtests.
One of the largest studies of cognitive function and ageing is the Seattle Longitudinal
Study, which was described above. The main findings from this study are that there
are declines in tests of reasoning, verbal memory, perceptual speed and spatial
orientation from the mid-twenties until age 81. In contrast, tests ofverbal ability and
other tests thought to reflect crystallised ability did not show decline until over age of
70 (Schaie, 1994; Schaie, 2000).
The above studies provide convincing evidence that certain cognitive abilities: those
involving a timed element and/or the learning, retention and manipulation ofnew
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information, decline with ageing, whereas those abilities involving prior learning
show little or no decline.
Studies focusing on memory
The following studies have tended to examine scores on different cognitive tests as
statistically separate entities and, because of the longstanding interest in the impact
of ageing on memory, have focused on performance on tests ofmemory.
Park and co-workers (Park et al., 2002) subjected 350 adults across an age-range of
20 to over 80 to tests ofworking memory, short-term memory and delayed memory.
They found that as expected, there is a steady decline in tasks requiring the
manipulation or learning ofnew information, including working memory and long-
term memory. Verbal knowledge increased with age.
In a longitudinal study Small and co-workers (Small et al., 1999) attempted to
answer the question of "whether aging is associated with memory decline." 212
community-based subjects aged 60-93 were tested annually on four occasions on a
battery comprising tests of simple orientation, language (including verbal fluency,
often described as a test of 'executive function'), abstract reasoning (including the
Similarities subtest of the WAIS), visuospatial ability and memory. The memory test
involves subjects recalling a list of words immediately after presentation over several
trials, and then after a fifteen-minute delay. To assess the effects of age in this
sample subjects were stratified into two age groups using 70 as the cut-off point.
They found that only performance on the verbal memory task showed an age group
by time interaction, that is the older age group had a higher relative decline compared
with the younger group. Interestingly, this effect was only observed for the non-
delayed component of the test. Age group also had significant effects on the
visuospatial tests and the Similarities subtest of the WAIS. Performance on many of
the tests showed improvements with time, which authors interpreted as being due to
practice effects.
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Important weaknesses of this study were that no attempt was made to control for
premorbid ability or other relevant constructs such as processing speed. Also, the
authors did not look at intercorrelations among the different tests. Thus it is difficult
to interpret the findings as they might represent baseline differences in overall
cognitive ability, or declines in fluid intelligence and/or processing speed rather than
specific deficits in memory. In this light, it is of note that only the non-delayed
component of the verbal memory test showed the significant effects. This study is a
good example of how failing to take account of latent traits in cognitive function
makes interpretation of the findings difficult.
Vakil and Agmon-Ashkenazi (Vakil and Agmon-Ashkenazi, 1997) compared
performance between young and older adults (two groups of 25, aged 21-35 and 60-
84) on two tests of immediate and delayed verbal and visual declarative memory and
two tests of procedural learning. They hypothesised that the older group would show
the greatest relative deficits on the declarative memory tasks. In fact the older
subjects were relatively impaired on both types of task, though the gap between the
rate of learning of the items in the declarative memory task was greater than for the
procedural memory tasks. Again, there was no attempt to control for baseline ability
or other intervening variables.
The above studies, and many others besides, show that performance on memory tests
involving the learning and recall of new information does tend to decline with
ageing. Furthermore, there is some evidence that performance on declarative
memory tasks might show greater decrements than performance on procedural
memory tasks. However, the majority of these studies have not examined the effects
ofpremorbid or peak overall ability, and have not tested the hypothesis that a decline
in a latent trait representing Gfor processing speed might be largely responsible for
the declines observed. Thus, many investigators have concluded that there is a
relatively circumscribed decrement in the construct of declarative memory.
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Studies focusing on frontal lobe function and working memory
As stated above, an important strand of the cognitive ageing literature is that looking
at impact of ageing on various cognitive constructs thought to be linked with frontal
lobe function. In this section some of the larger studies in this area are reviewed.
Ronnlund and co-workers (Ronnlund et al., 2001) examined performance on the
Tower of Hanoi puzzle, the Block Design subtest of the WAIS, verbal fluency and a
test of delayed declarative memory in relation to age. The subjects were part of the
large Betula prospective cohort study (Nilsson et al., 1997), but the data are from one
wave of analysis and are thus cross-sectional. There were 2798 male and female
subjects aged from 35 to 85, in 11 groups aged (at the time they were tested) 35, 40,
45, and so on. There were significant age effects on Tower ofHanoi performance;
however, these were almost eliminated by controlling for performance on Block
Design, verbal fluency and the delayed declarative memory task. This study, one of
the largest of its type, strongly suggests that tests involving active problem-
solving/manipulation of information, not only decline with age but decline together.
This adds support to the idea that changes in fluid intelligence underlie most changes
observed in cognitive ageing.
Isingrini and Vazou (Isingrini and Vazou, 1997) compared performance on standard
tests of intelligence, the WAIS Vocabulary, Information and Similarities subtests and
Cattell's matrices with performance on widely used tests of frontal lobe function, the
Wisconsin Card Sorting Test and two tests of verbal fluency. The aim was to test the
hypothesis that in an elderly population there would be a positive correlation
between fluid intelligence tests and frontal lobe tests. The subjects were 35 adults
aged 25 to 46 and 72 adults aged 80 to 99. None of the subjects fulfilled criteria for
dementia. The results were presented separately for each age group. In the younger
age group modest but largely non-significant correlations were found in the predicted
directions among frontal and intelligence tests. In the older age group the Similarities
subtest from the WAIS and Cattell's matrices correlated at levels of 0.32 to 0.59 with
the frontal tests. The authors interpreted these findings as demonstrating that there is
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some overlap among tests of fluid intelligence and frontal lobe function, at least in
older age groups.
Hanninen and co-workers wished to determine if patients with a formal diagnosis of
age-associated memory impairment also had deficits on other types of cognitive
function (Hanninen et al., 1997). In a cross-sectional study they compared
performance on traditional tests of frontal lobe function (verbal fluency, the modified
Wisconsin Card Sorting Test, the Trail Making Test and the Stroop test) in 43
patients who fulfilled criteria for 'age-associated memory impairment' with
performance in 47 age-matched controls. They found that performance on all of these
tests was significantly worse in patients versus the controls.
Schretlen and co-workers (Schretlen et al., 2000) wished to determine the
relationships among individual differences in 'perceptual comparison speed',
working memory, executive function, fluid intelligence and crystallised intelligence
in adults aged between 20 and 92. MRI was used to determine frontal lobe volumes;
these results are not considered in detail in this section. The test ofperceptual
comparison speed was developed by Salthouse and involved, "... the rapid
comparison of letter strings (composed of 3 or 6 letters each) or line patterns
(composed of 3 or 6 lines each). The participant was required to indicate whether the
letter strings or designs that comprised each pair were identical or different by
marking an 'S' or a 'D' in the space between them. The number of correct
comparisons made in 30s was recorded in each task ...". Working memory was
assessed using Schretlen's Brief Test ofAttention, in which subjects listen to audio
presentations ofmixed digit-letter strings from 4 to 18 in length, and is asked to keep
in mind the number of letters in each string. Executive function was assessed with
the Modified Wisconsin Card Sorting Test. For the fluid and crystallised intelligence
measures, a principal components analysis (with varimax rotation) was performed on
a battery of further tests. This yielded a two factor solution accounting for 68% of the
variance. The National Adult Reading Test, the WAIS-R Information, Arithmetic,
and Similarities subtests loaded onto one, designated the crystallised intelligence
factor (Gc). The Benton Facial Recognition Test, the Rey-Osterrieth Complex Figure
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Test and the WAIS-R Picture Completion and Block Design subtests loaded onto the
other, designated the fluid intelligence factor (Gf).
Age correlated at -0.56 (p<.001) with Gf; there was no correlation between age and
Gc. Interestingly, working memory correlated with Gfat 0.51 (p<.001); other
correlations among the tests and factors were not presented. Hierarchical multiple
regression analyses were then used. With Gf as the dependent variable, using age
alone accounted for 28% of the variance. The addition of terms for perceptual
comparison speed and working memory increased the variance explained to 46%, but
only the beta weight for perceptual comparison speed was significant. The analysis
was repeated without the inclusion of age. Terms for perceptual comparison speed
and working memory gave an equation explaining 45% of the variance; adding age at
that stage did not improve the model. Neither executive function nor Gc were
included in this set of analyses. A further set of analyses examined the relationships
among the above tests, executive function and frontal lobe volumes; these analyses
are discussed in a later section.
This study is an interesting attempt to integrate ideas of processing speed, Gf, Gc,
working memory and executive function. However, it is unfortunate that, despite the
strong correlation between working memory and Gf, the authors did not consider the
use of further principal components analyses. Inclusion ofGc would also have been
of considerable interest, as it would have helped to control for baseline differences in
cognitive ability, which are known to be of considerable importance (Deary et al.,
2000b). Because of these methodological issues it is difficult to interpret the results
of the hierarchical multiple regression analyses used here. The study provides partial
support to the processing speed hypothesis in that the age-related variance in Gf
scores was almost eliminated when performance on the perceptual comparison speed
was controlled for. This study also confirms that Gf is much more strongly related to
age than Gc.
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1.2.5 Conclusions
In young adulthood cognitive tests correlate to give rise to g and group factors. With
ageing, the pattern of these correlations changes. Tests involving real-time problem
solving, timing, and so on, tend to show decline and tests involving learned skills and
knowledge (vocabulary, general knowledge, tend to increase). This phenomenon has
been summarised by the Gf/Gc first proposed by Cattell and is related to the
processing speed construct proposed by Salthouse. Whether or not there is a decline
in specific cognitive functions in memory remains unclear.
In the literature neuropsychological and psychometric approaches can be identified,
with neuropsychological models focusing on a variety ofhypotheses linking decline
in specific cognitive functions to atrophy of specific brain regions. Psychometric
approaches are more concerned with the accurate measurement and classification of
cognitive functions in relation to age, and in particular with examining the hypothesis
that much age-related cognitive decline is due to a single pool of shared variance.
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1.3 Ageing and the brain
The ageing brain can be studied using different levels and modes of analysis, from
changes in neuronal DNA to changes in overall brain function, for example cognitive
functioning. Because of the large literature on the ageing brain, this section will
focus on macroscopic changes in the ageing brain together with a brief review of the
processes thought to underlie macroscopic brain changes with ageing. Cognitive
ageing, and ageing and glucocorticoids are covered in different sections.
As stated above, one of the key challenges in ageing research is in describing not just
the universal changes which occur with ageing but also taking account of the varying
degrees ofpathological processes which become more common with ageing. For
example, the evidence suggests that there is a degree of atrophy in the brain in all
ageing individuals. There is a substantial amount of variance in this process and
some of this can be attributed to disease processes such as Alzheimer's disease.
However, most of these disease processes are not all-or-none, and post-mortem
studies of the brains of apparently healthy older people commonly show features
such as B-amyloid plaques which are present, albeit in greater quantities, in the brains
ofpatients who had Alzheimer's disease.
A
1.3.1 Changes in the brain with ageing
In this section studies examining changes in the brain at the macroscopic level will
be reviewed. The issue of changes in neuron number with ageing and in the context
of pathology is also briefly considered.
In humans, brain weight is thought to decrease gradually from about the age of 60,
even in the absence ofAlzheimer's disease or other major pathologies. The brain
volume to skull volume shows a similar decline, from 95% to about 80% in people in
their ninth decade (Vinters, 2001). However, there is substantial variation, with some
individuals showing little change, and others showing gross atrophy (Mueller et al.,
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1998). Furthermore, there are different patterns of atrophy, with some regions
showing more atrophy than others in some individuals (Laakso, 2002). The incidence
ofneurodegenerative diseases rises with age, and many of these are associated with
brain atrophy. This means that it is difficult to know how much of the age-related
change in brain volume is due to these illnesses, and how much to universal age-
related change.
However, the literature does show that there might be distinct patterns of atrophy and
that to some extent these are related to the severe cognitive impairments of the
dementias. Using annual CT scans in a large prospective study, Jobst and co-workers
(Jobst et al., 1994) found that patients with AD (confirmed with histology) showed
dramatic declines in medial temporal lobe atrophy (15% reduction per year) versus
healthy, age-matched controls (1.5% per year). They concluded that there is not an
even distribution of decline and that rapid decline might reflect a qualitatively
different process such as Alzheimer's disease. These findings have been replicated
using MRI (Fox et al., 1996).
Cross-sectional studies have provided supportive evidence ofheterogeneity in age-
related atrophy of regional brain volumes. In one such study Laakso and co-workers
examined hippocampal volumes in the context ofAlzheimer's disease and age
(Laakso et al., 1998). Subjects were 55 patients with probable AD (by standard
criteria), 43 subjects with the National Institutes of Mental Health (NIMH) criteria
for the clinical category ofage-associated memory impairment, 42 cognitively
normal healthy elderly controls and also 20 young healthy controls. Patients with AD
had substantially and significantly smaller hippocampal volumes compared with all
of the other groups. Hippocampal volume was not significantly different among the
other groups. In particular, there was no difference between the young controls and
the older controls or subjects with age-associated memory impairment. These and
other studies (Laakso, 2002) suggest that hippocampal atrophymight be a marker of
Alzheimer's disease; put another way, specific hippocampal atrophy is not a
universal feature of ageing.
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Other studies not explicitly examining patients with dementia have shown that
although mean volume declines, not all people lose brain volume with age (Coffey et
al., 1992) and that there might not be accelerated decline of brain volume loss with
increasing age (Mueller et al., 1998). These studies strengthen the case for the
existence of two or more subgroups of rates of decline rather than a general, uniform
decline or an evenly-spread increased variability.
Good and co-workers (Good et al., 2001) used voxel-based morphometry, a
technique allowing unbiased estimation ofvariation in all brain regions, to analyse
the effects of age in 465 subjects selected for good health. Subjects were volunteers,
and comprised 200 females aged 18 to 79 and 265 males aged 17 to 67; the age-
range was skewed towards younger ages. Scans were all assessed as being "normal"
by a neuroradiologist. Increased age was associated with relative declines in overall
grey matter but not in overall white matter. Regional loss of grey matter was
observed in several regions, including the superior parietal gyri, pre- and postcentral
gyri, right cerebellum, anterior cingulate and left middle frontal gyrus. Somewhat
surprisingly, areas of relative preservation of grey matter were the hippocampus,
amygdala, and the entorhinal cortex as well as the thalamus. Regional loss ofwhite
matter was observed in the frontal regions, optic radiations, and the posterior limbs
of the internal capsule. Areas of relative preservation were observed in the posterior
frontal lobes, temporal lobes, and occipital lobes. The authors noted several
limitations of the study: older subjects were relatively underrepresented and probably
represented the healthy and high-functioning end of the spectrum, as older subjects
with evidence of illness and also of any self-reported cognitive impairment were
excluded. However, this study adds evidence to the proposal that brain ageing is
heterogeneous; in particular it suggests that relatively greater hippocampal atrophy is
not an inevitable consequence of ageing. This is a similar conclusion to that found in
an earlier and relatively large study by Raz and co-workers (Raz et al., 1997). Using
more conventional volumetric techniques in 148 healthy subjects aged 18 to 77, they
found that the prefrontal grey matter was most affected by age, with smaller
differences in the fusiform, inferior temporal and superior parietal cortices. There
was only a slight effect of age on hippocampal volumes.
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For many years it was almost universally believed that there was widespread
neuronal loss with ageing (Coleman and Flood, 1987). However, this seems to have
been due to artefacts in the only ways of counting neurons, which underestimated the
numbers ofneurons in 2-dimensional slides (West and Gundersen, 1990). West and
co-workers used unbiased stereological techniques to examine patterns of neuronal
loss in ageing in the brains of 45 subjects without Alzheimer's disease aged 13 to
101 and in 7 patients with Alzheimer's disease and 14 age-matched controls (West et
al., 1994). They found that patients with AD showed loss of 68% of neurons in cornu
ammonis area 1 of the hippocampus (CA1), 47% loss in the subiculum and 25% loss
in the hilus of the dentate gyrus. In the 45 subjects without Alzheimer's disease,
neuronal loss of 37% in the dentate hilus and 43% in the subiculum were found.
There were no differences in CA1. No significant differences were found in CA2 or
CA3 or in the dentate granule cell layer. Other studies have not found exactly the
same pattern, with some showing that there is neuronal loss in CA1 with 'normal
ageing' (Tang et al., 1997). Several other studies have confirmed the general
principle that although there is some neuronal loss with ageing, this is not a large loss
(in the order of 10%) and only seems to affect certain brain regions, such as parts of
the hippocampus. This small neuronal loss does not fully account for the changes in
brain volumes with ageing (Tang et al., 1997; Morrison and Hof, 1997; Peters et al.,
1996; Rasmussen et al., 1996; Rapp and Gallagher, 1996).
Studies in rodents have yielded similar findings. For example, Rasmussen and co¬
workers (Rasmussen et al., 1996) examined hippocampal and subicular neuron
number in relation to performance on memory tasks in aged rats. They first classified
performance of 52 aged (24 to 24.5 months) rats on the Morris water maze in relation
to 15 young controls (2.5 months). Aged rats performed significantly worse than
young rats. However, as others have demonstrated (Issa et al., 1990; Yau et al.,
1995), there was considerable variation in the performance of the aged rats, with a
considerable overlap with the young rats. The aged rats were divided into groups of
N=5 based on their watermaze performance with the best in one group and the worst
in another. There was also a third group (N-5) randomly-selected from the young
rats. Stereological counting ofneuron numbers in the dentate granule layer, the
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dentate hilus, the combined pyramidal cell layers ofCA2 and CA3, the pyramidal
cell layer ofCA1 and the pyramidal cell layer of the subiculum was performed. They
found that the impaired and unimpaired aged rats showed no differences in neuron
numbers. The only significant difference found was between the CA1 neuron
numbers in all 10 aged rats versus the 5 young rats in which the aged rats actually
had a higher number of neurons.
Other than neuronal death, there are dozens of other variables which have been
investigated as important factors in the ageing brain. Prominent amongst these are
the deposition of B-amyloid plaques, which probably occurs in all ageing brains,
increased neurofibrillary tangles with cells, loss of synapses and reduced numbers of
dendrites (Anderton, 1997; Uylings and de Brabander, 2002), decreases in
myelination (Nielsen and Peters, 2000), cerebral energy metabolism (Eberling et al.,
1997; Yamauchi et al., 1996) and the integrity of the blood-brain barrier (Ueno et al.,
2000).
1.3.2 Neuroimaging and cognitive ageing
Various neuroimaging techniques are being used to examine relationships between
the brain and cognitive function in health and disease across the age range. In this
section relationships between neuroimaging techniques generating data on brain
volumes and metabolite levels (magnetic resonance spectroscopy) and cognitive
function will be reviewed.
Brain volumes
In young, healthy adults, most studies have found a positive correlation between
brain size (as measured by various neuroimaging techniques) and cognitive ability
(Deary et al., 2000a). Vernon and co-workers reviewed the literature in 2000 and
found that for the 11 published studies (total N-432) the N-weighted mean
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correlation between IQ and brain size was 0.38 (Vernon et al., 2000). However, in
ageing research, the majority of the literature on cognitive function, brain volumes
and ageing is concerned with the dementias, examining hippocampal volumes and
performance on tests ofmemory in the context of the prediction ofAlzheimer's
disease (deLeon et al., 1997). There are few studies which have examined
relationships between comprehensive cognitive testing and brain volumes beyond the
hippocampus in older individuals.
Swan and co-workers examined relationships in 385 males with a mean age of 72
among a battery of cognitive tests, including the mini-mental status examination
(MMSE), visual and verbal memory, verbal fluency, vocabulary, colour-word
interference (similar to the Stroop test), the Trail-Making Test and the Digit-Symbol
Substitution Test (DSST) in relation to structural neuroimaging data and risk factors
for cerebrovascular disease (Swan et al., 2000). Some of the cognitive tests had been
administered to all of the subjects 10 years previously. The investigators divided the
subjects into those with 'atrophy' (n=101) versus 'non-atrophy' (n=284). Atrophy
was defined as, "... a measurement of total brain volume less than the median and
white matter hyperintensities volume more than the median for this sample." No
correlational analyses were done; all inferential statistics were done with logistic
regression after adjustment for age. Subjects with scores on the MMSE of 23 or less
were excluded. They found that the groups differed in performance on the Trail
Making Test, colour-word interference, verbal fluency and 10-year change in verbal
fluency and the DSST. There were no differences in visual or verbal memory. This
study does provide some evidence for a link between brain atrophy and age-related
cognitive decline but the dichotomisation of the continuous variable of total brain
volume is not the appropriate method for analysing this relationship (MacCallum et
al., 2002). The authors use the term 'subclinical brain atrophy' to describe the group
with the lower brain volumes but there is no agreed definition ofclinical atrophy.
Tisserand and co-workers (Tisserand et al., 2000) examined relationships among
cognitive function and brain volumes in 61 healthy men and women aged 21 to 81
(mean 55.7, standard deviation 16.1). Cognitive tests were only of immediate and
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delayed word-list recall, a test ofperceptual processing speed (the 'Memory
Scanning Test'') and two versions of the Stroop test. Neuroimaging measures were
intracranial volume, total brain volume, hippocampus, parahippocampal gyrus,
mamillary bodies and volume of the third ventricle. All brain volumes were
controlled for intracranial volume. They found significant age-related declines in all
brain regions apart from the mamillary bodies. No measured region showed more
decline than any other. There was also a significant rise in the volume of the third
ventricle. Relationships among cognitive test scores, brain volumes and age were
examined with hierarchical regression models. Without the inclusion of age, all
measured brain volumes other than the mamillary bodies were significantly
associated with the Memory Scanning Test and one of the Stroop test scores.
Immediate word list learning was not associated with hippocampal volumes but was
associated with total brain volumes, as was delayed word list learning. Controlling
for age eliminated all of the associations between cognitive tests and brain volume
other than the more difficult version of the Memory Scanning Test (MST 3) and total
brain volume. This study, though it used a small number of cognitive tests and did
not control for baseline cognitive ability, does add to the idea that in the absence of
overt pathology, relationships among cognitive ability and brain volumes are general
rather than involving specific relationships between specific brain regions and
specific cognitive domains.
As stated above, there are many studies which have examined the relationship
between hippocampal volumes and declarative memory, mainly in older populations
with cognitive impairment ofvarying degrees of severity (Scheltens et al., 2002;
Zaudig, 2002). These studies often show the predicted negative relationships, but
1 this task was described as follows (p. 571): "The Memory Scanning Test is a paper and pencil
cancellation test that consists of 12 rows of 12 letters and numbers, randomly interspersed with a
target symbol or letter that subjects have to cross out. The cognitive load can be enhanced by
increasing the number of targets that need to be memorized. In the present study, two targets were
used: one with one target symbol (MST%) and one with three letters (MST3), and the time needed for
completion was recorded."
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alternative explanations for the relationships observed, such as a correlation between
overall brain size and general cognitive ability, are often not tested.
Magnetic resonance spectroscopy
Proton magnetic resonance spectroscopy (Hi-MRS) can measure levels of certain
metabolites in the brain in vivo. Commonly identified metabolites are N-
acetylaspartate (NAA), choline (Cho), and total creatine (Cr). NAA is considered to
be neuron-specific (Simmons et al., 1991) and is considered to be a marker ofnormal
functioning neurons. Choline levels reflect the quantities of free choline. Since
choline-containing compounds are contained in phospholipid membranes, increased
choline may reflect increased membrane synthesis (eg. in gliosis) or breakdown (eg.
in necrosis) (Pettegrew et al., 1997). Creatine levels are thought to reflect the
combined quantity ofphosphorylcreatine and creatine, involved in energy
metabolism in neurons and glial cells (Pettegrew et al., 1995; Wyss and Kaddurah-
Daouk, 2000).
HI-MRS is increasingly used in the study ofneurodegenerative diseases. For
example, decreased levels ofNAA have been found in pathological states in which
there is known to be neuronal loss, such as Alzheimer's disease (Pfefferbaum et al.,
1999a; Schuff et al., 1998), epilepsy (Breiter et al., 1994; Aasly et al., 1999),
Huntington's disease (Sanchez-Pernaute et al., 1999) and schizophrenia (Deicken et
al., 1999).
Magnetic resonance spectroscopy and cognitive ageing
The majority ofpublished studies have examined metabolite levels, usually in the
form ofmetabolite ratios, in relation to Alzheimer's disease. In these studies there a
mixed picture of results, though most suggest a relative reduction inNAA in
comparison to healthy brains (Firbank et al., 2002; Pfefferbaum et al., 1999a).
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There are very few studies ofmetabolite changes in relation to changes in cognitive
function with ageing. In a study ofotherwise healthy people aged over 70, Catani
and co-workers reported higher myo-inositol/creatine ratios in 11 persons with mild
cognitive impairment versus 11 healthy controls (Catani et al., 2001). Pfefferbaum
and co-workers reported a positive correlation betweenNAA levels and a face
recognition task in 13 healthy elderly subjects (Pfefferbaum et al., 1999b). Even
fewer studies have been published in young, healthy adults. One group reported a
positive association between absolute NAA concentrations and performance on
cognitive tests in 40 subjects (Jung et al., 1999). Overall, the literature to date does
not allow firm conclusions to be drawn concerning changes in brain metabolites with
ageing.
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1.4 Glucocorticoids
1.4.1 Glucocorticoid physiology
The main function of the glucocorticoid hormones (Cortisol in humans,
corticosterone in rodents) is to enhance the organism's response to physical or
psychological stress (Seckl and Olsson, 1995). The presence of glucocorticoids is
also crucial in maintaining the normal functioning ofmultiple physiological systems.
Deficiency of glucocorticoids, such as in Addison' disease or in animal experiments
through adrenalectomy, causes widespread adverse effects under basal conditions
and can lead to death under conditions of stress (Kaplan, 2000).
The response to stress is complex and involves multiple components of the endocrine
and nervous systems. In the first few seconds and minutes the main physiological
actions are an increase in the supply of fuel to muscle, increased blood pressure,
inhibition of reproductive physiology, decreased appetite, and increased alertness
(Sapolsky et al., 2000). Many of these very early responses are mediated by the
nervous system and by the catecholamines, secreted from the adrenal medulla after
stimulation from the sympathetic nervous system. Glucocorticoids are secreted
immediately after stress but in the main do not act for at least 20 to 30 minutes
because most of their actions are genomic.
The roles of glucocorticoids appear to involve the facilitation of the initial response,
but also the restoration of the basal state. Glucocorticoids also influence the
organism's preparation for later stress (Sapolsky et al., 2000). Central to the
glucocorticoid response to stress is mobilisation of glucose, gluconeogenesis and
inhibition of energy storage (Kaplan, 2000). There are also multiple adaptive effects
on the brain. Although stress causes an immediate increase in glucose uptake by the
brain, probably mediated by catecholamines and the sympathetic nervous system,
stress-levels of glucocorticoids inhibit cerebral glucose uptake from about one hour
after the episode of stress (Kadekar et al., 1988; Doyle et al., 1993). Glucocorticoids
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also influence the formation ofmemories and influence other cognitive functions;
this is discussed below.
Glucocorticoids are released under the influence of adrenocorticotrophic hormone
(ACTH), a peptide, which is released from the pituitary gland when stimulated by
corticotrophin-releasing hormone (CRH) from the median eminence of the
hypothalamus. ACTH binds to a membrane receptor, activates adenylyl cyclase and
activating protein kinases which stimulate the manufacture of Cortisol from
cholesterol. Cortisol levels increase within a few minutes of stimulation with ACTH
to between two and five times basal levels in about 30 minutes. Elevations in Cortisol
occur as part of the normal circadian rhythm: in humans, Cortisol levels are at their
lowest between 12 midnight and 0400, rising to a peak at around 0800 and showing a
slow decline over the course of the day. Elevations also occur with a stressful
episode; glucocorticoids can increase to levels higher than the peak levels observed
in the normal circadian rhythm (Roy et al., 2001b).
In the circulation glucocorticoids are mainly bound to a specific glucocorticoid-
binding a2-globulin, corticosterone-binding globulin (CBG). CBG is saturated at a
glucocorticoid level of approximately 700nmol/l; the remainder is bound to albumin
or is unbound. The unbound fraction is about 5%. The plasma half-life ofCortisol is
between 70 and 90 minutes. It is either metabolised to cortisone, or excreted in the
urine unchanged or as 5b-tetrahydrocortisol (Seckl and Walker, 2001).
Receptors
Glucocorticoids are steroid hormones and enter cells by passive diffusion.
Glucocorticoids bind to two types of receptors: mineralocorticoid (MR or type I) and
glucocorticoid (GR or type II) receptors (de Kloet et ah, 1998). GR and MR are
situated in the cytoplasm and are complexed with other proteins. The hormone-
receptor complex translocates to the nucleus and binds to specific regulatory DNA
sequences called glucocorticoid response elements, influencing the transcription of
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hundreds of different genes (Vreugdenhil et al., 2001). Glucocorticoid receptor
monomers may also act indirectly by interacting with transcription factors and
influencing transcription rates ofmultiple genes (Reichardt et al., 1998).
MR have about 10 times the affinity ofGR to physiological glucocorticoids but are
thought to have a lower capacity than GR (de Kloet et al., 1998). In the brain MR are
almost 100% occupied by glucocorticoids, their main ligand in the brain, under basal
conditions. By contrast, GR are of lower affinity than MR and in the brain become
occupied only when glucocorticoid levels are at stress levels (Spencer et al., 1990).
De Kloet and others have proposed that this allows the brain to distinguish between
stress and circadian levels of glucocorticoid (de Kloet et al., 1998).
In rodents, MR are clearly present in the hippocampus, the amygdala, the basal
ganglia, the hypothalamus, the cerebellum, the eye and in the distal nephron (Sutanto
et al., 1988; de Kloet et al., 1998; Agarwal et al., 1993; Mirshahi et al., 1997). One
recent report indicates that MR are also expressed in the neocortex in non-human
primates (Patel et al., 2000). GR are present throughout the brain and in numerous
tissues throughout the body (Seckl and Olsson, 1995). Inter-species densities ofGR
vary, with some reports showing higher GR expression in the prefrontal cortex and
other parts of the neocortex in non-human primates as compared with rodents
(Sanchez et al., 2000; Patel et al., 2000).
Feedback regulation of the hypothalamo-pituitary-adrenal axis
There is a complex set of feedback loops which regulate Cortisol levels.
Glucocorticoids exert negative feedback on the adrenal cortex itself, the pituitary
gland and the hypothalamus. Several cortical regions are also involved in feedback
regulation including the hippocampus (Seckl and Olsson, 1995) and the medial
prefrontal cortex (Diorio et al., 1993).
The hippocampus is thought to have a tonic inhibitory effect on CRH production by
the hypothalamus. In rats, lesions to the hippocampus result in elevated
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corticosterone levels and slower recovery ofhormone levels following stress
(Sapolsky et al., 1984; Wilson et al., 1980; Feldman and Conforti, 1980). Animals
without hippocampi show increased CRH levels in the paraventricular nucleus
(Herman et al., 1989). Studies have demonstrated that both GR and MR appear to
have a role in feedback regulation. Administration of an MR antagonist via an
intraventricular catheter to rats causes elevations in basal levels of corticosterone and
ACTH, and also larger corticosterone responses to novelty (Ratka et al., 1989; Oitzl
et al., 1995).
Similar findings have been reported in non-human primates (Sapolsky et al., 1991)
and in humans, where elevations ofCortisol levels are observed following blockade
ofMR by spironolactone (Young et al., 1998; Heuser et al., 2000) or canrenonate
(Arvat et al., 2001).
However, although the hippocampus undoubtedly has an important role in
hypothalamo-pituitary-adrenal (HPA) axis feedback regulation the main site is
thought to be the pituitary (de Kloet et al., 1998). It is also important to note that
some studies have suggested that the impaired HPA axis feedback regulation
observed after hippocampal lesions recovers after several weeks or months (Sapolsky
et al., 1991), though the mechanism for this is unknown.
Glucocorticoid sensitivity
The strength of response to circulating glucocorticoids depends on multiple factors.
The first group of factors concerns local modulation of glucocorticoid levels.
Although glucocorticoids enter cells by passive diffusion, there are several
mechanisms which modify the quantity ofhormone actually reaching MR and/or
GR.
As stated above, most glucocorticoid is carried bound to CBG; reductions in CBG
lead to higher concentrations of active (free) hormone. Recent studies have
demonstrated that CBG levels may be locally altered by inflammation, for example
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by neutrophil elastase, which cleaves CBG so that local glucocorticoid levels are
enhanced (Hammond, 1995).
Another important mechanism of local tissue modulation of hormone levels is via
enzymes called 1 lB-hydroxysteroid dehydrogenases (1 lB-HSDs). In the distal
nephron the main ligand for MR is aldosterone. However, glucocorticoids typically
have much higher concentrations than aldosterone, and given that MR has a high
affinity for both glucocorticoids and aldosterone in vitro, how does aldosterone have
preferential access to these receptors in vivo? This paradox was explained by the
discovery of 1 lB-HSDs, which are co-localised with MR in the distal nephron and in
that site inactivate glucocorticoids before access to MR occurs. Thus, aldosterone,
present in lower concentrations, occupies MR (Edwards et al., 1988; Funder et al.,
1988). The syndrome of apparent mineralocorticoid excess, in which there is sodium
retention, hypokalemia and hypertension, was found to be due to congenital absence
of 1 lfl-HSDs, allowing mineralocortioid receptors to be occupied by active
glucocorticoids. Inhibition of 1 lB-HSDs by substances such as carbenoxolone also
causes this effect.
There are two isozymes of 11B-HSD: type 1 and type 2. 11B-HSD type 1 (11B-
HSD1) is widely expressed, in liver, lung, adipose tissue, vasculature, ovary and
brain (Stewart and Krozowski, 1999; Monder and White, 1993). To date, the bulk of
the evidence suggests that 11B-HSD1 acts as a reductase in vivo, that is, it
regenerates glucocorticoids from their inert metabolites (Rajan et al., 1996;
Kotelevtsev et al., 1997; Seckl and Walker, 2001). By contrast, 11B-HSD type 2
(11B-HSD2) is present only in the distal nephron, the colon, salivary glands, the
placenta and a few regions in the central nervous system which are involved in
central blood pressure and salt and water regulation (Seckl, 1997). 11B-HSD type 2 is
thought to function as a dehydrogenase, that is, it deactivates active glucocorticoids.
A further type of local modulation applies to synthetic analogues of glucocorticoids,
such as dexamethasone. Many synthetic compounds are denied access to the brain
via the mdrla P-glycoprotein (Schinkel et al., 1995). This is expressed in the
endothelial cells of the blood-brain barrier (Cordoncardo et al., 1989). Mice lacking
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the mdrla P-glycoprotein show greater accumulation in the brain of radiolabelled
dexamethasone than wild-types (Meijer et al., 1998). Therefore, in mice the brain
appears to be resistant to penetration of dexamethasone, though high doses can
overwhelm this system. These data are relevant to the site of action ofexogenous
steroids.
Chapter 1: Cognitive function and brain volumes
47
Cognitive function, the brain and glucocorticoids
1.4.2 Glucocorticoids, cognitive function and ageing
The hypothesis that elevated levels of glucocorticoids are causally associated with
ageing-related cognitive decrements was proposed several decades ago and was
developed by Sapolsky in the glucocorticoid cascade hypothesis (Sapolsky et al.,
1986). This hypothesis states that prolonged periods ofhigh glucocorticoid levels
lead to a down-regulation ofGR in the hippocampus. If this process continues
feedback regulation of the HPA axis is attenuated because the hippocampus exerts an
inhibitory influence on glucocorticoid levels. This leads to a further increase in
glucocorticoid levels and eventually to damage and even death of hippocampal
neurons, causing impairments in delayed memory.
In this section the literature on ageing-related changes in the functioning of the HPA
axis, in particular glucocorticoid levels, is reviewed. Then literature on the effects of
elevated glucocorticoids on the brain and cognitive function, in health and in ageing,
is reviewed.
Glucocorticoids and ageing: observational studies
The impact of ageing on the HPA axis can be measured in several ways. In terms of
basal glucocorticoid secretion, levels can be measured in saliva, blood or urine. Urine
sampling allows glucocorticoid secretion over 24 hour periods to be measured,
whereas saliva and blood sampling tend to be done as a one-off or a small number of
times during the day. As well as observational measurements, measurements of
glucocorticoid levels can be measured when the organism is subjected to stress or
challenge. For example, Cortisol levels in humans can be measured under situations
of social stress such as public speaking (Roy et al., 2001a). Dexamethasone, a
synthetic glucocorticoid, acts on various feedback sites and causes suppression of
glucocorticoid secretion. Individuals differ in their sensitivity to this test. Post-
Chapter 1: Cognitive function and brain volumes
48
Cognitive function, the brain and glucocorticoids
mortem studies can be used to examine levels ofMR and GR in the brain and also of
parts of the brain thought to be involved in HPA axis regulation and/or vulnerable to
the effects of elevated glucocorticoids.
There is uncertainty over whether overall levels of glucocorticoids increase with
ageing (Seeman and Robbins, 1994; Sapolsky, 1991; Seckl and Olsson, 1995).
Studies have tended to show either no changes, or slight increases (Barton et al.,
1993). Some of these differences can be put down to differences in methods of
measuring glucocorticoid levels, with studies using morning or evening plasma
levels, 24 hour urine output, etc. (Van Kampen and Fuchs, 1998). However, what is
in little doubt is that the average output of glucocorticoids shows a wider range, with
some individuals maintaining the same overall output and others showing decreases
or increases. For example, Lupien and co-workers measured Cortisol levels in 51
volunteers yearly for three to six years (Lupien et al., 1996). The subjects were aged
60 to 90, with a mean age of 73 years. Cortisol levels were sampled in a highly
detailed manner, using samples taken every hour over a 24-hour period through a
forearm catheter. They found that Cortisol levels showed a spread of change, and
divided the subjects into three groups: those with rising levels, those with stable
levels, and those with decreasing levels. Other studies have confirmed considerable
variance in Cortisol secretion in older population (Seeman et al., 1997).
There are also differences in the dynamics of glucocorticoid secretion. With respect
to circadian rhythms, some studies have reported higher morning and/or evening
Cortisol levels, whereas some others have reported no such difference (Ferrari et al.,
1995; Vermeulen et al., 1982; Kern et al., 1996). However, as with overall output of
glucocorticoids with ageing, there is no clear pattern which occurs with ageing in
humans.
Most of the research on the functioning of the HPA axis under conditions of stress
has been done with animals, using a variety of stressors, including restraint, cold, and
open field testing. Most of these studies have found that the consistent differences
have occurred in the period when hormone levels are returning to their basal levels,
in that older animals show a slower recovery (Seeman and Robbins, 1994). For
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example, in one study stress caused by injections and blood sampling caused a
similar peak in corticosterone levels in young and old animals, but levels in older
animals took longer to return to basal levels (Vaneekelen et al., 1995). However, not
all aged animals show this slower recovery (Issa et ah, 1990; Bizon et ah, 2001),
paralleling the findings with overall glucocorticoid output. There are no good quality
published studies examining the recovery ofCortisol levels following stress in older
humans.
There are several published studies examining the effects ofage on the extent to
which dexamethasone suppresses HPA axis activity. Studies differ in many ways,
including the numbers of subjects, age groups, exclusion criteria and importantly, the
dose ofdexamethasone used. Studies also often report the findings in terms of the
percentage of subjects showing suppression versus non-suppression dichotomy rather
than reporting the mean levels. Studies have tended to show that older subjects show
higher levels of Cortisol post-dexamethasone than young controls (Weiner, 1989;
Rosenbaum et al., 1984). This effect is more clearly seen when smaller doses of
dexamethasone are used (Branconnier et al., 1984). However, the overall pattern is
that in healthy older people there is a spread of response to dexamethasone whereas
in the absence of illness in young people, virtually all completely suppress output of
Cortisol in response to dexamethasone. Similar effects have been found in rodents.
In conclusion, it is uncertain whether some older humans or animals develop a higher
overall output of glucocorticoids. Similarly, the evidence for clear age-related
alterations in the circadian rhythm is scant. However, there is abundant evidence that
in a proportion of older animals and humans there is an impairment of negative
feedback at various levels of the HPA axis, resulting in a slower recovery of
glucocorticoid hormones to resting levels. Reviewing evidence from animal and
human studies Seeman and Robbins (Seeman and Robbins, 1994) concluded that,
"... aging per se is probably not associated with changes in HPA function but rather
than there are differentialpatterns ofHPA aging ..." (p.234).
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1.4.3 Chronic exposure to high levels of glucocorticoids and
cognitive function
Glucocorticoid hormones are essential for normal cognitive functioning (de Kloet et
al., 1999). Both MR and GR have been shown to play a role. The key findings are
that the involvement of glucocorticoids in learning varies according to the situational
and temporal context. If glucocorticoid levels are too low, or too high, or the
functioning ofMR or GR is affected, learning is attenuated. For example, Yau and
co-workers have demonstrated that MR activation is important in maintaining
memory in healthy rats. In a controlled study they administered intraventricular
spironolactone, a specific MR antagonist, or vehicle for 12 days and found that this
impaired learning in the Morris watermaze (Yau et al., 1999). Similar studies have
shown that blockade ofGR also impairs learning.
In the next sections, the effects of chronically high levels of glucocorticoids on
cognitive function and the brain are reviewed.
Animal studies
Observational animal studies
Landfield and co-workers were the first to report quantitative data linking ageing of
the HPA axis with brain ageing. This group had previously reported an increase in
reactive astrocytes in the hippocampus and other brain structures with ageing in
Fischer rats, and went on to examine the hypothesis that plasma levels of
corticosterone and adrenal weights were related to the extent of these changes
(Landfield et al., 1978). They compared three groups of 9 rats of three age groups: 4,
13 and 25 months old. They found progressively higher densities of reactive
astrocytes and adrenal weights with increasing age. Mean corticosterone levels also
Chapter 1: Cognitive function and brain volumes
Cognitive function, the brain and glucocorticoids
increased with age, though the authors noted that this was because of two outliers in
the aged group; median levels actually showed a slight decrease compared with the
middle-aged group. In the conclusions section of the paper they acknowledged that
the existence of a correlation, whilst intriguing, did not prove any causative role for
elevated corticosterone levels in brain ageing, or vice versa.
Probably the most important study in this area was provided by Issa and co-workers,
who screened 58 aged rats (23-27 months) for impairments in spatial memory with
the Morris water maze (Issa et al., 1990). Animals with performance greater than two
standard deviations worse than young controls were classified as impaired (28%) and
animals with performance within half of one standard deviation of the young controls
were classified as being unimpaired. They found that compared to the unimpaired
aged animals and young controls the impaired group had higher basal corticosterone
levels. They also found that under conditions of restraint stress the impaired animals
showed a relatively slower recovery of corticosterone levels to basal levels despite
sharing the same peak levels of corticosterone with the unimpaired animals and
young controls. A recent study reported the same pattern of results: older animals
differed in spatial ability and this difference correlated with the speed of recovery of
corticosterone to basal levels (Bizon et al., 2001).
However, other studies have failed to show relationships between impairments in
cognitive function and indices ofHPA function. Yau and co-workers found no
relationship between corticosterone levels and performance on the Morris water
maze in aged Wistar rats, though the normal age-related decrement in performance
was observed (Yau et al., 1994). They also found that there were no changes in the
expression ofGR and MR in the hippocampus in aged versus young rats.
Interventional animal studies
Following on from their observational study correlating corticosterone levels to
ageing-related changes in the hippocampus, Landfield's group tested the hypothesis
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that long-term reductions in corticosterone levels are associated with a reduction in
ageing-related decrements in spatial memory and changes in the hippocampus
(Landfield, 1981). There were several experimental groups, which are summarised in
Table 1.3. Interventions were either drug (ORG 2766, an ACTH analogue;
pentylenetetrazole (PTZ), a 'neural stimulant'), or adrenalectomy with glucocorticoid
replacement. Outcome variables were performance on a delayed-memory maze task 2
and several hippocampal morphological measures of variables which had previously
been shown to show change with ageing, including neuronal density, changes in
neuronal nuclear morphology. A "brain aging index" was also derived from a
combination of the morphological variables.
The main findings were that the young controls and the drug treatment groups
showed significantly better performance than the aged controls and the
adrenalectomised group on the maze task. There was no significant difference
between the aged controls and the adrenalectomised group on this task, though a
trend is evident from examining the bar charts. However, there were differences in
several indices ofmorphological change and in the 'brain aging index'.
2 the task was described as follows (p. 584, note 13): "Animals were trained in a cross-shaped maze
(three arms plus one start box) to choose one arm (left) to avoid or escape footshock: after 1 week,
they were then reversed and trained to the right arm. A footshock trial consisted ofplacing a rat in the
start box and after 5 seconds delivering shock (0.35 mA) to the grids of the start alley and to the two
incorrect maze arms until a correct choice was made. On nonfootshock trials rats were placed in the
maze until a choice was made, or until 2 minutes had elapsed, but no shock was given. At the
beginning of initial training, three acquisition footshock trials were given, and animals were then
tested for retention performance by giving them one nonfootshock trial, and one footshock trial on
each of days 1,4, 5 and 6 after the acquisition session. Two (reversal) acquisition footshock trials were
then given for the reversal phase, and animals were subsequently tested in the same manner and
sequence as after the initial phase acquisition trials. Mean latencies (time from start to correct choice)
on footshock trials were subjected to analyses of variance. Acquisition footshock trials were not
included in this analysis since the study was aimed at assessing retention performance (although
reversal data are also significant if acquisition trials are included)."
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19 11 16,27 Adrenalectomised at 18 months and
maintained on low-dose glucocorticoid
(2) ORG 2766 12 10 16,27 Injection of ORG 2766 once per day,
five times per week, for 8.5 months.
(3) PTZ 12 10 16,27 Injection of PTZ once per day, five
times per week, for 8.5 months.
(4) Vehicle or non-
vehicle controls
33 20 16,27 Injection of vehicle once per day, five
times per week, for 8.5 months, or no




11 11 0,8 No treatment
Despite the considerable interest in this study (it has been cited hundreds of times)
there have been no attempted replications published. Thus there is little strong
evidence that an excess of endogenous glucocorticoids is causally related to changes
in the brain with ageing and parallel decrements in cognitive function.
However, there are several studies which have examined the effects on cognitive
function and the brain of long-term administration of exogenous glucocorticoids.
Virtually all of the studies have focused on the hippocampus; few other brain regions
have been studied in this context. Most studies have shown that chronic exposure to
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glucocorticoids does result in changes in the hippocampus, for example loss of third-
order dendrites (Seckl and Olsson, 1995), but not perhaps the extensive neuronal loss
as was originally suggested (Sapolsky et al., 1986). Studies suggest that it is the CA3
field of the hippocampus which appears to be especially vulnerable to glucocorticoid
exposure. For example, Woolley and co-workers showed that in rats three weeks of
treatment with high dose corticosterone causes a reversible regression of apical
dendrites of neurons in the CA3 field of the hippocampus (Woolley et al., 1990).
Another study found that in primates long-term (one year) implantation of Cortisol
pellets in the hippocampus caused neuronal shrinkage and dendritic atrophy in the
hippocampal subfields of CA2/3 (Sapolsky et al., 1990).
Since the development of unbiased stereological counting techniques, very few
studies have been published revisiting the hypothesis that chronic exposure to high
levels of glucocorticoids actually cause neuronal death, particularly in the
hippocampus. Sousa and co-workers compared several different regimes of
administration of corticosterone in rats (Sousa et al., 1998). Rats were treated in the
neonatal period for 30 days before histological analysis. In the neonatal category the
experimental groups were, control, vehicle-treated, or corticosterone-treated
(subcutaneous injections at lOmg/kg on days 0-10, 20mg/kg on days 11-20, and
30mg/kg on days 21-30). In the adult group the experimental groups were controls,
given no corticosterone and also no injections of vehicle at any stage, a 'recovery'
group, which received no corticosterone beyond the 30 day neonatal treatment
period, and three corticosterone-treated groups. All of the corticosterone groups were
treated as per the neonatal group, then given either (i) 40mg/kg for the remainder of
the 180 day period, or (ii) 40mg/kg from days 90-180, or (iii) 40mg/kg from days
150 to 180. Corticosterone-treated rats showed lower brain weights than vehicle-
treated groups. Corticosterone treatment also caused a reduction in the number of
dentate granule and CA3 pyramidal cells, however this effect was only seen in rats
treated in the neonatal period. That is, adult animals treated with corticosterone did
not show neuronal loss compared with adult animals which received no treatment.
However, the adult-treated animals did show loss of volume in the dentate gyrus and
in CA3. The recovery group also showed greater volumes of the dentate gyrus in
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comparison to the treated groups. Overall, there was a significant effect of
corticosterone treatment on overall hippocampal volume for both the 30-day old and
the 180-old groups. This study does add weight to the hypothesis that prolonged
exposure to high levels of glucocorticoids causes hippocampal atrophy and that this
seems to affect CA3 more than CA1. A potential confounder in this study, however,
is that the aged control group received no injections and therefore one cannot rule out
the general effects of stress caused by injection rather than the direct effects of high
corticosterone levels.
Leverenz and co-workers (Leverenz et al., 1999) conducted a placebo-controlled
prospective study of the effects of high-dose Cortisol supplementation on 16 macaque
monkeys aged between 18 and 29. Monkeys were given Cortisol or placebo for one
year. Cortisol exposure made no difference to total or subfield hippocampal volumes
and also made no difference to neuronal numbers. The authors did not report on any
dendritic changes.
The relationship between decrements in cognitive function and exposure to high
levels of exogenous glucocorticoids is less clear. For example, Bardgett and co¬
workers tested the effects of chronic corticosterone administration on performance
on a test of spatial memory, the Platform Maze Task (Bardgett et al., 1996). This task
had previously been shown to be sensitive to hippocampal dysfunction (Poucet et al.,
1991). Two groups of 13 male Long-Evans rats aged 80-100 days old were given
eight weeks of either daily injections of corticosterone (lOmg/kg) or vehicle. This
group had previously published evidence that this regime produced stress levels but
not supraphysiological plasma levels of corticosterone. No differences between the
groups were found on any of the task outcome variables. No analysis of brain was
included in this report.
Another group of studies has looked at the effects of antidepressants on
corticosterone levels and age-related cognitive decrements in animals, based on the
observations that (1) in some studies hippocampal MR and GR are reduced and (2)
antidepressants have been shown to increase expression of hippocampal MR and GR
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in young rats, thus enhancing feedback sensitivity of the HPA axis (Seckl and
Olsson, 1995; Yau and Seckl, 2001).
Yau and co-workers administered long-term amitriptyline to young and aged Wistar
rats and examined effects on Morris water maze performance and also on expression
ofhippocampal MR and GR (Yau et al., 1995). They found that amitriptyline
treatment only affected young rats, in terms of increased performance and higher
expression of hippocampal MR, but not hippocampal GR. Compared with the young
rats, aged rats did show worse performance on the watermaze and had higher basal
corticosterone levels. Interestingly, in the aged rats, hippocampal GR expression was
positively associated with watermaze performance and negatively associated with
corticosterone levels.
A similar study was conducted with a different breed of rats, the Lister-hooded, as
the Wistar rats in the original study had shown difficulties in learning the watermaze
task across the age range (Yau et al., 2002). Rats were treated from 16 months with
amitriptyline or vehicle and at 24 months. Corticosterone levels were measured at 22
months. Performance on the watermaze and levels ofanxiety as measured by the
elevated-plus maze were measured at 24 months. Amitriptyline-treated rats showed
significantly better performance than vehicle-treated rats, with virtually all showing
comparable performance to the young control group. The mean performance of aged
rats treated with placebo was lower in comparison to a young control group, but there
was considerable overlap between the aged and young rats, with around one third of
the aged rats showing no impairment, as had been previously observed (Issa et al.,
1990). Amitriptyline-treated rats also showed lower corticosterone levels and lower
levels of anxiety.
Further and compelling evidence that elevated glucocorticoids might affect
vulnerable regions of the brain has emerged with the development of a mouse with
the gene for 11B-HSD1 knocked out. 11B-HSD1 is thought to function
predominantly as a reductase in vivo, regenerating active glucocorticoids from their
inactive metabolites (Rajan et al., 1996). Thus it was hypothesised that mice lacking
the 1 lfi-HSDl gene would show less age-related cognitive decline because of
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reduced exposure of neurons containing 11I3-HSD1 to active glucocorticoids -
'intraneuronal' glucocorticoids as opposed to plasma levels. Yau and co-workers
compared watermaze performance and corticosterone levels in aged wild-type and
116-HSD1 knockout mice. The knockout mice showed significantly better
performance on the watermaze despite having higher mean corticosterone levels
(possibly because of reduced feedback to the HPA axis). Wild-type mice showed the
predicted higher variation in performance and corticosterone levels seen with ageing




Cushing's syndrome is characterised by chronic excess of glucocorticoids, largely
caused by ACTH-secreting tumours in the pituitary gland and elsewhere, or by
chronic excess of exogenous steroids (Williams and Dluhy, 2001). Cushing's
syndrome is of considerable interest as there is a relatively pure increase in Cortisol
levels. This disorder thus serves as a model for understanding the effects of Cortisol
hypersecretion onmultiple systems. This is in contrast to other conditions in which
hypercortisolaemia is seen, such as depressive illness, in which there are many other
hormonal and neurotransmitter abnormalities.
Patients with Cushing's syndrome commonly have abnormalities in multiple
systems: centripetal obesity, increased weight, tiredness, hypertension, hirsutism,
amenorrhoea, purple cutaneous striae, depression and other psychiatric changes,
cognitive impairment, osteoporosis, hyperglycaemia with diabetes mellitus in some
patients, bruising, proximal myopathy and fluid retention. There is a higher excretion
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ofurinary free Cortisol and plasma Cortisol levels show little or no suppression with
dexamethasone.
One of the first reports of links between Cushing's syndrome and changes in the
brain was provided by Momose and co-workers (Momose et al., 1971).
Pneumoencephalography was used to study the 31 patients with Cushing's
syndrome. They found that 90% of cases met criteria for atrophy of the cerebrum and
the cerebellum. The same techniques were applied to 64 patients with acromegaly;
30% were found to have atrophy. The authors noted that the appearances of atrophy
were similar to those observed in many patients with old age.
Other published studies have replicated this finding. Starkman and co-workers
demonstrated that patients with Cushing's syndrome showed atrophy of the
hippocampus in association with deficits in verbal memory (Starkman et al., 1992).
More recently the same group reported that in 22 patients with Cushing's disease,
treatment caused an increase in the volume of the hippocampus; the 'control' region
of the head of the caudate nucleus showed no such increase post-treatment (Starkman
et al., 1999). Unfortunately no other brain regions were studied.
There are several studies examining the impact ofCushing's syndrome on cognitive
function and mood. Whelan and co-workers administered a large battery ofcognitive
tests, including the full WAIS and tests of delayed verbal memory, to 35 patients
with Cushing's syndrome before treatment (Whelan et al., 1980). They compared
patients' scores on this battery with the norms provided for the battery of tests.
Patients were classified into four groups on the basis of their performance, with
Group I being normal or equivocal performance and Group IV being frequent and
marked signs ofneuropsychological deficits. 22 of the 35 patients were classified as
being in the clearly impaired groups. The deficits were present in virtually all tests:
"... no function was spared; all tests of higher (cognitive) and lower (sensory and
motor) functions showed marked defects in at least one patient." (p.755). No group
of tests appeared to be affected more than the others. However, this study was
weakened by the lack of a control group; the use ofnorms fails to take account of
pre-morbid ability. Starkman and co-workers did a similar study in 48 untreated
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Cushing's syndrome patients and 38 healthy controls (Starkman et al., 2001). They
used standard test batteries: the WAIS-R and the Wechsler Memory Scale-Revised,
and assessed mood with two standard scales. Significant differences between patients
and controls were found on all of the cognitive tests, though the differences were not
large. For example, mean scores on delayed paragraph recall (Logical Memory II)
were 8.4 (SD 3.3) for the control group and 6.2 (SD 2.5) for the patient group.
However, no measures ofpremorbid or prior IQ such as the NART were used and
therefore differences cannot with certainty be attributed to the effects of chronic
exposure to higher levels of Cortisol. However, the general pattern of results is
similar to Whelan's study. Forget and co-workers (Forget et al., 2000) studied 19
patients with Cushing's syndrome in relation to controls matched for age, sex,
occupation. Subjects completed a large battery of cognitive tests, including standard
tests ofmemory and intelligence. They found widespread deficits in the patients'
performance. These small studies suggest that (1) chronic exposure to high levels of
Cortisol is associated with cognitive decrements and that (2) these cognitive
decrements are general, that is, no particular cognitive domain is affected more than
any other.
Human observational studies
There are few human studies with adequate statistical power which have examined
glucocorticoid - cognitive function relationships. The two largest are considered
here. Seeman and co-workers examined the relationship between Cortisol levels and
cognitive function, both measured at two time points 2.5 years apart, in a sample of
194 healthy men and women aged 70-79 (Seeman et al., 1997). Cortisol levels were
measured using 12-hour urinary free Cortisols. Cognitive function was assessed with
a battery of tests involving immediate and delayed memory tasks, a copying task
designed to measure spatial ability, and 'abstraction' (the details of this tasks are not
provided). Cross-sectional analyses revealed that in women Cortisol secretion was
negatively correlated with delayed verbal recall (r=-0.2, p=0.04); there were no other
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significant correlations for the women or the men. Cortisol excretion showed a
widening of the variance (that is, a flatter distribution) with a small decrease in the
mean excretion for both men and women. In women, there was a significant negative
correlation between Cortisol increases and delayed paragraph recall (r=-0.23,
p=0.01). There was no such correlation in men. This study did demonstrate the
possibility that elevated Cortisol might be associated with decrements in cognitive
function. However, the population was selected for good health and the age group
was comparatively old. This might mean that individuals with the combination of
high Cortisol and cognitive decrements are selected out before the onset of the study.
Kalmijn and co-workers performed a prospective study of cognitive function and
Cortisol levels in 189 healthy volunteers aged 55 to 80 who had two sets of
measurements two years apart (Kalmijn et al., 1998). Cortisol levels were measured
before and after administration of lmg of dexamethasone. Cognitive function was
measured with the MMSE, with subjects being classified as being cognitively
impaired if their score was 25 or less, and described as showing cognitive decline if
the MMSE score dropped by more than one point. Analyses were conducted after
controlling for age, sex, education and depressive symptoms. Using logistic
regression an increase of 1 SD in Cortisol was associated with only a trend in
cognitive impairment but post-dexamethasone Cortisol levels were significantly
associated with cognitive decline. This study also suggested a possible link between
higher Cortisol levels and cognitive function despite the use of a relatively insensitive
cognitive test.
These studies and a small number of other observational studies lend some support to
the hypothesis that there is an association between higher glucocorticoid levels and
cognitive function with ageing. However the direction of causation cannot be
determined by observational studies. In the next section interventional studies will be
reviewed.
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Human interventional studies
Most human studies have examined the effects of the administration of Cortisol or
synthetic glucocorticoids such as dexamethasone or prednisolone over varying
periods, from those attempting to mimic the hours-long glucocorticoids seen with
stress to several days or weeks of exposure to high doses of glucocorticoids, with
varying dosages and different sets of cognitive tests. These studies do not directly
address the roles of glucocorticoids in normal human cognitive function and are
considered in the next section.
The studies involving synthetic glucocorticoids are difficult to interpret because
these drugs probably do not enter the brain because of the mdrla P-glycoprotein
(Schinkel et al., 1995). These drugs might actually cause brain levels of
glucocorticoid to decrease by inhibiting production of Cortisol (which enters the brain
freely) via feedback effects on the pituitary. There are also correlational studies
which have demonstrated associations among declarative memory and other
cognitive functions, stress and Cortisol levels (Roy et al., 2001a). However, studies of
social stress cannot be used as direct evidence for a causal effect ofCortisol on
cognitive function because of the complexity of the stress response. There are no
published studies examining the effects of blockade ofMR or GR on cognitive
function in humans.
The first studies reviewed here have examined the effects of short-term increases of
Cortisol on various cognitive functions. Lupien and co-workers performed a small but
interesting study in which four groups of 10 young, healthy men were given placebo,
40, 300, or 600 mg/kg/hr of intravenous hydrocortisone (Lupien et al., 1999).
Cognitive function was assessed during the infusions with tests ofworking memory,
declarative memory and a continuous performance task. They found that neither
declarative memory nor performance on the continuous performance task was
affected in any condition, but that working memory was affected in the highest dose
condition. Subjects were only tested during the infusion and unfortunately
declarative memory was not assessed after washout, for example, the next day.
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In a double-blind, placebo-controlled, crossover trial De Quervain and co-workers
examined the effects of acute elevations ofCortisol in 36 healthy subjects (18 males
and 18 females) aged between 20 and 40 a declarative memory task (de Quervain et
al., 2000). No other cognitive tasks were used. Subjects were shown 60 nouns on a
computer screen, one at a time, at intervals of four seconds. 24 hours later they
completed free recall and recognition tasks. 25mg cortisone (which is metabolised to
Cortisol in vivo) was given at one of three different times: (A) one hour before the
initial presentation, (B) immediately after presentation, or (C) one hour before the
recall and recognition tasks. Each subject performed each condition at intervals of
two weeks. The report does not state at what time of day the tasks were carried out.
Performance was worse on the free recall task in condition C but there were no
effects in the other conditions and on the recognition tasks. At the end of condition
C, subjects were also administered an immediate free-recall test for an additional
immediate free-recall task of 20 words. No effect was observed on performance on
this task. The authors interpreted this as showing that stress levels of Cortisol impair
retrieval but not acquisition or consolidation processes in declarative memory.
Plihal and Born (Plihal and Bom, 1999) hypothesised that a drop in Cortisol levels
overnight is necessary for memory consolidation, based on three pieces of evidence:
(1) that slow-wave sleep (as opposed to rapid eye movement sleep or no sleep)
facilitates performance on declarative memory tasks, (2) similar patterns of
hippocampal neuronal firing during slow wave sleep to those seen during spatial
memory learning tasks, and (3) that slow wave sleep tends to occur when
glucocorticoid levels are at their lowest. Subjects were 14 healthy men aged between
21 and 31. The study was double-blind placebo-controlled crossover in design. In the
first experiment, declarative and non-declarative memory tasks were administered in
late evening and after falling asleep subjects were then given either 30mg
intravenous Cortisol or saline over 3 hours. Then subjects were awoken and
performance tested. Cortisol levels increased to a peak of420 nmol/1 in the Cortisol
infusion condition and dropped to a trough of 51nmol/1 in the placebo condition.
Declarative memory but not non-declarative memory was impaired in the Cortisol
condition. There was no effect on the duration of slow wave sleep. In the second
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experiment the authors wished to test the idea that ongoing MR stimulation
facilitates memory formation in the hippocampus. 14 similarly aged male subjects
were given either 200mg intravenous canrenoate, a specific MR antagonist, over 10
mins at 0900 and 1700, or saline. Interestingly, subjects given canrenoate showed a
reduction in slow wave sleep; Cortisol levels showed small but significantly different
levels (canrenoate: 100 nmol/1; placebo: 33 nmol/1). However, although there were
trends in the predicted directions, there were no significant differences in
performance on the declarative or non-declarative tasks. The authors interpreted
these findings as demonstrating that optimal memory consolidation in slow wave
sleep requires GR to be predominantly unoccupied, but that blockade ofMR had
little effect.
There is another small group of studies which have examined the effects of longer-
term elevations of glucocorticoids induced pharmacologically. In a double-blind,
placebo-controlled (but not crossover) study Newcomer and co-workers administered
placebo, or 40mg or 160mg ofCortisol to 51 healthy subjects aged 18 to 30
(Newcomer et al., 1999). Cortisol was given in two divided doses for four days.
Cognitive assessments, performed on days one and four of treatment, were paragraph
recall (immediate and delayed; oddly the authors only present data on commission
errors - 'intrusions or confabulations' - and not the standard omission errors),
delayed match to sample (spatial memory), the Stroop test, the continuous
performance task, verbal fluency and spatial memory. The 160mg Cortisol dose
produced mean Cortisol levels ofapproximately 750nmol/l, as compared to levels of
approximately 200nmol/l for the placebo and 40mg Cortisol treatment. The 160mg
dose affected performance on both the immediate and delayed components of the
paragraph recall task on day four of treatment, but not at day one or performance on
any of the other cognitive tasks at day one or four. The 40mg dose had no effect on
any cognitive test versus placebo. Performance was similar for all groups after the
six day washout period.
Young and co-workers administered placebo or Cortisol 20mg twice a day for 10
days to 20 males aged between 21 and 44 (Young et ah, 1999). Subjects were given
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both treatments with a three-week washout period. Significant differences were
found in tasks of spatial working memory and delayed spatial memory. No deficit
was observed in the Tower of London task (a test of 'executive' function).
Few studies have studied the effects of long-term administration of glucocorticoids
on cognitive function in humans. Keenan and co-workers (Keenan et al., 1996a)
examined cognitive function in a group of 25 patients who had been taking between
5 and 40mg ofprednisolone for at least 1 year compared with 25 controls (age-
matched patients with similar diagnoses). They found that the patients performed
worse than the controls on a test of delayed verbal memory but showed the same
performance on tests of procedural memory, fluid intelligence and other cognitive
tests.
The above studies, though interesting, are difficult to interpret because of several
reasons, including the generally low statistical power and the different paradigms
used. In the light of the animal studies demonstrating that situational and temporal
context is crucial in determining the effects of short-term fluctuations in
glucocorticoids perhaps the only clear conclusion from the human studies is that
giving high doses of glucocorticoids for sustained periods (that is, for longer than the
duration of a typical stress response), or in such a way as to override circadian
rhythms, probably reduces performance on some cognitive tasks. In animals,
performance on tasks known to be dependent on intact hippocampi is often affected.
In humans the number of studies is too small to determine if any there are specific
effects on tasks involving immediate and delayed memory.
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1.4.4 Conclusions
Currently there is enough evidence to suggest that some ageing animals and humans
develop dysregulation of the HPA axis. In most studies this is manifested by a slower
return to normal of glucocorticoids following an episode of stress but some studies
have shown a flattening of the distribution curve of overall output of glucocorticoids,
with the result that some ageing animals and humans do show relative hypersecretion
of glucocorticoids. However, there are surprisingly few informative studies in
humans; the two published studies of sufficient size have only had follow-up periods
of two to three years.
The pathophysiology of ageing-related changes in the HPA axis is unclear. Although
the main sites ofHPA axis feedback are the pituitary gland and the hypothalamus,
the hippocampus and other sites in the brain also exert influence on the HPA axis.
The hippocampus exerts an inhibitory effect on the HPA axis: lesions of the
hippocampus cause rises in glucocorticoid levels. Both MR and GR are thought to
play a role in this. The significance of ageing-related hippocampal atrophy and
changes in receptor densities and other determinants of glucocorticoid sensitivity
such as 1 lfl-HSDs in this context are as yet unclear.
That prolonged elevations of glucocorticoids result in changes in the brain is in little
doubt. Animal studies have demonstrated that interventions which result in an
increase in exposure of the brain to glucocorticoids cause atrophy of the
hippocampus, particularly in the CA3 field. Landfield's important interventional
study (Landfield, 1981) in which ageing-associated elevations of corticosterone in
rats were prevented by adrenalectomy and low-dose replacement provided strong
initial evidence and multiple studies have confirmed varying degrees of atrophy
following prolonged exposure to high levels of glucocorticoids. In humans, the
strongest evidence undoubtedly comes from the brain atrophy observed in Cushing's
syndrome.
The evidence directly linking elevated glucocorticoids with cognitive impairments in
animals is perhaps less clear-cut. Some observational studies, in particular that of
Chapter 1: Cognitive function and brain volumes
66
Cognitive function, the brain and glucocorticoids
Issa and co-workers (Issa et al., 1990), have provided evidence suggesting that there
is an association between rising glucocorticoid levels and cognitive impairment.
However, not all interventional studies have shown such an association. Some
indirect evidence has emerged from the antidepressant studies ofYau and co-workers
(for example, (Yau et al., 2002), which have shown that antidepressant treatment
attenuates ageing-related cognitive impairments. The effects on cognitive function
are paralleled by lower overall output of corticosterone in the treated animals, and an
explanation for this effect is provided by the relatively higher levels ofMR and GR
in the hippocampus of the treated animals, which might enhance feedback regulation
of the HPA axis. Further and more direct evidence is provided by the recent
development ofmice with the gene for 11B-HSD1 (which regenerates active
corticosterone from deoxycorticosterone) knocked out; these mice show striking
attenuation of ageing-related cognitive deficits in comparison to controls.
In humans very strong evidence of the adverse effects ofprolonged elevated
glucocorticoids on cognitive function is provided by several studies demonstrating
widespread cognitive deficits in Cushing's syndrome. Observational studies with
sufficient power are lacking but those that do exist have shown small associations
between glucocorticoid levels and ageing-related cognitive decrements.
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1.5 Hyperglycaemia and cognitive ageing
A key feature of ageing is the increasing degree of carbohydrate intolerance observed
(Arking, 1998). There are several methods ofmeasuring this, including fasting
glucose levels, glucose levels after a carbohydrate (usually glucose) load, and also
levels of glycosylated haemoglobin (HbAlc). HbAlc levels reflect the average blood
glucose concentration over a 6-8 week period and are used in diabetic patients to
monitor blood glucose control.
Type II diabetes mellitus (DM) is defined by the American Diabetic Association as
fasting glucose greater than or equal to 7.0 mmol/1, and the intermediate category of
'impaired fasting glucose' as a fasting glucose of 6.1 to 6.9 mmol/1 (Harris et al.,
1998). Associated with hyperglycaemia is the 'metabolic syndrome'. An individual
is said to have the metabolic syndrome if they have three or more of the following
abnormalities: waist circumference greater than 102 cm in men and 88 cm in women;
serum triglycerides level of at least 1.69 mmol/1; high-density lipoprotein cholesterol
level of less than 1.04 mmol/1 in men and 1.29 mmol/1 in women; blood pressure of
at least 130/85 mm Hg; or serum glucose level of at least 6.1 mmol/1. Although not a
part of the formal definition of the metabolic syndrome, insulin resistance is also
common, with higher fasting insulin levels clustering with these abnormalities.
The incidence of all of these abnormalities increases with age, and therefore the
number ofpeople with the metabolic syndrome is rising. In the United States the
prevalence of the metabolic syndrome is now 40% in people over the age of 60. The
metabolic syndrome is known to be an important cardiovascular risk factor (Ford et
al., 2002). Recently there is growing interest in the role that type II DM,
hyperinsulinaemia and components of the metabolic syndrome might have in
determining age-related cognitive decrements.
Type II DM is an established risk factor for Alzheimer's disease (Ott et al., 1999)
and also for vascular dementia (Hebert et al., 2000). However, it is also associated
with milder cognitive impairments. Strachan and co-workers reviewed the literature
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in 1997 and found that of 17 published studies, 13 showed an association of diabetes
mellitus with milder cognitive impairment, most often affecting tests of verbal
memory (Strachan et al., 1997). Since then other studies have largely confirmed this
finding (MacKnight et al., 2002).
In keeping with the associations with ageing-related cognitive impairment type II
DM is probably associated with changes in the brain, though the number of studies is
small. Animals with streptozocin-induced diabetes (in which rats are injected with
streptozicin, causing damage to insulin-producing pancreatic beta-cells) show
deficits in processes underlying memory formation in the hippocampus (Biessels et
al., 2002). In humans, two small studies have linked type II DM with cerebral
atrophy (Soininen et al., 1992; Araki et al., 1994).
Type II DM is well known to be associated with increased risk of vascular disease,
including stroke and cardiovascular disease. Recently there have been attempts to
link evidence of relative carbohydrate intolerance in subjects not meeting the criteria
for diabetes mellitus, for example subjects with impaired fasting glucose or elevated
HbAlc. In a prospective study of 4662 men Khaw and co-workers found that in
HbAlc levels were continuously related to mortality from all-cause and
cardiovascular causes in both diabetics and non-diabetics (Khaw et al., 2001). This
effect was independent of age, blood pressure, serum cholesterol, body mass index,
and smoking. There are no current studies linking HbAlc with cognitive function in
non-diabetics, but other related variables have been studied, including
hyperinsulinaemia (Kuusisto et al., 1993), hyperlipidaemia (Kivipelto et al., 2001)
and hypertension (Meyer et al., 1999; Meyer et al., 2000; Starr, 1999; Swan et al.,
1998), with most studies finding small but significant associations.
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1.6 Aims and Hypotheses
This thesis has several aims. Firstly, the relationships among performance on
different cognitive tests are analysed, with the hypothesis that the tests will be
significantly and positively intercorrelated. Principal components analyses will be
used to derive latent traits. Secondly, detailed volumetric and spectroscopic
neuroimaging is used to characterise volumes of certain brain regions (hippocampi,
temporal lobes and frontal lobes) and metabolite levels. Thirdly, relationships among
cognitive and neuroimaging variables are examined. Specifically the hypotheses that
larger brain volumes and that higher levels ofN-acetylaspartate are associated with
better performance on cognitive tests are tested. Fourthly, the hypotheses that
increased glucocorticoid levels are associated with (a) relative atrophy of the
hippocampi, (b) lower N-acetylaspartate levels and (c) relative cognitive impairment
are tested. Finally, the hypothesis that hyperglycaemia is associated with relative
cognitive impairment is tested.




Subjects were 111 healthy, unmedicated male volunteers aged 65-70. They were
recruited with the help of local general practitioners in several practices in
Edinburgh. After the initial approach by means of an explanatory letter, general
practitioners were asked to provide a list ofmen aged 65 to 70 in their practice who
were not known to have significant illness and who were not taking regular
medication. Once this list was supplied, I visited each practice and screened the
casenotes of the men on the list, looking for evidence of ill health or regular
medication. Once these notes had been screened, letters with stamped, addressed
envelopes were sent to subjects asking if they would agree to being telephoned to
hear more about a research study.
Of those written to, about half in each practice replied positively. These volunteers
were then telephoned and the basics of the study were explained. If they continued to
show interest then I conducted a brief telephone screening questionnaire asking the
volunteer about serious illness, attendance at their general practice or at hospital
outpatient clinics, alcohol intake (those with an intake of greater than 28 units per
week were excluded), and use of prescribed, regularmedication. If the screening
tests were negative then a visit to the volunteer's home was arranged. In the home
visit a more detailed screening of symptoms was taken and any subjects with
evidence of illness were excluded and referred to their general practitioner. This
included, for example the subject describing angina or symptoms of depression or
anxiety. If the medical screening was negative I then went on to describe the study in
greater detail and obtain consent.
Age, body mass index and waist-hip data are shown in Table 2.1. As might be
expected in a group of healthy elderly volunteers, social classes I and II were
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overrepresented in comparison to the population: 33.9% (N=39) were in social class
I, 33% (N=38) were in social class II, 18.3% (N=21) were in social class III, 10.4%
(N=12) were in social class IV and 0.9% (N=l) in social class V.
Table 2.1: Age, Body Mass Index and Waist-Hip Ratio data
Mean Range Standard Deviation
Age (years) 67.8 65.4-70.4 70.4
Body Mass Index 26.9 20.4-34.6 2.94
Waist-Hip Ratio 0.94 o 000 1 —X 0.057
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2.2 Cognitive tests
These tests were selected on the basis that they are well-established, reliable and
valid. Also, none has a strong ceiling effect, that is, few or none of the subjects will
score maximum points. The tests are thought to test different cognitive domains, and,
other than the National Adult Reading Test, show substantial decrements with ageing
(Lezak, 1995). Because of hypotheses concerning the effects of glucocorticoids on
medial temporal lobe structures, and because damage to medial temporal lobe
structures is known to be associated with decrements in tests involving recall of
previously-presented information, there is an emphasis on assessments ofmemory in
the selection of the tests.
'Premorbid' or 'prior' IQ
National adult reading test
The National Adult Reading Test (NART) (Nelson and Willison, 1991) is a test in
which the subject is asked to pronounce irregularly spelt words such as "chord",
"ache" and "leviathan". This is thought to indicate familiarity with the word and thus
is related to a subject's vocabulary. Performance on this test correlates highly with
full scale IQ as measured by the Wechsler Adult Intelligence Scale (Lezak, 1995). In
healthy populations scores on the NART correlate more highly with verbal IQ than
with performance IQ (Crawford et al., 1989). The main use of the NART is as a
means of estimating 'premorbid' IQ, as scores correlate highly with IQ scores in
childhood and adulthood (Crawford et al., 2001), though the term 'prior' IQ is
perhaps preferable in ageing populations without specific disease.
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Verbal memory
Auditory-verbal learning test (AVLT)
The auditory-verbal learning test (AVLT) (Lezak, 1995) involves reading out a list of
15 words at a rate of one per second, then asking the subject to repeat as many words
back as possible (Appendix 2). The examiner then reads out the same list at the same
rate and the subject then attempts to repeat back the same list, including words
previously recalled. This procedure is repeated until the list is read a total of five
times. Then a different list ofwords is read once and the subject is asked to repeat as
many as he or she can from the new list. After this, the first list is read out again and
the subject is asked to again recall as many words as possible from the first list.
There then follows a delay of 30 minutes, after which the subject, without having the
original list read out again, is asked to recall as many words from the first list as
possible.
Logical Memory
Logical Memory is one of the subtests from the Wechsler Memory Scale - Revised
(Wechsler, 1981). This is a test involving the presentation of two short stories with
25 scoring units or 'memorable ideas'. The examiner stops after each story and asks
the subject for immediate free recall. After a delay of 30 minutes the subject is asked
to recall as much of each story as possible. In the current studies, some of the
subjects were also asked to return the following day for testing of free recall of
Logical Memory; this is termed 'Logical Memory - 24hr delayed'. Ageing and
dementia are both associated with reduced scores in both the AVLT and Logical
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Visuospatial memory
Visual Reproduction
This test is also part of the Wechsler Memory Scale - Revised (Wechsler, 1987). In
this test the subject is shown a series of four simple geometric designs. An example
is shown in Figure 2.1. A subject is given five seconds to look at one design, then
this is hidden and the subject is asked to draw the design. The test is repeated,
without further prompting, 30 minutes after the initial presentation. Performance on
Visual Reproduction declines with age and with dementia (Wilson et al., 1983; Bak
and Greene, 1981; Lezak, 1995).
Figure 2.1: Sample item from Visual Reproduction
Benton Visual Retention Test
The Benton Visual Retention Test (BVRT) is a test of visuospatial recall (Sivan,
1992). The subject is shown a series of 10 cards with between one and three simple
geometric designs on each. An example is shown in Figure 2.2. The subject is asked
to look at the card for 10 seconds, then the card is hidden and the subject has to wait
five seconds before reproducing the shapes on a blank sheet of paper. This method is
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known as Administration B. Each item was scored either 0 or 1. As with Visual
Reproduction, performance on the BVRT declines with age and dementia (Giambra
etal., 1995; Lezak, 1995).
Figure 2.2: Sample item from the Benton Visual Retention Test
Verbal Fluency
The most commonly-used test of verbal fluency is the Controlled Oral Word
Association Test (Lezak, 1995). The examiner speaks out loud a letter from the
alphabet and the subject is instructed to speak out loud as many words beginning
with that letter as possible in one minute, excluding proper nouns and the same word
with different suffixes. In this thesis, the letters C, F and S were used. This test has
been shown to be sensitive to damage to the frontal lobe (Lezak, 1995) and is often
considered a test of 'executive' or 'frontal lobe' function. As with the above tests,
performance on the Controlled Word Association Test shows decline with ageing
and also in dementia (Lezak, 1995).
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Non-verbal reasoning
Raven's Standard Progressive Matrices
Raven's Standard Progressive Matrices (RSPM) consists of a series of visual pattern
matching and analogy problems shown in abstract designs (Raven et al., 1977).
RSPM is thought to be one of the best tests of fluid intelligence and loads highly on
to the general cognitive factor (Carroll, 1993). There are 60 items organised in five
groups of 12. Subjects were given 20 minutes to complete the test and the score was
the number correct. Performance on RSPM shows decline with ageing (Carlson and
Jensen, 1981) and with dementia (Gainotti et al., 1992).
Attention and Processing Speed
Digit Symbol
The Digit Symbol Substitution Test (DSST) of the Wechsler Adult Intelligence
Scale-Revised (Wechsler, 1981)was used as an indicator of attention and processing
speed. Subjects are instructed to draw in symbols in blank boxes under numbers
according to a code given at the top of the answer sheet. The score was the number
of correct substitutions in 90 seconds. The DSST is highly sensitive to age
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2.3 Testing protocol
Subject were asked to fast overnight before attending, and then either arranged their
own transport or were brought in a taxi to the Western General Hospital. Blood was
taken for Cortisol, glucose, full blood count, B12 and folate, urea and electrolytes,
total cholesterol and thyroid function tests. Once the blood was taken, subjects were
given breakfast in the hospital canteen. Subjects were given decaffeinated tea and
coffee.
After 30 minutes, subjects were brought to the cognitive testing room and the
protocol started. The following tests were administered:
National Adult Reading Test, Digit-Symbol Substitution Test, Auditory-Verbal
Learning Test, Raven's Matrices, Logical Memory, Visual Reproduction, and the
Benton Visual Retention Test. The delayed components of the Auditory-Verbal
Learning Test, Logical Memory and Visual Reproduction were administered 30
minutes after the immediate components. The tests were administered with a
standardised sequence ofbreaks which allowed the tests of the delayed components
to be administered at 30 minutes. The length of the testing session was two-and-half
hours and there were three breaks.
Subjects were then given lunch and returned at 2.30pm to have blood taken for
Cortisol. The following day a proportion of subjects returned to have recall on
Logical Memory re-tested.
At least one week later subjects were asked to take dexamethasone 0.25mg at 11pm
and come to the Western General Hospital the following morning (0900) to have
blood taken for Cortisol measurement.
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2.4 Blood sampling
Levels ofplasma glucose, HbAlc and other standard clinical tests were carried out
by the Clinical Biochemistry department in the Western General Hospital. Glucose
levels were measured with a Roche Hitachi 912 using the enzymatic method; the
between-batch precision for this assay is 1.4%. HbAlc levels were measured with a
BioRad Variant 2 using ion-exchange high performance liquid chromatography; the
between-batch precision for this assay is 1.2% (details of the glucose and HbAlc
assays were provided by Dr. Susan Walker of the Clinical Biochemistry department).
Blood samples for Cortisol were immediately spun and frozen at -20°C. The
radioimmunoassay for Cortisol levels is described in Chapter 6.
2.5 Magnetic resonance imaging and spectroscopy
Subjects were scanned in a 1,9T Elscint scanner in the Brain Imaging Research
Centre for Scotland in the Department ofClinical Neurosciences in the Western
General Hospital. Scanning protocols allowed for detailed volumetric imaging,
imaging ofwhite matter lesions and magnetic resonance spectroscopy.
Neuroimaging data reported here are in two categories: brain and intracranial
volumes and spectroscopy. As the scanning protocols and methods of analysis were
designed and carried out by staff in the Brain Imaging Research Centre for Scotland,
these methods are in Appendix 1.
2.6 Statistical analyses
All statistical analysis was carried out using SPSS versions 10 and 11 apart from the
structural equation modelling, which was carried out by Professor Ian Deary using
the EQS program. Specific analyses are described in each chapter.
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3.1 Introduction
Because the cognitive data apply to all of the remaining data chapters, an overview
of the data is provided here. First, basic descriptive data are provided, then the data
are reduced by means of correlational and principal components analyses. These
latter two procedures were carried out because in much of the literature relationships
among scores on cognitive tests and other types of variables, such as brain volumes,
are analysed without accounting for shared variance among cognitive test scores.
Overall, 111 men were tested but because 97 had usable scans, the data from these 97
are described here.
3.2 Descriptive Statistics
Table 3.1 shows the minimums, maximums, means and standard deviations for the
data. N= 97 for all tests except N=96 for Logical Memory and Visual Reproduction,
in which two different subjects had their testing session interrupted, Raven's
Standard Progressive Matrices (RSPM) (N=95), in which two subjects did not
complete their answer sheets correctly, and Logical Memory 24hr, in which 59
subjects returned the following day for testing of recall.
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Table 3.1: Descriptive data for cognitive tests
Cognitive Test N Minimum Maximum Mean SD
NART 97 13 50 36.2 9.3
Verbal Fluency 97 17 85 43.4 13.1
DSST 97 23 73 48.4 10.5
AVLT trials 1 to 5 97 30 66 49.1 7.8
AVLT trial 7 97 7 15 11.7 2.0
BVRT 97 0 10 6.7 2.0
Logical Memory 1 96 10 42 25.3 6.1
Logical Memory 2 96 4 40 20.9 6.9
Logical Memory 24hr 59 5 33 18.7 6.7
Visual Reproduction 1 96 19 41 33.5 5.2
Visual Reproduction 2 96 8 41 27.5 7.8
RSPM 95 11 59 41.5 8.6
Abbreviations: NART: National Adult Reading Test; DSST: Digit-Symbol Substitution Test; AVLT1JS: summed
scores from the Auditory Verbal Learning Test trials 1 to 5; AV7: Auditory-Verbal Learning Test trial 7; AVLT:
Auditory-Verbal Learning Test; BVRT: Benton Visual Retention Test; RSPM: Raven's Standard Progressive
Matrices.
Data from some of the tests (National Adult Reading Test, the Benton Visual
Retention Test and Visual Reproduction) showed some skew to the right (histograms
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for all the tests are shown in Appendix 2). However, this was not so severe as to
preclude the use ofparametric statistical tests.
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3.3 Correlations
Studies have shown scores from the immediate and delayed components ofmemory
tests are often very highly correlated. Therefore these components of Logical
Memory, Visual Reproduction and the AVLT were correlated. These correlations are
shown in Table 3.2.
Table 3.2. Correlations between immediate and delayed components of
memory tests
Tests Correlation (Pearson)
Logical Memory 1 versus Logical Memory 2 r=0.86, (p<0001, N=96)
Visual Reproduction 1 versus Visual Reproduction 2 r=0.78 (p<.0001, N=96)
AV1_5 versus AV7 r=0.64 (pc.0001, N=97)
Abbreviations: AV15: summed scores from the Auditory Verbal Learning Test trials 1 to 5; AVI: Auditory-
Verbal Learning Test trial 7.
Because these correlations are high and because of the high degree of overlap in
terms of constructs, and also because of concerns over multicollinearity when
multiple regression and other multivariate techniques are used, the scores from each
of these pairs of immediate and delayed memory tests were standardised and
summed. In the rest of this thesis, the variables Logical Memory, Visual
Reproduction and AVLT refer to these summed scores.
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The data were then explored in terms ofpatterns of correlations, using initially
Pearson's correlations and then principal components analysis. The correlation
matrix for the cognitive tests is shown in Table 3.3. This shows that all of the tests
are positively and significantly intercorrelated. However, it is clear that some tests
are more related than others. For example, AVLT correlates at r=0.56 with Logical
Memory, another test of verbal memory, whereas it correlates at r=0.30 with the
Benton Visual Retention Test, a test of visuospatial memory. These findings prompt
the use ofprincipal components analysis to uncover the underlying structure of the
relationships among these tests.
Table 3.3. Pearson correlations among cognitive tests
VF DSST AVLT LM LM 24 VR BVRT RSPM
NART .52** .52** .32** 44** .36** 42** .42** 44**
VF .42** .27** .27** .29* .35** .38** .35**
DSST .37** .42** .38** .54** .48** .57**
AVLT .56** .64** .34** .30** .35**
LM .94** .46** .31** .32**
LM 24 .48** .47** .37**
VR .61** .63**
BVRT .65**
**p<01; *p<.05 (2-tailed). Listwisedeletion.
Abbreviations: NART: National Adult Reading Test; VF: verbal fluency; DSST: Digit-Symbol Substitution Test;
AVLT: Rey Auditory-Verbal Learning Test; BVRT: Benton Visual Retention Test; LM: Logical Memory; LM 24:
Logical Memory - 24hr delayed; VR1: Visual Reproduction; RSPM: Raven's Standard Progressive Matrices.
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3.4 Principal Components Analyses
Principal components analysis is a technique used, amongst other things, to explore
the relationships among variables and to determine if relationships among variables
can be summarised by a smaller number of variables, termed 'components' (in the
case ofprinciple component analysis, 'latent variables' (a general term) or 'factors'
(a term used in the related technique of factor analysis) (Norman and Streiner, 2000).
In this thesis the term 'factor' is used, because it has now entered into common usage
for both principal components analysis and factor analysis. Principal components
analysis is useful when the data represent multiple measurements of features of a
system which might be related. For example, a group of individuals have the lengths
of the bones in their limbs measured. These measurements would probably show
multiple positive intercorrelations; principal components analysis could be used to
determine whether these intercorrelations are best represented by one large factor.
This technique could also be used to determine if certain variables cluster together
more than others, for example, whether lengths of bones in the fingers showed
intercorrelations higher than the general positive correlation among all the bones.
Principal components analysis was performed on the following cognitive tests:
Verbal Fluency, Digit-Symbol Substitution Test, AVLT, BVRT, Logical Memory,
Visual Reproduction and Raven's Standard Progressive Matrices (n=95). The
National Adult Reading Test was excluded from this analysis because it is a measure
ofpremorbid or prior IQ. Logical Memory 24hr - delayed was also excluded because
of clear overlap between it with Logical Memory scores and also because the number
of subjects (N=59) was substantially lower.
There were two components with eigenvalues of greater than one. The first unrotated
component accounted for 51.3% of the total variance, which represents the typical
amount of test covariance accounted for by the general cognitive factor or 'g'
(referred to in Chapter 1: Introduction). The second component accounted for 14.5%
of the total variance. A scree plot of this analysis is shown in Figure 3.2. Although
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there were two components with eigenvalues greater than one, the scree plot suggests
one significant component. Loadings (analogous to beta-weights in a multiple
regression analysis) for each test score on the two components are shown in Table
3.4.
Figure 3.2. Scree plot for the unrotated principal components analysis
of cognitive tests
Component Number
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Table 3.4. Loadings on the first two unrotated components from the
unrotated principal components analysis
Component 1 Component 2
Verbal Fluency .56 -.11
Digit-Symbol Substitution Test .76 -.01
Auditory-Verbal Learning Test .63 .61
Logical Memory .65 .61
Visual Reproduction .81 -.18
Benton Visual Retention Test .75 -.38
Raven's Matrices .81 -.30
Rotation
Table 3.4 shows that Verbal Fluency, the Digit-Symbol Substitution Test, Visual
Reproduction, the Benton Visual Retention Test and Raven's Standard Progressive
Matrices all show positive loadings on to the first component, and either zero or
negative loadings on the second component. Logical Memory and the Auditory-
Verbal Learning Test show approximately equal loadings on both components. These
loadings are plotted in Figure 3.3.
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Figure 3.3. Plot of loadings of individual tests on the first and second












Abbreviations: AVLT: Auditory-Verbal Learning Test; VF: verbal fluency; DSST: Digit-Symbol Substitution Test;
VR: Visual Reproduction; BVRT: Benton Visual Retention Test; RSPM: Raven's Standard Progressive Matrices.
These results suggest that it might be appropriate to rotate the axes. One aim of
rotation is to achieve 'structural simplicity' (Norman and Streiner, 2000) (p. 171).
Rotation is carried out when, for example, the variance is unequally distributed,
and/or when some variables load strongly on more than one factor. In the present
case, Logical Memory and the Auditory-Verbal Learning Test show strong loadings
on two different components. Therefore rotation was carried out, using the Direct
Oblimin method, which allows for correlated (oblique) factors.
This yielded two correlated components (r=0.47). The loadings for these components
are shown in Table 3.5, and the plot of these loadings in Figure 3.4. Component 1
has higher loadings from Verbal Fluency, the Digit-Symbol Substitution Test, the
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Benton Visual Retention Test, Visual Reproduction and Raven's Standard
Progressive Matrices. Component 2 has larger loadings from the Auditory-Verbal
Learning Test and Logical Memory. Component 1 seems to reflect tests involving
visuospatial memory and processing, and also tests involving an element of the
poorly-understood but empirically prominent construct ofprocessing speed.
Component 2 reflects verbal memory.
Table 3.5. Pattern matrix for rotated principal components analysis
Component 1 Component 2
Verbal Fluency .54 .07
Digit-Symbol Substitution Test .66 .18
Auditory-Verbal Learning Test .01 .87
Logical Memory .03 .88
Visual Reproduction .79 .08
Benton Visual Retention Test .90 -.16
Raven's Matrices .88 -.05
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Figure 3.4. Plot of loadings of individual tests on the first and second
rotated components from the principal components analysis
-1.0 -.5 0.0 .5 1.0
Component 1
Abbreviations: AVLT: Auditory-Verbal Learning Test; VF: verbal fluency; DSST: Digit-Symbol Substitution Test;
VR: Visual Reproduction; BVRT: Benton Visual Retention Test; RSPM: Raven's Standard Progressive Matrices.
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3.6 Conclusions
In summary, tests showed a wide spread of variance. Scores were normally
distributed apart from the National Adult Reading Test and the Benton Visual
Retention Test, which were skewed towards the right (that is, higher scores). This
might indicate that the sample has a higher average overall cognitive ability than the
general population. Because these tests tend to show normal distributions in larger
samples, they were treated as if they had normal distributions.
Correlational analyses first showed that the immediate and delayed components of
the memory tests were highly correlated and for the reasons given above these
components were combined to give a single variable representing performance on
each test. Correlations between all tests were universally significant and positive,
indicating a substantial amount of shared variance. Because of this, cognitive test
scores were subjected to data reduction with principal components analysis. This
showed initially that 51.5% of the total variance was common, in keeping with
findings summarised by Carroll (Carroll, 1993) and other investigators (Deary,
2001a). Rotation revealed that to some extent a visuospatial processing / fluid factor
could be distinguished from a verbal memory factor.
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4.1 introduction
In investigating possible neuroanatomical substrates of ageing-related cognitive
decline, magnetic resonance imaging (MRI) and cognitive function studies in elderly
people predominantly focus on relationships between ageing-related changes in
specific brain regions and specific cognitive functions, such as hippocampal volume
and declarative memory (Lupien et al., 1998). However, cognitive ability differences
are stable over several decades (Deary et al., 2000b) and, in young, healthy adults,
brain size is associated with individual differences in cognitive function (Vernon et
al., 2000). Therefore, brain structure-cognitive function relationships observed in
elderly people may be due not only to the effects of ageing-associated atrophy, but
also to baseline differences in cognitive functioning.
Estimates of young-adult brain size in elderly people can be derived from intracranial
volume. The cranial vault is virtually fixed by the age of seven, and brain size closely
approximates this until the sixth or seventh decades (Sgouros et al., 1999; Mori et al.,
1997). Intracranial volume is important in helping to estimate the degree of brain
atrophy with ageing. It is also of interest as a measure in itself because, if intracranial
volume is associated with cognitive function in older people, this suggests that
genetic and early life factors may be important in determining variations in cognitive
function in late life (Brandt et al., 1993; Vallee et al., 1999).
Another important issue is that, in health, performances on diverse cognitive tests
show virtually universal positive correlations (Carroll, 1993; Carroll, 1993; Deary,
2001a). Factor analysis can be used to derive a measure of the common variance in a
set of cognitive tests; this general factor is often termed g (Neisser et al., 1996).
Performance on a test ofmemory is thus influenced by g and test-specific variance
(Tremont et al., 1998a). Because of the association between brain size and IQ in
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young adults, it may be that, in elderly people, relationships between regional brain
volumes and certain tests are mediated partially by associations between overall
brain volume and g.
In this study the hypothesis that intracranial volume and regional brain volumes are
positively associated with cognitive function is tested. To determine whether there
were specific relationships between specific brain regions and particular cognitive
tests, or whether any relationship was due to overall relationships between overall
brain size and overall cognitive ability, structural equation modelling was used.
Chapter 4: Cognitive function and brain volumes
93
Cognitive function, the brain and glucocorticoids
4.2 Methods
Subjects and cognitive testing were as described in Chapter 2: methods.
4.2.1 Neuroimaging
Neuroimaging analyses were conducted by Dr. Karen J. Ferguson (appendix 1).
These analyses yielded data for intracranial area (ICA), hippocampal volumes,
temporal lobe volumes and frontal lobe volumes. Intracranial area was used as an
estimate for intracranial volume. Dr. Ferguson measured intracranial volume in 40
subjects, blind to the values for ICA, and this correlated at r=0.88 (p<0.001) with
ICA. ICA is therefore a good estimate of intracranial volume.
4.2.2 Statistical Analysis
Descriptive statistics for the neuroimaging data were generated, then cognitive test
scores were correlated with each other and with MRI data (including brain volumes,
unadjusted and adjusted for ICA (created by saving residuals from a linear
regression)) using Pearson's correlation coefficient. Data reduction was performed
using principal components analysis as described in Chapter 3. Structural equation
modelling was used to test competing models of the association between brain
volumes and cognitive functions3.
3 Structural equation modelling was performed by Professor lan Deary
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Figure 4.1: Intracranial area
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4.3 Results
Of the 100 participants scanned, three were excluded when unexpected pathology on
structural MRI was discovered: two because of congenital arachnoid cysts, and one
because of a pituitary adenoma.
The descriptive statistics for the regional brain volumes and ICA are presented in
Table 4.3. All brain volumes and ICA were normally distributed. Regional brain
volumes were correlated significantly and positively, with right and left sides of the
same region more strongly correlated than different regions. ICA was significantly
associated with all the brain regions measured (Table 4.4).
Table 4.5 shows the correlation matrix between the cognitive tests, and regional
brain volumes and ICA. This shows that standard intelligence tests, including the
National Adult Reading Test, the Digit-Symbol Substitution Test and Raven's
Standard Progressive Matrices, and tests of visuospatial memory were significantly
and positively correlated with several brain region volumes. By contrast, tests of
verbal memory and verbal fluency did not correlate significantly with any brain
volumes. When brain volumes were adjusted for ICA, only the correlation between
right temporal lobe volume and Visual Reproduction remained significant.
Chapter 4: Cognitive function and brain volumes
96
Cognitive function, the brain and glucocorticoids
Table 4.3: Descriptive statistics for regional brain volumes and
intracranial area (ICA)
Mean Median Minimum Maximum SD
Left hippocampus (mm3) 3500 3491 2111 4580 439.5
Right hippocampus (mm3) 3626 3637 2582 5196 465.5
Left frontal lobe (mm3) 61220 60174 44313 88566 8911.6
Right frontal lobe (mm3) 65041 65000 38067 108350 11497.6
Left temporal lobe (mm3) 68408 68591 46979 85115 7878.7
Right temporal lobe (mm3) 72928 73545 48599 99254 8649.3
ICA (mm2) 15923 16011 14005 19095 986.8
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Left hippocampus .83" .40" .33* .59" .52" .39"
Right hippocampus .41" .39" .46" .54" .44"
Left frontal lobe .75" .46" .39" .45"
Right frontal lobe .29* .49** .50"
Left temporal lobe .75" .43"
Right temporal lobe .51**
*p<005; "p<000, 2-tailed. N=97.
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Table 4.5: Pearson correlations among regional brain volumes,




















NART .07 .11 .23* .16 .06 .17 .SO1
VF -.02 .06 .15 .11 -.07 .16 .16
DSST .23* .21* .26* .16 .17 .21* .32*
AVLT .01 .00 .02 .00 -.10 -.03 -.01
LM .04 .10 .06 .02 -.04 .06 .12
VR .23* .21* .19 .18 .19 ,33t .27**
BVRT .10 .09 .23* .22* .11 .20* .26**
RSPM .23* .20* .22* .25* .22* .32* .39**
*p<05; "p< 01; tp< 005; ttp<000, 2-tailed. N=97 except for RSPM (N=95), LM (N=96), and VR (N=96).
Abbreviations: NART: National Adult Reading Test; VF: verbal fluency; DSST: Digit-Symbol Substitution Test;
AVLT: Auditory-Verbal Learning Test; LM: Logical Memory; VR: Visual Reproduction; BVRT: Benton Visual
Retention Test; RSPM: Raven's Standard Progressive Matrices
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Data reduction
Principal components analysis
Because of the large amount of shared variance throughout the different brain
regions and across different cognitive domains these variables were subjected to data
reduction. Principal components analysis of the right and left hippocampi, temporal
lobes and frontal lobes revealed that the first unrotated component accounted for
59% of the total variance (N=97). Thus, individual differences in these specific brain
areas reflect, to a large degree, differences in overall brain size. Principal
components analysis was performed on the cognitive tests as described in Chapter 3.
Structural equation modelling
The model applied to the present data is illustrated in Figure 4.2. The arrows
represent the relationships between the measured variables and the derived latent
traits, and also between the two latent traits. Numbers beside arrows that connect
variables are parameter weights estimated by the EQS program: squaring them
indicates the variance shared by adjacent variables. Because of the high correlations
between volume measurements from the right and left sides, these were reduced (via
summed standardised scores) to a single value for each brain region. The three brain
region volumes were hypothesised to load on a general brain volume latent trait. The
eight cognitive test variables were hypothesised to load on a single general cognitive
latent trait. The correlation between these two latent traits was estimated as a free
parameter in the model. After this correlation was estimated the hypotheses that there
were additional, significant associations between specific brain regions and cognitive
functions was tested. Ninety-three subjects had complete data for the cognitive tests
and MRI variables shown in Figure 4.2. The statistical 'fit' of the model in Figure
4.2 is described first, and then the meaning of the model is explained.
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There are several different indications of fit adequacy in EQS. The average of the
off-diagonal standardized residuals was 0.047, indicating that most of the covariance
was accounted for by the model. The largest two residuals were between temporal
lobe volume and AVLT and Logical Memory scores, and were negative in direction.
The chi square for the model was 35.6 (df=41, p=0.71). Non-significant chi-square
values indicate good fit. EQS gives three fit indices which have values between 0 and
1, with values over 0.9 indicating good fit. For the model in Figure 4.2 these were:
Bentler-Bonett normal fit index = 0.91; Bentler-Bonett non-normal fit index = 1;
comparative fit index = 1.0. All indicated a well-fitting model. All of the pathways in
the model were significant and the Wald test indicated that no pathways in the model
should be dropped.
The model in Figure 4.2 shows that individual variation in the three brain areas was
substantially derived from overall brain size, here derived as a latent trait.
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Figure 4.2: Structural equation model of the relationships among
individual brain region volumes, the general brain size factor, and the
individual cognitive tests and the general cognitive factor.
Abbreviations: NART: National Adult Reading Test; RSPM: Raven's Standard Progressive Matrices; DSST:
Digit-Symbol Substitution Test; BVRT: Benton Visual Retention Test; VR: Visual Reproduction; AVLT: Rey
Auditory-Verbal Learning Test; LM: Logical Memory; VF: verbal fluency. All relationships are at p<0.05.
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The covariance among the cognitive tests was successfully captured by
hypothesising that this was derived substantially but not wholly from a general
cognitive latent trait. These two latent traits - 'overall brain size' and 'general
cognitive function' - correlated 0.42. Note that two verbal tests (National Adult
Reading Test and Verbal Fluency) and two verbal memory tests (Auditory-Verbal
Learning Test and Logical Memory) had correlated residuals. This reflects the
similarity of the two pairs of tests, which are indicators of 'group factors' of ability.
The Lagrange Multiplier Test showed that there were no additional significant paths
between specific cognitive tests and brain size or between specific brain region
volumes and the general cognitive factor.
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4.4 Discussion
The main findings were that in this sample of 97 healthy men aged 65-70,
intracranial area correlated positively with tests of general intelligence and
visuospatial memory. Positive correlations between these tests and several regional
brain volumes were also found. When regional brain volumes were adjusted for ICA
there were virtually no significant correlations between brain volumes and cognitive
tests.
There were significant positive correlations among all the cognitive tests, suggesting
much shared variance among the tests. This was confirmed by principal components
analysis, in which the first unrotated component accounted for 50% of the total
variance. Thus these findings replicate the vast majority of previous studies which
have examined correlations in performance on diverse cognitive tests (Carroll, 1993).
A key finding in this study was the set of significant positive correlations between
several cognitive tests and ICA. In studies of cognitive ageing which use structural
brain imaging, brain volumes are often adjusted for a measure of head size.
However, these findings indicate that the present measure ofhead size, ICA, may
itself be of some importance. In fact, in this relatively large dataset adjusting for ICA
removed virtually all of the associations. These findings have implications for
research into brain structure-cognitive function relations, particularly in the field of
mild cognitive impairment, where deficits in cognitive function and changes in the
brain are subtle. Many studies report an association between hippocampal size and
deficits in declarative memory in mild cognitive impairment and in Alzheimer's
disease (Jack et al., 1997), but using sensitive tests and detailed imaging in a large
sample of healthy elderly men this study did not demonstrate such an association.
This concurs with a recent study which found a negative association between
hippocampal volume and performance on a delayed memory task in 75 women aged
18-30 (Foster et al., 1999). Although there is often severe hippocampal atrophy in
frank Alzheimer's disease which is associated with deficits in declarative memory
(Petersen et al., 2000), the present findings suggest that specific changes in
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hippocampal volume may only become an important variable in the presence of
pathology.
Smaller head size has been linked with lower cognitive ability in a large sample of
non-demented elderly adults (Reynolds et al., 1999) and may also be a risk factor for
Alzheimer's disease (Graves et al., 1996). These findings have been advanced in the
context of the 'cognitive reserve hypothesis' which proposes that individuals with
larger brains can sustain more relatively more damage from a pathological process
before developing the overt symptoms of dementia (however there are some studies
which have failed to show this (Jenkins et al., 2000)). However, there are other
possible explanations. For example, it is well established that low birth weight is
linked with the insulin resistance syndrome (Seckl, 1997), and hyperinsulinaemia is a
risk factor for cognitive impairment in later life (Vanhanen et al., 1998). Small head
size clusters with low birth weight and therefore associations between head size and
cognitive function in late life may be partially mediated by metabolic factors. Indeed,
small head circumference at birth has been shown to associate with an increased risk
of cardiovascular mortality at age 65 (Barker et al., 1993), suggesting that other
vascular disease (ie. cerebrovascular) may also cluster with small head size as
determined by early life events.
Using structural equation modelling to best describe the underlying relationships
among the cognitive tests and brain volumes it was found that the best-fitting model
suggested that the relationship between overall cognitive ability and a common factor
representing hippocampi, temporal lobes and frontal lobes best accounts for the data.
That is, relationships between performance on specific cognitive tests and specific
brain regions are best accounted for by these variables' respective contributions to
the general cognitive and brain volume factors. In summary, in terms of brain
volumes, the main association was between overall brain size and general cognitive
ability.
There are certain methodological limitations of the study. Whole brain, parietal,
occipital or cerebellar volumes were not measured and specific associations between
these regions and cognitive tests cannot be ruled out. The sample was all men and
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thus the findings cannot be confidently generalized to women. The sample can be
described as "young-elderly" and was selected for good health and thus any effects
of ageing on cognitive function and on brain volumes are likely to be slight; the
present findings may have more in common with studies looking at younger
populations. However, it is possible some subjects were in subclinical stages of
dementia, which could affect both brain volumes and cognitive function. Only a
prospective study commencing in mid-life or earlier could examine this question
adequately.
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Chapter 5: Cognitive function and magnetic
resonance spectroscopy
5.1 Introduction
Deficits in cognitive function become more common with ageing. Alzheimer's
disease and other dementias are at the severe end of the spectrum, but milder deficits
in cognitive function are also important in terms of the associated morbidity and also
because milder deficits are a risk factor for the development of dementia (National
Research Council, 2000). The mechanisms underlying these changes are poorly
understood. Pathological studies demonstrate that neuronal loss does occur in
dementias such as Alzheimer's disease but there may be very little neuronal loss in
the absence of such disease processes (West et al., 1994) suggesting that changes in
the function of neurons might play an important role in cognitive ageing.
As discussed in Chapter 1, N-acetylaspartate (NAA) is thought to be specific to
neurons (Simmons et al., 1991) and some studies have suggested that NAA levels are
reduced in conditions in which there is known to be neuronal loss, such as
Alzheimer's disease (Schuff et al., 1998). NAA levels are therefore often used as a
marker of 'neuronal integrity'. Choline levels reflect the quantities of free choline-
containing compounds, which are involved in both the synthesis and breakdown of
phospholipid membranes (Pettegrew et al., 1997). Creatine levels are thought to
reflect the quantity of phosphorylcreatine and creatine, involved in energy
metabolism, in neurons and glial cells (Pettegrew et al., 1995; Wyss and Kaddurah-
Daouk, 2000). However, whether there are variations in levels ofNAA or other
metabolites such as choline (Cho) and creatine (Cr) in milder ageing-related
cognitive impairments, in which changes in the brain might be more subtle, is
unknown.
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In this study, relationships between tests of cognitive function and metabolite levels
using HI-MRS in a large sample of healthy elderly men are explored. The main
hypothesis was that higher levels ofNAA as estimated by NAA/Cr and NAA/Cho
ratios correlate with better cognitive performance.
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5.2 Methods
Subjects and cognitive testing were as described in Chapter 2.
5.2.1 Neuroimaging
Spectroscopic analyses were conducted by Dr. Karen J Ferguson, Professor Joanna
M Wardlaw and Dr. Ian Marshall (Appendix 1). Placement of the voxel is shown in
Figure 5.1. These analyses yielded data forNAA, Cho and Cr levels. These
metabolite levels are in 'institutional units', that is, they are not directly related to
absolute concentrations. Raw data are not comparable between subjects and thus
metabolite levels are traditionally analysed as ratios.
Figure 5.1: Placement of the voxel4 in the parietal cortex
4 The term "voxel" refers to the element of 3-D space corresponding to a pixel, for a given slice
thickness.
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5.2.2 Statistical analysis
To avoid making assumptions about whether any particular metabolite levels
remained relatively constant, an alternative method to the use ofmetabolite ratios
was developed by the author and Professor Ian Deary. In this method, each
metabolite value was regressed against the remaining two and the standardised
residual values saved. This method is similar in aim to the use of ratios but has the
advantage of not assuming that creatine levels are an appropriate internal control. In
the present chapter these derived values are termed "adjusted metabolite levels".
Because of the substantial positive intercorrelations among cognitive test scores (as
discussed in Chapter 1) (Carroll, 1993), the cognitive test data were subjected to
principal components analysis (PCA), excluding the National Adult Reading Test
because it is a measure of premorbid or prior IQ, and Logical Memory 24-hr delayed
because the number of subjects was substantially less than for the other tests.
Individual cognitive test results and factor scores derived from PCA were correlated
with metabolite ratios and with the adjusted metabolite levels derived as described
above.
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5.3 Results
Of the 100 participants scanned, three were excluded when unexpected pathology
was discovered on structural MRI: two because of congenital arachnoid cysts, and
one because of a pituitary adenoma (non-secretory). Of the remaining 97 subjects, 88
spectra were suitable for metabolite quantification analysis as determined by
evaluation of the appearance of the spectra by a neuroradiologist (Professor JM
Wardlaw) and assessment of the quality of curve fitting during analysis of spectra by
a research fellow (Dr. KJ Ferguson). Data from two further spectra were excluded as
the standardised residual values in the linear regression analysis were greater than
three standard deviations from the mean. Sample spectra from the present study are
shown in figure 5.2.
Figure 5.2: Sample spectra from magnetic resonance spectroscopy
0 -100 -200 -300 0 -100 -200 -300
Hertz Hertz
These spectra show high (the spectrum on the left) and low (the spectrum on
the right) Cho and Cr in relation to NM.
Principal components analysis of the cognitive tests revealed two factors with
eigenvalues greater than one, explaining a total of 66% of the variance. The factors
were subjected to Direct Oblimin rotation. Because of the pattern of loadings (as
described in Chapter 3), the two factors were designated the Visuospatial / Fluid
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Factor and the Verbal Memory Factor. These factor loadings were entered into the
correlational analysis in addition to the raw cognitive test scores with the metabolite
ratios and the adjusted metabolite levels.
For the correlational analyses, there were 86 subjects for all comparisons except:
Raven's Standard Progressive Matrices (N=84), where two subjects were excluded
because of incorrect completion of the answer sheets; Logical Memory (N=85),
where one subject's score was invalid in this test because of interruption of the
testing session, and Visual Reproduction (N=85); where a further subject also had the
test session interrupted. Listwise deletion meant that factor scores from 82 subjects
were available. For Logical Memory 24-hr delayed 58 subjects returned for retesting,
ofwhich 50 had spectra suitable for inclusion.
Correlations between metabolite level ratios and cognitive test results are shown in
Table 5.1. NAA/Cr ratios were positively correlated with Logical Memory (r=0.25,
p<0.05), Logical Memory 24-hr delayed r=0.43, p<0.01) and the Verbal Memory
Factor (r=0.25, p<0.05). Cho/Cr ratios were positively correlated with the Benton
Visual Retention Test, Visual Reproduction, the Auditory-Verbal Learning Test,
Logical Memory, Logical Memory 24-hr delayed, and the Verbal Memory Factor (r
values 0.21 to 0.38, p<0.05). NAA/Cho ratios did not correlate significantly with any
test scores.
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Table 5.1: Pearson correlations between metabolite ratios and cognitive
test results
NAA/Cho NAA/Cr Cho/Cr
National Adult Reading Test -.17 .13 .20
Raven's Matrices -.00 .19 .15
Benton Visual Retention Test -.15 .17 .25*
Visual Reproduction -.05 .21 .21*
Digit-Symbol Substitution Test -.06 .06 .07
Auditory-Verbal Learning Test -.08 .21 .22*
Logical Memory -.10 .24* .25*
Logical Memory (24-hr delayed) -.07 .43** .38**
Verbal Fluency -.18 -.01 .11
Visuospatial / Fluid Factor -.09 .16 .18
Verbal Memory Factor -.09 .25* .25*
*p<05(2-tailed) **p<.010(2-tailed).
N=86 for all tests except Raven's Standard Progressive Matrices (N=84), Logical Memory (N=85), Visual
Reproduction (N=85) and Logical Memory - 24hr-delayed (N=50) and the Visuospatial / Fluid Factor and Verbal
Memory Factors (N=82).
The correlations between the adjusted metabolite levels and cognitive test results are
shown in Table 5.2. Adjusted creatine levels were significantly negatively correlated
with Logical Memory (r=-0.26, p<0.05), Logical Memory 24-hr delayed (r=-0.39,
p<0.01) and the Verbal Memory Factor (r=-0.26, p<0.05). There were trends in the
same negative direction with Raven's Standard Progressive Matrices, Visual
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Reproduction, and the Auditory-Verbal Learning Test. Adjusted choline levels and
adjusted NAA levels did not correlate significantly with any of the cognitive test
scores.
Table 5.2: Pearson correlations between adjusted metabolite levels and
cognitive test results.
AdjCr Adj_Cho Adj_NAA
National Adult Reading Test -.20 -.19 -.08
Raven's Matrices -.18 .03 .10
Benton Visual Retention Test -.12 .20 .05
Visual Reproduction -.17 .13 .21
Digit-Symbol Substitution Test -.05 .07 .06
Auditory-Verbal Learning Test -.19 .12 .08
Logical Memory -.26* .14 .05
Logical Memory (24-hr delayed) -.39** .13 .17
Verbal Fluency -.01 .21 -.11
Visuospatial / Fluid Factor -.11 .15 .11
Verbal Memory Factor -.26* .13 .09
**p<01 (2-tailed) *p< 05 (2-tailed)
N=86 for all tests except Raven's Standard Progressive Matrices (N=84), Logical Memory (N=85), Visual
Reproduction (N=85) and Logical Memory - 24hr-delayed (N=50) and the Visuospatial / Fluid Factor and Verbal
Memory Factors (N=82).
Abbreviations: Adj-Cr: adjusted creatine; Adj_Cho: adjusted choline; Adj_NAA: adjusted NAA.
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5.4 Discussion
The main findings in this study were that higher NAA/Cr and Cho/Cr ratios were
associated with better performance on several cognitive tests. Both ratios correlated
positively with Logical Memory, Logical Memory 24-hr delayed and a derived
Verbal Memory Factor. Cho/Cr also correlated positively with the Benton Visual
Retention Test, Visual Reproduction and the Auditory-Verbal Memory Test. Higher
adjusted creatine levels were associated with worse performance on Logical
Memory, Logical Memory 24-hr delayed and the Verbal Memory Factor. All of the
remaining cognitive variables correlated in a negative direction with adjusted
creatine and the strength ofmany of these correlations approached statistical
significance. There were no correlations between NAA/Cho ratios, adjusted NAA
levels or adjusted choline levels and cognitive tests or the derived factors.
This is the largest study to date examining brain metabolite-cognition associations in
a healthy human sample and is the first to show these relationships. The findings
have implications for the understanding of the mechanisms underlying the variations
in cognitive ageing. However, the findings also raise important issues concerning the
use ofmetabolite ratios instead of absolute values. Most HI-MRS studies do not use
water-referencing or phantom-referencing for the calculation ofmetabolite levels and
thus express results as ratios. Traditionally, creatine levels are thought to show less
inter-individual variation (Catani et al., 2001) and thus are commonly used as the
denominator. They are also considered to change little in disease, or only because of
marked disease. The practice ofusing ratios may also be because of the emphasis
placed on NAA as a marker of neuronal integrity. Some studies of normal ageing
have reported reductions in NAA/Cr (Angelie et al., 2001). In most published papers
reductions in NAA/Cr are interpreted as signifying reductions in absolute NAA, but,
clearly, increases in creatine would have the same arithmetical effect, and perhaps
the previous studies should be reanalysed in this light. Using the traditional method
of analysis, the present findings would suggest that higher NAA and choline levels
are associated with better cognitive function. However, the regression analysis
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suggests that higher creatine levels might better explain the correlations between
NAA/Cr and Cho/Cr ratios and cognitive variables rather than lower NAA or choline
levels. Alternatively, the correlations with adjusted creatine might reflect the
association of reduced levels of both NAA and choline levels with cognitive
variables. Only measurement of the absolute levels of these metabolites would
resolve these alternatives.
There is some evidence that creatine levels may themselves be important in the
pathophysiology of cognitive ageing. Some HI-MRS studies using absolute
metabolite concentrations have reported higher creatine levels in healthy ageing
brains compared with healthy younger brains (Pfefferbaum et al., 1999b; Saunders et
ah, 1999; Leary et ah, 2000; Schuff et ah, 2001). Creatine levels as detected by Hl-
MRS reflect the sum of phosphocreatine (PCr) and creatine. PCr is present in the
brain at high levels, providing a store of ~P for phosphorylation ofADP and thus
maintaining ATP levels. The conversion of phosphocreatine to ATP is catalyzed by
creatine kinase. Creatine kinase levels, activity and forward flux decrease in ageing
(Smith et ah, 1991; Smith et ah, 1997) while P31-MRS studies have shown
increasing PCr levels in the ageing rat (Pettegrew et ah, 1990). Pettegrew and co¬
workers (Pettegrew et ah, 1995) identified a cognitively normal man of 55 who had
P31-MRS changes suggestive of dementia. Follow-up over 46 months showed a
progressive decline in cognitive function to frank dementia, paralleled closely by a
linear rise in PCr. Control subjects showed no changes in PCr. Although the number
of studies and their samples sizes are small, together these findings suggest the
possibility that the conversion ofphosphocreatine to ATP may be impaired in ageing,
accounting for an accumulation of PCr. Thus, increased levels of creatine may be a
marker of decreased brain energy metabolism (Wyss and Kaddurah-Daouk, 2000)
which may be associated with ageing-related mild cognitive impairment, as well as,
in more extreme cases, frank dementia.
This study did not find any relationship between adjusted NAA and cognitive
function. This may reflect the healthy state of the participants since NAA is thought
to be a marker of neuronal number and integrity. Other studies, with subject numbers
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of between 30 and 50, have reported thatNAA is not reduced in the white matter of
healthy elderly subjects (Pfefferbaum et al., 1999b; Lundbom et al., 1999; Saunders
et al., 1999) although one study did find decreased NAA in 50 healthy elderly
subjects (Brooks et al., 2001). Broadly speaking, however, these findings fit with
stereological findings suggesting that brain atrophy in healthy ageing is not caused
by neuronal death (West et al., 1994).
Adjusted choline levels did not correlate significantly with any cognitive variables.
Interpretation of choline levels derived from HI-MRS is difficult as free choline is
increased both in membrane breakdown (eg. necrosis) and increased formation (eg.
gliomas). This confusion is reflected in the variety of findings for choline changes
with ageing: higher choline in grey matter (Pfefferbaum et al., 1999b; Pfefferbaum et
al., 1999a; Chang et al., 1996), lower choline in grey matter (Charles et al., 1994)
and no change in choline levels in white matter with ageing (Pfefferbaum et al.,
1999b; Saunders et al., 1999; Schuff et al., 2001; Schuff et al., 1999; Lundbom et al.,
1999) have all been reported.
There are several methodological limitations of the present study which should be
noted. Without determining absolute concentrations ofmetabolites, interpretation of
the results must remain speculative. Regression analysis was used in an attempt
indirectly to look for the unique variance for each metabolite, but, as with ratios, the
biological significance ofmetabolite values generated with this method is unclear.
Techniques which generate absolute values are extremely time-consuming and,
especially with older people, the long scanning times make large-scale studies
impractical. Even in techniques which generate values to be used in ratios, HI-MRS
is not free ofproblems, in that subjects must lie still for considerable periods; in large
groups it is likely that a proportion of subjects will not tolerate these long scanning
times. Even in co-operative subjects, there may be problems with the technique, like
poor shimming (this procedure is carried out to optimise the homogeneity of the
magnetic field around the subject), which preclude obtaining measurable spectra.
The study is cross-sectional, so it cannot be known whether individual differences in
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metabolite levels are longstanding at this stage in life or represent differences
accruing with brain ageing which may predate overt dementia
In conclusion, this study provides evidence that individual differences in metabolite
levels relate significantly to variations in cognitive function at age 65 to 70. The
pattern of results seen in the ratios, as well as the regression analysis, suggest that
creatine but not choline and NAA are associated with these variations. This is in
contrast to studies focusing on neurodegenerative diseases, which suggest that lower
NAA levels are associated with cognitive decrements. Further HI-MRS studies using
spectroscopy protocols which can generate absolute levels of these metabolites are
essential to clarify the nature of these associations. The use ofP31-MRS may also
help to understand the relative concentrations ofPCr and creatine in ageing brain and
to examine further the hypothesis that individual differences in cognitive ageing may
stem in part from changes in brain energy metabolism.
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Chapter 6: Cortisol levels, and neuroimaging and
cognitive function
6.1 Introduction
The hypothesis that a proportion of ageing animals and humans develop rising levels
of glucocorticoids and that these elevations are linked with atrophy of certain
structures of the brain and cognitive decrements was first proposed many decades
ago and received its first empirical support in the work of Landfield (Landfield et al.,
1978; Landfield, 1981). Sapolsky developed this notion with the glucocorticoid
cascade hypothesis, in which reduced feedback sensitivity to glucocorticoid levels at
the level of the hippocampus leads to higher glucocorticoid levels which are
damaging to the hippocampus, leading to further reductions in feedback sensitivity,
and so on (Sapolsky et al., 1986).
Currently the direct evidence in favour of this hypothesis is mixed. It is clear that the
hippocampus is involved in feedback regulation of the hypothalamic-pituitary-
adrenal (HPA) axis and under most conditions exerts an inhibitory effect (Seckl and
Olsson, 1995). In animals, experimental lesions to the hippocampus cause rises in
glucocorticoids. In humans the effects ofhippocampal lesions on feedback regulation
of the HPA axis are less clear. In diseases in which there is damage to the
hippocampus, such as Alzheimer's disease, there is evidence of disturbance in
feedback regulation of the HPA axis. Some studies have shown reduced suppression
ofCortisol following dexamethasone (Murialdo et al., 2000) and others have shown
increased overall output of glucocorticoids (Rasmuson et al., 2001). However, it is
not possible to be certain that these disturbances are all due to compromise of the
role of the hippocampus in HPA axis regulation, as Alzheimer's disease involves
widespread damage to the brain, and there are other routes by which glucocorticoids
might rise, such as with the depressive illness commonly seen in Alzheimer's
disease. What is clearer is that there is increased variability in the feedback
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sensitivity of the HPA axis with ageing, with older animals and humans more often
showing a slower decline in glucocorticoid levels after a stressful episode (Seeman
and Robbins, 1994; Seckl and Olsson, 1995), or showing reduced sensitivity to
suppression by dexamethasone (Ferrari et al., 2001).
Regarding elevations in glucocorticoids with ageing, animal and human studies,
though few in number, do suggest that there is an increase in variability in overall
glucocorticoid secretion. An even smaller number of studies has linked these
elevations with decrements in cognitive function (Issa et al., 1990; Lupien et al.,
1996; Seeman et al., 1997). Some studies have suggested that interventions such as
adrenalectomy and low-dose corticosterone replacement (Landfield, 1981), and
administration of antidepressants from mid-life (which is associated with lower
corticosterone levels in ageing animals) (Yau et al., 2002), are associated with an
attenuation of ageing-related cognitive decrements.
Neuroimaging studies linking cognitive function, hippocampal volumes and indices
ofHPA axis activity are few. Most of these studies involve patients with Cushing's
syndrome or Alzheimer's disease. The studies in Cushing's syndrome suggest that
cognitive function is affected across several domains; in terms of neuroimaging
studies using modern techniques have only examined the possibility that there is
hippocampal atrophy; no other regions have been studied (Starkman et al., 2001;
Starkman et al., 1992). The only study looking at the whole brain used
pneumoencephalopathy and found global atrophy in patients with Cushing's
syndrome versus controls patients who had acromegaly (Momose et al., 1971). In
Alzheimer's disease a higher degree ofhippocampal atrophy has been linked with
hypercortisolaemia (deLeon et al., 1988; Magri et al., 2000). There are very few
studies of this type in older healthy adults. Lupien and co-workers (Lupien et al.,
1998) examined Cortisol levels over five years in 11 healthy elderly subjects and then
measured cognitive function and hippocampal, parahippocampal gyrus, fusiform
gyrus, superior temporal gyrus, and middle and inferior temporal gyri volumes,
controlled for head size. They divided the subjects into two groups based on the
pattern of change in Cortisol secretion over the five years: an 'increasing/high' group
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and a 'decreasing/moderate' group. They found that the 'increasing/high' group had
14% smaller hippocampi (4.00cm3 versus 4.54cm3, p<0.001) and significantly
poorer performance on the delayed declarative memory task. There were no
significant differences for the other brain volumes. Although interesting, the number
of subjects is too small to draw any strong conclusions from this study. In a cross-
sectional study, Wolf and co-workers (Wolf et al., 2002) did not find a correlation
between hippocampal volume and Cortisol output in 11 men aged 59-76; cognitive
function was not measured. Thus there are no adequately-sized studies which have
examined the links among volumetric neuroimaging variables, in particular
hippocampal volume, in normal ageing populations. There are no published studies
examining links among glucocorticoid measures and other types of neuroimaging
variables, such as white matter lesions or metabolite levels as measured by magnetic
resonance spectroscopy.
In this chapter data gathered from glucocorticoid measurements are presented and
analysed. Then the hypotheses that glucocorticoid levels are related to cognitive
function and also to brain region sizes are examined. Glucocorticoid levels are also
analysed in relation to metabolite levels as measured by magnetic resonance
spectroscopy.
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6.2 Methods
Three domains ofmeasurements are used: neuroimaging, glucocorticoids and
cognitive function. Neuroimaging was performed using structural magnetic
resonance imaging, giving data on regional brain volumes, intracranial capacity, and
magnetic resonance spectroscopy (Appendix 1). 9am, 2.30pm and post-
dexamethasone (0.25mg) plasma Cortisol levels were obtained as detailed in Chapter
2. The cognitive testing battery was also described in Chapter 2.
Radioimmunoassay
10ml of blood was taken and immediately spun at 3000rpm at 4°C. Then 2-3ml of
plasma was extracted and stored at -20°C until analysis. lOpl aliquots of plasma from
each sample were diluted with 290pl of the assay diluent (lOOnM of citrate-
phosphate buffer at pH 4.0 containing 0.1% gelatin). A pre-prepared set of standards
(concentrations: 10,20,40,80 ... 5120nM) was also used. Samples and standards were
prepared in triplicate in disposable LP4 (Luckhams) polystyrene tubes. Solutions
were mixed with 50pl 1251-cortisol (producing around 10000 counts per minute) and
50pl Cortisol antibody (SAPU: Scottish Antibody Production Unit). The tubes were
vortexed gently and incubated at room temperature for 4 hours. Then 50pl of the
second antibody (donkey anti-sheep/goat serum @1:15 initial; SAPU) and 50pl non¬
immune sheep serum (@1:200 initial with InM EDTA; SAPU) were added. The
tubes were incubated at 4oC overnight and then spun at 4oC for 45 minutes at 1720
G. The supernatant was decanted to waste and the bound fraction counted in a
gamma-counter (LKB Wallac 1260).
Samples were rejected if there was a greater than 10% difference (of the smaller
value) between the counts. The mean intraassay coefficient ofvariation was 6.2%.
The interassay coefficient of variation (calculated through quality control samples
included in each batch) was 9.2%.
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Statistical Analyses
Neuroimaging and cognitive data were explored and prepared as detailed in earlier
chapters. Cortisol levels from the three types ofmeasurement: 9am, 2.30pm and
post-dexamethasone levels were first subjected to data exploration. Relationships
among these levels were then examined with correlations and principal components
analysis. Neuroimaging and cognitive data were then examined in turn in relation to
the Cortisol levels using correlations and principal components analyses.
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6.3 Results
Cortisol levels: descriptive data
Descriptive data for 9am, 2.30pm and post-dexamethasone Cortisol are shown in
Table 6.1. Of the 97 possible 9am Cortisol levels, two were unavailable for reasons of
technical failure. Not all subjects were able to return for testing of 2.30pm Cortisol
levels or for testing of post-dexamethasone Cortisol levels, hence the N's of 88 and
89, respectively.
As expected, 9am Cortisol levels were the highest of the three Cortisol measures.
2.30pm levels were the lowest and post-dexamethasone levels were intermediate.
Histograms for 9am, 2.30pm and post-dexamethasone levels are shown in Figure 6.1.
These show that 2.30pm and post-dexamethasone Cortisol levels were somewhat
skewed to the left, whereas the 9am levels showed a normal distribution. The
distributions were not so skewed as to preclude analysis with parametric tests.
However, scatterplots for each comparison were examined.
Table 6.1: Cortisol levels: descriptive data
N Minimum Maximum Mean SD
9am Cortisol (nmol/l) 95 105 898 444.1 171.0
2.30pm Cortisol (nmol/l) 88 23 369 168.1 66.0
Post-dex Cortisol (nmol/l) 89 38 632 233.5 142.0
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Cortisol levels showed positive intercorrelations, with 9am Cortisol correlating at
r=0.26 (p=0.017, N=86) with 2.30pm Cortisol and at r=0.24 with post-dexamethasone
Cortisol (p=0.001, N=88). A correlation matrix for the Spearman's correlations is
provided in Appendix 3. These correlations are similar. There was a non-significant
positive correlation between 2.30pm Cortisol and post-dexamethasone Cortisol
(r=0.17, p=0.108, N=84).
Table 6.2: Pearson correlations among Cortisol measures
2.30pm Cortisol Post-dex Cortisol
9am Cortisol .26 (p=0.017, N=86) .34 (p=0.001, N=88)
2.30pm Cortisol .17 (p=0.108, N=84)
Cortisol levels and brain volumes
Each of the Cortisol measures was correlated against brain volumes. These showed
some small, significant, negative correlations with the Cortisol measures. Non¬
significant correlations tended also to be negative. Scatterplots were then performed
for each correlation. Because these revealed the possibility that outliers might affect
the correlations (sample scatterplots are show in Figure 6.2), correlations were
repeated using the nonparametric equivalent of Pearson's r, Spearman's rho. Both
Pearson and Spearman correlations are shown in Table 6.3. The nonparametric
correlations show that the left temporal lobe correlated negatively and significantly
with 9am Cortisol (r=-0.22) and 2.30pm Cortisol (r=-0.26), the right temporal lobe
correlated with 9am Cortisol (r=-0.21), the right hippocampus correlated with 9am
Cortisol (r=-0.22) and post-dexamethasone Cortisol (r=-0.24). These correlations were
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significant at p<0.05, 2-tailed. The left hippocampus showed no significant
correlations but showed a trend towards a negative correlation with 9am Cortisol (r=-
0.19, p=0.065) and the left frontal lobe showed a trend towards a negative correlation
with 2.30pm Cortisol (r=-0.21, p=0.052). Brain volumes adjusted for intracranial area
showed correlations in the same negative direction, but all but one (2.30pm Cortisol
and left temporal lobe r=0.025 (p=0.018)) were statistically nonsignificant.
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Pearson -015 -.03 -.16
Spearman -.19 (p=0.065) -.08 -.16
Right
hippocampus
Pearson -.12 -.02 -.25* (p=0.018)
Spearman -.22* (p=0.034) -.04 -.24* (p=0.021)
Left
frontal lobe
Pearson .02 -.22* (p=0.044) -.03
Spearman -.02 -.21 (p=0.052) -.02
Right
frontal lobe
Pearson .03 .01 -.15
Spearman -.02 .02 -.13
Left
temporal lobe
Pearson -.21* (p=0.038) -.20 -.04
Spearman -.22* (p=0.033) -.26 (p=0.016) 0
Right
temporal lobe
Pearson -.16 .02 -.15
Spearman -.21* (p=0.038) -.03 -.12
N=95 for 9am Cortisol correlations, N=88 for 2.30pm Cortisol correlations and N=89 for post-dexamethasone
Cortisol correlations.
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Cortisol levels and magnetic resonance spectroscopy
Cortisol levels were correlated against metabolite ratios and adjusted metabolite
levels using the Pearson correlation coefficient. The correlations are show in Table
6.4. None of the correlations was significant.
Table 6.4: Correlations between Cortisol levels, and metabolite ratios
and adjusted metabolite values
9am Cortisol 2.30pm Cortisol Post-dex Cortisol
NAA/Cho .07 -.04 -.01
NAA/Cr -.03 -.04 -.19
Cho/Cr -.07 .02 -.16
AdjJMAA .06 -.12 -.11
Adj_Cho -.11 .01 -.06
AdjCr .01 -.02 .13
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Cortisol levels and cognitive function
Cortisol measures were correlated against cognitive test scores. The correlations are
presented in Table 6.5. 9am Cortisol correlated with Logical Memory 24 hour
delayed correlated at r=-0.31 (p=0.018, N=58) and Raven's Standard Progressive
Matrices at r=-0.21 (p=0.044, N=93). Of the remaining correlations, several showed
non-significant trends towards correlations in the predicted direction.
Table 6.5: Pearson correlations between Cortisol levels and cognitive
tests
9am Cortisol 2.30pm Cortisol Post-dex Cortisol
NART .01 -.05 .06
Verbal Fluency -.08 -.04 -.02
DSST -.17 -.15 -.07
AVLT -.07 -.20 -.03
Logical Memory -.11 .10 -.01
Logical Memory 24hr -.31* (p=0.018) -.17 -.09
BVRT -.11 -.10 -.06
Visual Reproduction -.12 -.04 .03
RSPM -.21* (p=0.044) -.14 -.11
For Logical Memory 24 hr delayed, N=58 for 9am Cortisol levels, N=55 for 2.30pm Cortisol levels, and N=54 for
post-dexamethasone levels. For all other tests, 9am Cortisol levels, N's=93 to 95; 2.30pm Cortisol levels N's=86
to 88; post-dexamethasone Cortisol levels, N's 87 to 89.
Abbreviations: NART: National Adult Reading Test; DSST: Digit-Symbol Substitution Test; AVLT: Auditory-
Verbal Learning Test; BVRT: Benton Visual Retention Test
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Data reduction with principal components analysis (yielding first a general cognitive
factor and then, following Direct Oblimin rotation, two correlated factors, the
visuospatial / fluid factor and the verbal memory factor) was carried out as described
in Chapter 5. There were no significant correlations between Cortisol measures and
the cognitive factors.
Cognitive tests were then adjusted for premorbid IQ (using linear regression). The
purpose of this was to control for the influence of baseline general cognitive ability.
The adjusted cognitive test scores were then correlated against the Cortisol measures.
The pattern of correlations was similar to the correlations with the unadjusted tests,
with all but two correlations being in the negative direction but only two reaching
statistical significance. These were both with 9am Cortisol, with the Digit-Symbol
Substitution Test correlating at r=-0.21 (N=95, p=0.04) and Logical Memory 24h
delayed correlating at r=-0.28 (N=58, p=0.03).
Because there were several negative correlations between the adjusted cognitive test
scores and the Cortisol measures, the cognitive factors were also adjusted for
premorbid IQ and correlated against the Cortisol measures. Both the adjusted general
cognitive factor and the adjusted visuospatial / fluid factor correlated with 9am
Cortisol at r=-0.23 (N-91, p=0.028). There were no significant correlations with the
other Cortisol measures, though all correlations were in the predicted direction (Table
6.7).
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Table 6.7: Correlations between Cortisol levels and adjusted cognitive
factors
9am Cortisol 2.30pm Cortisol Post-dex Cortisol
General cognitive
factor (adjusted)
-.23* (p=0.028) -.15 -.11
Visuospatial / fluid
factor (adjusted)




N=91 for 9am Cortisol levels, N=84 for 2.30pm Cortisol levels and N=85 for post-dexamethasone Cortisol levels.
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6.4 Discussion
In this chapter, three different Cortisol measures were correlated against brain
volumes and metabolite levels as measured by magnetic resonance spectroscopy. The
Cortisol measures were, 9am levels, 2.30pm Cortisol and post-dexamethasone. These
Cortisol levels were also correlated against cognitive function. The main hypotheses,
given the previous animal and human work, were that Cortisol levels would correlate
negatively with hippocampal volumes, and that Cortisol levels would correlate
negatively with cognitive function.
9am Cortisol levels correlated significantly and negatively with right hippocampal
volumes, left temporal lobe volumes and right temporal lobe volumes. There was a
trend to a negative correlation between 9am Cortisol and left hippocampal volume
(Spearman's rho=-0.19, N=95, p=0.065). Post-dexamethasone Cortisol levels were
negatively and significantly correlated with right hippocampal volumes. There was
also a significant negative correlation between 2.30pm Cortisol levels and left
temporal lobe volumes. None of the frontal lobe volumes correlated significantly in
any direction with any of the Cortisol measures, though the correlation between the
left frontal lobe and 2.30pm Cortisol approached statistical significance.
To date there are two published studies which have addressed these hypotheses
(Lupien et al., 1998; Wolf et al., 2002), and both have had inadequate sample sizes.
The present study provides support for the hypothesis that elevated glucocorticoids
are negatively associated with hippocampal volumes and also suggest that
glucocorticoid levels might also be associated with relatively smaller temporal lobes.
A re-analysis of the above data using temporal lobe volumes with hippocampal
volumes subtracted made no differences to the pattern of correlations.
Of interest is the fact that hippocampal volumes and not temporal lobe volumes
appear to be more closely associated with post-dexamethasone Cortisol levels.
Although the sites in the brain which participate in feedback regulation of the HPA
axis have not been fully delineated, with, for example, the medial frontal cortex
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thought to play a role (Diorio et al., 1993), it is clear that the hippocampus plays an
important role in feedback inhibition of the HPA axis. However, the studies with
Cushing's syndrome show that elevated glucocorticoids probably cause widespread
atrophy, in keeping with the widespread distribution of glucocorticoid receptors in
the brain (Patel et al., 2000; Sanchez et al., 2000).
Because this is a cross-sectional study, it cannot be determined whether higher
Cortisol levels cause hippocampal atrophy and temporal lobe atrophy, or vice versa.
It is possible that other variables contribute to ageing-related variations in brain
volumes and Cortisol levels. However, given the known causal effects of high levels
of glucocorticoids on brain volumes in some animal studies it is plausible that the
two variables are linked.
There were no significant correlations between Cortisol levels and spectroscopy.
These data suggest that variations in Cortisol levels do not affect metabolite levels.
Alternatively, in this healthy and young-elderly group, any effects of Cortisol might
be small. Follow-up studies will help to establish whether variations in Cortisol levels
are predictive of changes in metabolites.
There were few significant correlations between Cortisol levels and cognitive
function. 9am Cortisol levels were significantly and negatively associated with the
unadjusted scores ofRaven's Standard Progressive Matrices and Logical Memory
24hr delayed, and when cognitive tests were adjusted for prior IQ, with the Digit-
Symbol Substitution Test and Logical Memory 24hr delayed. Because there were
several negative correlations between the cognitive tests and the Cortisol measures,
the cognitive factors were adjusted for prior IQ. To some extent this procedure
reduces the amount of variance in the cognitive factors which is attributable to
baseline general cognitive ability. This is of interest because the hypothesis is that
elevated Cortisol levels are associated with decrements in cognitive function with
ageing, not with prior or baseline cognitive ability. The adjusted general cognitive
factor and the adjusted fluid intelligence / visuospatial factor correlated significantly
and negatively with 9am Cortisol levels. Overall, these data are consistent with the
hypothesis that there is a weak negative association between Cortisol levels and
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cognitive function in healthy men aged 65-70. Previous studies of comparable size
have also shown relationships in the same direction and of similar effect size, though
on different tests (Seeman et al., 1997; Greendale et al., 2000).
Some methodological limitations must be noted. This is a cross-sectional study and
therefore the direction of causation, or any causation at all, cannot be inferred. The
subjects were all male. The subjects are all volunteers and this is therefore not a
population sample. Multiple analyses were carried out and this increases the risk of
Type I statistical error. However, the hypotheses were made explicit from the outset,
that is, these were planned analyses. Additionally, the relationships between Cortisol
levels and cognitive function were still statistically significant when principal
components analysis was used to derive latent traits for cognitive function.
In summary, these data suggest that Cortisol levels are negatively related to
hippocampal and temporal lobe volumes in healthy men aged 65-70. The data are
consistent with previous much smaller studies in humans, and with observational and
interventional studies in animals. There were no significant relationships between
metabolite levels and Cortisol levels. Cognitive function showed weak and mostly
statistically insignificant relationships in the predicted negative direction with 9am
Cortisol levels. Reducing the data with factor analysis and adjusting for prior IQ
yielded a weak but statistically significant correlation between the first unrotated
principal component, a variable accounting for half of the variance in the cognitive
tests, and 9am Cortisol levels. A similar significant correlation was found with the
adjusted visuospatial / fluid factor.
This study adds to the small body ofwork examining the hypothesis that elevated
glucocorticoid levels are negatively associated with the hippocampus and other brain
structures, and also have a negative relationship with cognitive function. Future work
will examine the impact of these variations in glucocorticoids on later changes in
brain volumes and declines in cognitive function with ageing.
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7.1 Introduction
Type II diabetes mellitus is an established risk factor for Alzheimer's disease (Ott et
al., 1999) and also milder cognitive decrements, specifically in verbal memory
(Strachan et al., 1997). Impaired glucose tolerance in people without diabetes may
also be associated with cognitive decline with age (Vanhanen et al., 1998). The
metabolic syndrome, of which impaired glucose homeostasis is a key component,
now has a prevalence of over 40% in people over 60 in the US (Ford et al., 2002).
Glycosylated haemoglobin (HbAlc) reflects the average blood glucose concentration
over a 6-8 week period and is used in diabetic patients to monitor blood glucose
control. However, in people without diabetes there is considerable variation in
HbAlc, which is predictive of other morbidity and mortality (Khaw et al., 2001). In
this study the hypothesis that higher levels ofHbAlc are associated with relatively
worse cognitive function in a group of healthy, unmedicated, non-diabetic elderly
males is tested.
7.2 Methods
Recruitment of subjects was described in Chapter 2. The cognitive testing battery
was also described in Chapter 2. A 9am morning specimen of blood was obtained for
estimation ofHbAlc and plasma glucose, along with the other blood tests as
described in Chapter 2.
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7.3 Results
111 subjects were included in the study. The mean HbAlc was 5.9% (SD 0.36; range
4.7-6.7) and the mean 9am plasma glucose was 5.1 mmol/1 (SD 0.53; range 4.1 -
6.7). All variables were normally distributed and all reported correlations are
Pearson's r. HbAlc correlated significantly with 9am plasma glucose (r=0.23;
p=0.01). HbAlc had significant negative correlations with scores on the Rey
Auditory-Verbal Learning Test (i=-0.24, p=0.01) and Logical Memory - 24 hr
delayed (r=-0.31, p=0.02). Correlations with the remaining cognitive tests were not
statistically significant, but were all in the same negative direction. Controlling for
National Adult Reading Test scores, in case premorbid ability contributed
substantially to the significant correlations, did not affect the pattern of the results.
9am plasma glucose did not correlate significantly with any of the cognitive tests.
Correlations are shown in Table 7.1.
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Table 7.1: Pearson correlations between cognitive tests, and
glycosylated haemoglobin and fasting plasma glucose
HbA1c Glucose
National Adult Reading Test -.13 -.04
Auditory-Verbal Learning Test -.24a 0.01
Logical Memory -.16 -.04
Logical Memory - 24 hr delayed -,31b -.07
Benton Visual Retention Test -.03 -.06
Visual Reproduction -.08 0.05
Verbal Fluency -.13 -.09
Digit-Symbol Substitution Test -.01 0.07
Raven's Standard Progressive Matrices -.16 -.08
ap=0.01, bp=0.018, 2-tailed.
Abbreviations: HbA1c: glycosylated haemoglobin (%); glucose: fasting plasma glucose (mmol/l)
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7.4 Discussion
These findings suggest that, even within the notional normal range, relatively higher
long-term blood glucose concentrations are negatively associated with two separate
tests of verbal memory in healthy elderly men without diabetes. In this population
HbAlc levels explained about 5-9% of the variance in verbal memory. About half
the variance in cognition in old age is explained by childhood cognitive ability
(Deary et al., 2000b) and so it is important to identify the determinants of the large
amount of change in cognition that takes place between childhood and old age. These
results extend the established association between Type II diabetes mellitus and
deficits in verbal memory, and add to the growing evidence that the components of
the metabolic syndrome act as risk factors for vascular and other disease along
continua, rather than beyond a particular level. Khaw and colleagues recently
reported that, in a large population sample of non-diabetic men, HbAlc levels are
continuously associated with all cause, cardiovascular, and ischaemic heart disease
mortality (Khaw et al., 2001). Similar data have recently been published for
cholesterol (Stamler et al., 2000) and blood pressure (Vasan et al., 2001).
There are several possible explanations for the present association. In the shorter
term this might reflect a pathogenic role ofminor fluctuations in glucose homeostasis
and/or its regulatory factors early in the process of ageing-related cognitive decline.
This could involve attenuated forms of the metabolic and vascular changes of
chronic hyperglycemia, or subtle glycosylation ofCNS proteins, which associates
with their dysfunction (Gispen and Biessels, 2000). These mechanisms may act over
several decades, as neurons are post-mitotic. Another possible explanation is that the
association is at least partially accounted for by a common causal antecedent such as
low birthweight. Low birthweight is associated with a higher risk of insulin
resistance later in life (Phillips et al., 1994) and has also been shown to be negatively
associated with cognitive function in 11 year-olds (Shenkin et al., 2001) and in adults
(Richards et al., 2001).
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Certain methodological limitations should be noted. The sample size was modest,
and the sample was non-random. The subjects were all male and relatively healthy
and therefore the full spectrum of ill-health was not represented; however the
experimental intention was to avoid possible disease or drug confounders. Multiple
cognitive tests were performed and the significant correlations could represent Type I
statistical error. However, it is persuasive that two different tests of verbal memory
were significantly and negatively correlated with HbAlc, and it is this cognitive
function that emerges from the literature as related to type 2 diabetes.
There is recent evidence that lifestyle measures can attentuate the tendency towards
impaired glucose tolerance and type II diabetes (Knowler et al., 2002). Prospective
studies will help to determine whether variations in glucose homeostasis are causally
associated with variations in cognitive function, and if so, whether measures to
correct impaired glucose homeostasis might impact on cognitive impairment in later
life.
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The studies in this thesis were aimed at understanding the links among three domains
of variables: cognitive function, glucocorticoids and other metabolic variables, and
brain structure and metabolite levels. The main hypothesis was that Cortisol levels are
negatively associated with both cognitive function and with hippocampal volumes in
111 healthy men aged 65 to 70, ofwhom 97 had usable neuroimaging data.
The study in Chapter 4 showed that, as in young adults, brain volumes are correlated
with cognitive function, and that this relationship is best accounted for by a
relationship between overall brain size and general cognitive ability rather than by
relationships between specific brain regions and specific cognitive abilities
(MacLullich et al., 2002). This is a potentially provocative finding, as the medical
literature tends to ignore the concept of general cognitive ability or g, and also has
tended not to examine the possibility that such general relationships exist.
Brain metabolite levels, as measured by magnetic resonance spectroscopy, also
showed relationships with some cognitive ability tests (Ferguson et al., 2002).
Specifically, choline / creatine and NAA / creatine ratios were positively correlated
with performance on verbal and visuospatial tests and adjusted creatine levels also
correlated negatively with performance on these tests. Because these metabolite
levels are not absolute, it cannot be determined which is or are responsible for these
correlations. However, the pattern of correlations and also the correlations with
adjusted creatine levels suggest that perhaps creatine levels are responsible for some
of the variance in cognitive ability. This is an interesting finding, as most
investigators make the assumption that of the metabolite levels measured, creatine
shows the least change in pathological conditions and in ageing and thus is used as
the denominator in metabolite ratios (Catani et al., 2001). However, a small number
of studies in the literature do suggest the possibility that creatine levels may change
with ageing (Pettegrew et al., 1990; Pettegrew et al., 1995), and studies with
spectroscopic techniques allowing for absolute quantification ofmetabolite levels
will help to address this issue.
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There are few studies which have examined relationships between cognitive function
and glucocorticoid variables in humans. Research combining measurements of
cognitive function, glucocorticoids and neuroimaging data is even more scarce, with
one small published study in healthy elderly individuals (Lupien et al., 1998), and
one in patients with Cushing's syndrome (Starkman et al., 1992). In the present
study, Cortisol levels showed some small, statistically significant negative
correlations with hippocampal and temporal lobe volumes. There was also a smaller
number of small, statistically significant negative correlations with cognitive
function, though these correlations were only with 9am Cortisol and only present
when premorbid or prior IQ was controlled for. However, the general cognitive
factor and the rotated visuospatial / fluid factor, adjusted for prior IQ, also showed
small but significant negative correlations with 9am Cortisol, suggesting that this may
be a true finding. These data are consistent with animal studies, which have tended to
show that there is an association between higher glucocorticoid levels and cognitive
decrements with ageing, though this is not a large effect, and the mechanisms
responsible for this association remain unclear (Seckl and Olsson, 1995; Yau et al.,
2002).
Diabetes mellitus is a risk factor for Alzheimer's disease (Ott et al., 1999) and for
milder cognitive decline (Strachan et al., 1997). Relative hyperglycaemia in the non-
diabetic range has been linked with cardiovascular mortality and morbidity (Khaw et
al., 2001). In this thesis glycosylated haemoglobin and fasting glucose were
correlated against cognitive function. Glycosylated haemoglobin correlated
significantly and negatively with performance on two different tests of declarative
memory; there were no significant correlations with fasting glucose. In the context of
the small effect size of hyperglycaemia on cognitive function (Strachan et al., 1997)
this is a small study, but these results are consistent with the hypothesis that relative
hyperglycaemia is associated with ageing-related cognitive decrements, though
causation cannot be inferred. At this stage, this study can be seen as a prompt for
larger-scale, longitudinal studies examining this association. Hyperglycaemia is of
particular interest as a risk factor because there is already evidence that lifestyle
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changes and treatment with widely-available drugs are effective in improving
glucose tolerance (Knowler et al., 2002).
There are certain methodological limitations applying to all of the studies in this
thesis which must be noted. All of the investigations are cross-sectional. This means
that it cannot be known whether any of the significant relationships are of recent
onset (that is, are related to ageing) or whether they are longstanding. The author and
collaborators plan to repeat the measurements made in this study in the near future
and in subsequent waves. The participants were not selected randomly and were all
healthy and male, therefore are not representative of the population. Although this is
a large study in comparison to most studies involving neuroimaging or
glucocorticoid measurements in humans, the correlations observed are relatively
small. Associations between neuroimaging and glucocorticoid variables and
cognitive function are not large and therefore this study is perhaps at the lower limit
of acceptable size.
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FutureWork
Cognitive ageing research has to date largely consisted of two broad domains:
measuring and characterising the variations in cognitive function with ageing, and
investigating the biological substrates of these variations. A third domain, which has
yet to develop in any substantial sense in human studies, is the investigation of
measures which prevent ageing-related decrements in cognitive function.
The measurement and characterisation of cognitive function in healthy adults at a
particular point in time, that is, baseline cognitive function, is well-established. There
are many reliable and valid tests available, and the underlying statistical structure of
individual differences in cognitive function is well understood (Carroll, 1993; Deary,
2001a). However, the characterisation of changes in cognitive function with ageing is
less clear. Certainly, there are mean declines in performance on many tests,
particularly those involving cognitive speed and the manipulation and storage of new
information. This phenomenon has been conceptualised in the work of Salthouse, in
whose theory a single latent trait termed 'processing speed' accounts for much of the
age-related variance in cognitive ability (Salthouse, 1985; Salthouse et al., 1996), and
Cattell (Cattell, 1963), who introduced the constructs of fluid intelligence and
crystallised intelligence.
However, much research in cognitive ageing, particularly that published in
medically-orientated journals, operates without reference to the empirical and
conceptual bases of psychometric psychology. This other main strand of cognitive
ageing research draws on the neuropsychological and cognitive psychology
traditions; essentially, this strand examines changes in various cognitive domains
without considering latent traits. It has tended to be focused on either changes in
cognitive functions thought to be dependent on the frontal lobes (West, 1996), or on
declarative memory (Jelicic et al., 1996). Many of the studies in this approach are
concerned with the prediction of dementia and/or examining relationships between
specific cognitive tests and specific brain regions (deLeon et al., 1997; Golomb et al.,
1993).
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This theoretical divide is curious, not least because there is little debate or even
awareness of its existence; each body of research seems to operate almost
independently of each other. An important consequence of this is that there are very
few studies using the latent trait approach in attempting to discover patterns of
cognitive decline predictive of dementia and to the author's knowledge there are no
published studies of neuroimaging and cognitive function in older populations which
have employed principal components analysis or factor analysis, other than the study
presented in Chapter 4 (MacLullich et al., 2002). Progress in cognitive ageing
research would be aided by at least the beginnings of a debate in the medical
literature about what might constitute the basics of a common conceptual and
methodological framework for cognitive ability at baseline and with ageing. There
are some recent documents which have started this process (Deary, 2001b; National
Research Council, 2000).
There are still several unresolved issues in terms of the measurement and
characterisation of cognitive function with ageing. Although many cognitive tests
show a mean decline and an increase in variance with ageing (Christensen et al.,
1999), it is not clear whether there are identifiable clusters of impairment affecting
one or more domains or whether there is a more-or-less continuous spectrum of
change. It can be hypothesised that there is a universal but varying amount of
relatively steady decline in cognitive functions which to some extent can be placed
under the general heading of 'fluid intelligence'. This is the typical finding in
psychometrically-orientated studies, which mainly study healthy people. There are
also one or more syndromes of often much more rapid and severe declines in
cognitive function, perhaps particularly in declarative memory, which may represent
the early part of a trajectory towards dementia. There is evidence to support this
hypothesis from prospective studies of cognitive function (Collie et al., 2001; Elias et
al., 2000), neuroimaging studies, which have shown that subjects who later develop
Alzheimer's disease dementia show much more rapid loss of brain volumes than
controls (Jobst et al., 1994; Fox et al., 1996), and pathological studies, which show
that there are large differences in pathological changes in patients with even early
Alzheimer's disease versus controls (Morris and Price, 2001). It is not known if there
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are intermediate levels of decline which also have functional significance; in the
medical literature there have been attempts to characterise possible intermediate
states using various terms and definitions, including age-associated memory
impairment, mild cognitive decline and so on, though the somewhat arbitrary nature
of these definitions has been criticised (Deary, 1995; Ritchie and Touchon, 2000).
Future studies in this field are only likely to be of use if they are longitudinal, large-
scale, population-based and use sensitive, reliable and valid cognitive tests.
Furthermore, an open empirical approach is required when trying to understand such
changes: it is conceivable that traditional ways of classifying individual differences
in cognitive function, for example, into domains such as executive function,
declarative memory, and so on, will turn out to be inappropriate.
Integration of detailed cognitive testing with detailed neuroimaging techniques is
also likely to yield much information about the patterns of brain ageing. For
example, the use of registration and digital subtraction of serially-collected brain
images, as developed by Fox and co-workers (Fox et al., 1996), in conjunction with
detailed cognitive testing, could help to answer the important question ofwhether
there is a syndrome of relatively specific decline in memory and atrophy ofmedial
temporal lobe structure. There are dozens of small studies which suggest this but, to
this author's knowledge, none which has the minimum required characteristics of
being population-based, longitudinal (with a starting age of under 60), having
detailed cognitive testing, adequate statistical power and using appropriate statistical
methods. Until such a study or studies are undertaken, attempts to classify variations
in cognitive ageing in relation to changes in the brain will remain speculative and of
minimal clinical benefit.
A large number ofputative influences on cognitive ageing have been studied, often
in the context of the prediction of the dementias. For example, the s4 allele of the
apolipoprotein E gene is associated with a higher risk ofAlzheimer's disease (Corder
et al., 1993) but also milder cognitive decline (Deary et al., 2002; MacLullich et al.,
1998). Other potentially important associations include common illnesses such as
hypertension (Waldstein, 1995), hyperlipidaemia (Fillit et al., 2002) and diabetes
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mellitus (Elias et al., 1997; Strachan et al., 1997; Ott et al., 1999). There is likely to
be another category ofprocesses which are less well understood, for example,
changes in the permeability of the blood-brain barrier with ageing (Blatt et al., 1997;
Hanyu et al., 2002). Initial efforts to understand such candidate processes will
usually involve small studies, but it is still important that standard sensitive and
reliable cognitive tests are used.
The findings from this thesis are relevant to important areas of cognitive ageing
research, including the use of statistical techniques which allow for the analysis of
latent traits, and the relationships of variations in cognitive abilities to structural
neuroimaging and magnetic resonance spectroscopy variables. In terms of
mechanisms, the findings are consistent with an association of elevated
glucocorticoids with decrements in cognitive function. Further research, including
further investigations of the cohort studied in this thesis, will help to establish
whether glucocorticoids are significantly associated with variations in cognitive
ageing and underlying changes in the brain.
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Appendices
Appendix 1: Neuroimaging protocols
Structural magnetic resonance imaging
Analysis of volumes was performed by Dr. Karen J. Ferguson.
Magnetic Resonance Imaging: Brain imaging was performed in an Elscint Prestige
MR scanner operating at 1.9T. Structural image acquisition followed a 3-view
localiser and consisted of a coronal Ti-weighted three-dimensional gradient echo
sequence covering the entire brain and skull (TE = 9.254, TR = 28.5, tip angle = 25°,
slice thickness = 1.5mm (no interslice gap), 18cm field of view, matrix = 180 x 180).
Image analysis:
Image analysis was carried out on Sun workstations using Analyze™ software
(Mayo Clinic, Rochester, MN). An intensity threshold separating the brain from the
meninges was imposed for semi-automated analysis.
Hippocampalformation: this was defined as subiculum, hippocampus proper and
dentate gyrus with the alveus and fimbria. The hippocampus was measured
bilaterally using manual tracing from the first slice in which it appeared until the full
extent of the crus fornicis appeared. In the posterior head of the hippocampus, an
arbitrary judgement of the boundary between the hippocampus and the amygdala was
made from the position of the temporal horn and the alveus or by comparing a slice
with subsequent slices in which the division was more obvious. A line was drawn at
the angle between the superior and medial surfaces of the parahippocampal gyrus to
separate the subiculum from the parahippocampal gyrus. Intra-rater error was 4±
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0.03% for left and 4± 0.04% for right mean hippocampal volumes; this was within
limits identified in previous studies.
Prefrontal lobe: measured from the slice in which the frontal pole could be
distinguished from the meninges. Measurements were made using automated
methods with manual tracing to separate the lobes through the inter-hemispheric
fissure. The last slice was that before the appearance of the genu of the corpus
callosum.
Temporal lobe: the anterior part of the temporal lobe was measured semi-
automatically. Subsequently, a line was drawn manually along the lateral fissure to
the Sylvian point and then diagonally to the superior-most point of the amygdalo-
hippocampal complex and along the superior boundary of this structure. The last
slice of the temporal lobe was the same as for the hippocampus.
Intracranial area (ICA) : this was measured in the midline sagittal slice of the sagittal
localiser by manually tracing round the inner table of the cranial vault, along the
superior surface of the floor of the frontal fossa and across the pituitary fossa to the
dorsum sella. Tracing continued down the posterior surface of the clivus and was
completed by a line joining the anterior and posterior rims of the foramen magnum.
Magnetic Resonance Spectroscopy
Analysis of spectra was performed by Dr. Karen J. Ferguson, Professor Joanna M.
Wardlaw and Dr. Ian Marshall.
All MR scanning was performed on an Elscint Prestige scanner operating at 1.9T
(Elscint, now GE Medical, Israel). Spectroscopy was carried out following structural
imaging. Placement of the volume of interest (VOI) for spectroscopy was carried out
using the structural images acquired for volumetric analysis in the coronal plane. The
VOI was a voxel (15mm x 15mm x 15mm) placed over the parietal lobe and
included mainly white matter with some grey, but avoided any contamination from
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non-cerebral tissue. Following shimming on the VOI, water-suppressed, PRESS-
localized 'H signals (TR/TE = 1500/145 ms) were acquired with 200 repetitions
("number of excitations"; NEX). Phase reference signals (8 NEX) were acquired
from the same VOIs without water suppression. The time domain signals sampled
the second half of the PRESS echo and consisted of 1024 complex data points
sampled at 1ms intervals.
Spectral quantification
Spectroscopic data were transferred to a network of Sun workstations (Sun
Microsystems, Mountain View, CA, USA). The water reference signals were used
for time domain correction of eddy current effects (Ordidge and Cresshull, 1986),
and the residual water signal removed by Hankel-Lanczos Singular Value
Decomposition (HLSVD) identification ofwater components (Van den Boogart et
al., 1994). Signals were then transformed to the frequency domain. Spectral peaks
areas corresponding to the metabolites choline, creatine and N-acetylaspartate
(NAA) were quantified in the frequency domain, fitting for frequencies, areas and
line widths with a Gaussian lineshape using in-house software (Marshall et al.,
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Appendix 2: Auditory-Verbal Learning Test word lists
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Appendix 3: Histograms of distributions of cognitive
tests
Figure A3.1: Histograms of raw scores from the cognitive tests
13 15 18 20 23 25 28 30 33 35 38 40 43 45 48 50
National Adult Reading Test
IS 20 25 30 35 40 45 50 55
Verbal Fluency
70 75 00 85
25 30 35 40 45 50 55 60 65 70 75
Digit-Symbol Substitution Test
35 40 45 50 55 60
Auditory-Verbal Learning Test trials 1 to 5
9 10 11 12 13 14 15
Auditory-Verbal Learning Test trial 7
|
S* 30
Benton Visual Retention Test
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Figure A3.1 (cont). Histograms of raw scores from the cognitive tests
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Appendix 4: Spearman correlations among Cortisol
levels
2.30pm Cortisol Post-dex Cortisol
9am Cortisol .26 (p=0.017, N=86) .22 (p=0.039, N=88)
2.30pm Cortisol .06 (p=0.061, N=84)
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Appendix 5: Glossary of technical terms
Crystallised intelligence: intelligence involving the ability to recall and use
previously learned information.
Direct Oblimin rotation: in factor analysis, a method of obtaining correlated
(oblique) factors in order to approximate simple structure.
Eigenvalue: Column sum of squared loadings for a factor; also referred to as the
latent root. It conceptually represents that amount of variance accounted for by a
factor.
Fluid intelligence: intelligence involving processing of novel information.
g: general intelligence.
Latent variable: a theoretical variable hypothesized to influence a number of
observed variables. This term is synonymous with Latent Trait.
Principal components analysis: a data reduction method used to identify patterns in
a data matrix. This method yields a smaller set of new orthogonal (non-correlated)
latent variables.
Shimming: a procedure carried out to optimise the homogeneity of the magnetic
field around the subject during magnetic resonance spectroscopy.
Volume of Interest (VOI): In magnetic resonance spectroscopy, the volume
selected for measurement.
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